QUERY,MATCH_SCORE,PRG_NUM,PRG_TXT,filtered,FORMATTED,G_finBERT_ntl_pos_neg,G_finBERT_maxSentiment,G_fineTuned_ntl_pos_neg,G_fineTuned_maxSentiment,G_twitter_ntl_pos_neg,G_twitter_maxSentiment
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",81.01,7,"Business Risk Factors Unresolved Staff Comments Properties Legal Proceedings Mine Safety Disclosures Information About Our Executive Officers Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities Not Applicable Management’s Discussion and Analysis of Financial Condition and Results of Operations Quantitative and Qualitative Disclosures About Market Risk Financial Statements and Supplementary Data Changes in and Disagreements with Accountants on Accounting and Financial Disclosure Controls and Procedures Other Information Disclosure Regarding Foreign Jurisdictions that Prevent Inspections Directors, Executive Officers and Corporate Governance Executive Compensation Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters Certain Relationships and Related Transactions, and Director Independence Principal Accountant Fees and Services Item 15. Item 16.","['Business Risk Factors Unresolved Staff Comments Properties Legal Proceedings Mine Safety Disclosures Information About Our Executive Officers Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities Not Applicable Management’s Discussion and Analysis of Financial Condition and Results of Operations Quantitative and Qualitative Disclosures About Market Risk Financial Statements and Supplementary Data Changes in and Disagreements with Accountants on Accounting and Financial Disclosure Controls and Procedures Other Information Disclosure Regarding Foreign Jurisdictions that Prevent Inspections Directors, Executive Officers and Corporate Governance Executive Compensation Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters Certain Relationships and Related Transactions, and Director Independence Principal Accountant Fees and Services Item 15.']","<b>Business Risk Factors Unresolved Staff Comments Properties Legal Proceedings Mine Safety Disclosures Information About Our Executive Officers Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities Not Applicable Management’s Discussion and Analysis of Financial Condition and Results of Operations Quantitative and Qualitative Disclosures About Market Risk Financial Statements and Supplementary Data Changes in and Disagreements with Accountants on Accounting and Financial Disclosure Controls and Procedures Other Information Disclosure Regarding Foreign Jurisdictions that Prevent Inspections Directors, Executive Officers and Corporate Governance Executive Compensation Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters Certain Relationships and Related Transactions, and Director Independence Principal Accountant Fees and Services Item 15.[r.1]</b> Item 16.","[5.71, 92.48, 1.81]",positive,"[99.99, 0.0, 0.01]",neutral,"[78.16, 3.13, 18.71]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",79.89,592,"The information required by this Item is incorporated by reference from the sections entitled Director Compensation, Compensation Discussion and Analysis, Compensation Committee Report, Compensation Tables and Information and Summary of Employment Agreements and Plans in the Proxy Statement for the Company’s 2022 annual meeting of shareholders (provided that the Compensation Committee Report shall not be deemed to be filed).","['The information required by this Item is incorporated by reference from the sections entitled Director Compensation, Compensation Discussion and Analysis, Compensation Committee Report, Compensation Tables and Information and Summary of Employment Agreements and Plans in the Proxy Statement for the Company’s 2022 annual meeting of shareholders (provided that the Compensation Committee Report shall not be deemed to be filed).']","<b>The information required by this Item is incorporated by reference from the sections entitled Director Compensation, Compensation Discussion and Analysis, Compensation Committee Report, Compensation Tables and Information and Summary of Employment Agreements and Plans in the Proxy Statement for the Company’s 2022 annual meeting of shareholders (provided that the Compensation Committee Report shall not be deemed to be filed).[r.1]</b>","[4.77, 93.34, 1.89]",positive,"[99.99, 0.0, 0.01]",neutral,"[80.22, 3.88, 15.9]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",79.64,75,"Danaher is committed to attracting, developing, engaging and retaining the best people from around the world to sustain and grow our science and technology leadership. As noted above, Consistently attracting and retaining exceptional talent is one of our three strategic priorities and The Best Team Wins is one of our five Core Values, reflecting the critical role our human capital plays in supporting our strategy. Our human capital strategy spans multiple, key dimensions, including the following Culture and Governance ◦ Our culture is rooted in DBS and in our Shared Purpose, Helping Realize Life’s Potential. At its core, DBS reflects a commitment to use process to continuously improve every aspect of our business. Our Shared Purpose gives meaning and direction to our continuous improvement. ◦ Danaher’s Board of Directors reviews the Company’s human capital strategy annually and at other times during the year in connection with significant initiatives and acquisitions, supported by the Compensation Committee’s oversight of our executive and equity compensation programs. At the management level, our Senior Vice President of Human Resources, who reports directly to our President and CEO, is responsible for the development and execution of the Company’s human capital strategy.","['Danaher’s Board of Directors reviews the Company’s human capital strategy annually and at other times during the year in connection with significant initiatives and acquisitions, supported by the Compensation Committee’s oversight of our executive and equity compensation programs.', 'At the management level, our Senior Vice President of Human Resources, who reports directly to our President and CEO, is responsible for the development and execution of the Company’s human capital strategy.', 'Our human capital strategy spans multiple, key dimensions, including the following Culture and Governance ◦', 'As noted above, Consistently attracting and retaining exceptional talent is one of our three strategic priorities and The Best Team Wins is one of our five Core Values, reflecting the critical role our human capital plays in supporting our strategy.']","Danaher is committed to attracting, developing, engaging and retaining the best people from around the world to sustain and grow our science and technology leadership. <b>As noted above, Consistently attracting and retaining exceptional talent is one of our three strategic priorities and The Best Team Wins is one of our five Core Values, reflecting the critical role our human capital plays in supporting our strategy.[r.4]</b> <b>Our human capital strategy spans multiple, key dimensions, including the following Culture and Governance ◦[r.3]</b> Our culture is rooted in DBS and in our Shared Purpose, Helping Realize Life’s Potential. At its core, DBS reflects a commitment to use process to continuously improve every aspect of our business. Our Shared Purpose gives meaning and direction to our continuous improvement. ◦ <b>Danaher’s Board of Directors reviews the Company’s human capital strategy annually and at other times during the year in connection with significant initiatives and acquisitions, supported by the Compensation Committee’s oversight of our executive and equity compensation programs.[r.1]</b> <b>At the management level, our Senior Vice President of Human Resources, who reports directly to our President and CEO, is responsible for the development and execution of the Company’s human capital strategy.[r.2]</b>","[0.99, 81.98, 17.03]",positive,"[99.81, 0.19, 0.01]",neutral,"[30.67, 68.88, 0.46]",positive
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",79.13,379,"As indicated in the accompanying Report of Management on Danaher Corporation’s Internal Control Over Financial Reporting, management’s assessment of and conclusion on the effectiveness of internal control over financial reporting did not include the internal controls of Aldevron, which is included in the 2021 consolidated financial statements of the Company and constituted 12% of total assets as of December 31, 2021 and less than 1% of the Company’s total revenue for the year then ended. Our audit of internal control over financial reporting of the Company also did not include an evaluation of the internal control over financial reporting of Aldevron.","['As indicated in the accompanying Report of Management on Danaher Corporation’s Internal Control Over Financial Reporting, management’s assessment of and conclusion on the effectiveness of internal control over financial reporting did not include the internal controls of Aldevron, which is included in the 2021 consolidated financial statements of the Company and constituted 12% of total assets as of December 31, 2021 and less than 1% of the Company’s total revenue for the year then ended.', 'Our audit of internal control over financial reporting of the Company also did not include an evaluation of the internal control over financial reporting of Aldevron.']","<b>As indicated in the accompanying Report of Management on Danaher Corporation’s Internal Control Over Financial Reporting, management’s assessment of and conclusion on the effectiveness of internal control over financial reporting did not include the internal controls of Aldevron, which is included in the 2021 consolidated financial statements of the Company and constituted 12% of total assets as of December 31, 2021 and less than 1% of the Company’s total revenue for the year then ended.[r.1]</b> <b>Our audit of internal control over financial reporting of the Company also did not include an evaluation of the internal control over financial reporting of Aldevron.[r.2]</b>","[5.72, 92.09, 2.19]",positive,"[99.98, 0.0, 0.01]",neutral,"[54.42, 3.46, 42.12]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",79.11,375,"The Company’s management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2021. In making this assessment, the Company’s management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal ControlIntegrated Framework (2013 framework). Based on this assessment, management concluded that, as of December 31, 2021, the Company’s internal control over financial reporting is effective.","['Based on this assessment, management concluded that, as of December 31, 2021, the Company’s internal control over financial reporting is effective.', 'The Company’s management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2021.', 'In making this assessment, the Company’s management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal ControlIntegrated Framework (2013 framework).']","<b>The Company’s management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2021.[r.2]</b> <b>In making this assessment, the Company’s management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal ControlIntegrated Framework (2013 framework).[r.3]</b> <b>Based on this assessment, management concluded that, as of December 31, 2021, the Company’s internal control over financial reporting is effective.[r.1]</b>","[1.31, 82.28, 16.41]",positive,"[99.93, 0.06, 0.01]",neutral,"[58.31, 41.14, 0.55]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",78.73,374,The management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting for the Company. Internal control over financial reporting is defined in Rules 13a15(f) and 15d15(f) promulgated under the Securities Exchange Act of 1934.,"['The management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting for the Company.', 'Internal control over financial reporting is defined in Rules 13a15(f) and 15d15(f) promulgated under the Securities Exchange Act of 1934.']",<b>The management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting for the Company.[r.1]</b> <b>Internal control over financial reporting is defined in Rules 13a15(f) and 15d15(f) promulgated under the Securities Exchange Act of 1934.[r.2]</b>,"[2.4, 94.89, 2.71]",positive,"[99.99, 0.0, 0.01]",neutral,"[88.14, 3.35, 8.51]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",78.65,384,"A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.","['A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.', 'A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.']","<b>A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.[r.2]</b> <b>A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.[r.1]</b>","[3.86, 93.35, 2.79]",positive,"[99.99, 0.01, 0.01]",neutral,"[86.26, 11.18, 2.56]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",78.54,378,"We have audited Danaher Corporation and subsidiaries’ internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Danaher Corporation and subsidiaries (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on the COSO criteria.","['We have audited Danaher Corporation and subsidiaries’ internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria).', 'In our opinion, Danaher Corporation and subsidiaries (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on the COSO criteria.']","<b>We have audited Danaher Corporation and subsidiaries’ internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria).[r.1]</b> <b>In our opinion, Danaher Corporation and subsidiaries (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on the COSO criteria.[r.2]</b>","[1.12, 85.78, 13.1]",positive,"[99.99, 0.01, 0.01]",neutral,"[70.27, 28.52, 1.21]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",78.46,405,"Accounting Principles—The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States (GAAP). The Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation. The Consolidated Financial Statements also reflect the impact of noncontrolling interests. Noncontrolling interests do not have a significant impact on the Company’s consolidated results of continuing operations, therefore earnings attributable to noncontrolling interests for continuing operations are not presented separately in the Company’s Consolidated Statements of Earnings. Earnings attributable to noncontrolling interests have been reflected in selling, general and administrative expenses and were insignificant in all periods presented. Reclassifications of certain prior year amounts have been made to conform to the current year presentation.","['The Consolidated Financial Statements include the accounts of the Company and its subsidiaries.', 'The Consolidated Financial Statements also reflect the impact of noncontrolling interests.', 'Accounting Principles—The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States (GAAP).']","<b>Accounting Principles—The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States (GAAP).[r.3]</b> <b>The Consolidated Financial Statements include the accounts of the Company and its subsidiaries.[r.1]</b> All intercompany balances and transactions have been eliminated upon consolidation. <b>The Consolidated Financial Statements also reflect the impact of noncontrolling interests.[r.2]</b> Noncontrolling interests do not have a significant impact on the Company’s consolidated results of continuing operations, therefore earnings attributable to noncontrolling interests for continuing operations are not presented separately in the Company’s Consolidated Statements of Earnings. Earnings attributable to noncontrolling interests have been reflected in selling, general and administrative expenses and were insignificant in all periods presented. Reclassifications of certain prior year amounts have been made to conform to the current year presentation.","[17.8, 80.04, 2.16]",positive,"[99.99, 0.0, 0.01]",neutral,"[69.04, 9.55, 21.41]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",78.36,385,"Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. /s/ Ernst & Young LLP Tysons, Virginia February 23, 2022 Report of Independent Registered Public Accounting Firm To the Stockholders and the Board of Directors of Danaher Corporation Opinion on the Financial Statements We have audited the accompanying consolidated balance sheets of Danaher Corporation and subsidiaries (the Company) as of December 31, 2021 and 2020, the related consolidated statements of earnings, comprehensive income, stockholders’ equity and cash flows for each of the three years in the period ended December 31, 2021, and the related notes and financial statement schedule listed in the Index at Item 15(a) (collectively referred to as the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2021, in conformity with U.S. generally accepted accounting principles.","['Ernst & Young LLP Tysons, Virginia February 23, 2022 Report of Independent Registered Public Accounting Firm To the Stockholders and the Board of Directors of Danaher Corporation Opinion on the Financial Statements We have audited the accompanying consolidated balance sheets of Danaher Corporation and subsidiaries (the Company) as of December 31, 2021 and 2020, the related consolidated statements of earnings, comprehensive income, stockholders’ equity and cash flows for each of the three years in the period ended December 31, 2021, and the related notes and financial statement schedule listed in the Index at Item 15(a) (collectively referred to as the consolidated financial statements).', 'In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2021, in conformity with U.S. generally accepted accounting principles.']","Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. /s/ <b>Ernst & Young LLP Tysons, Virginia February 23, 2022 Report of Independent Registered Public Accounting Firm To the Stockholders and the Board of Directors of Danaher Corporation Opinion on the Financial Statements We have audited the accompanying consolidated balance sheets of Danaher Corporation and subsidiaries (the Company) as of December 31, 2021 and 2020, the related consolidated statements of earnings, comprehensive income, stockholders’ equity and cash flows for each of the three years in the period ended December 31, 2021, and the related notes and financial statement schedule listed in the Index at Item 15(a) (collectively referred to as the consolidated financial statements).[r.1]</b> <b>In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2021, in conformity with U.S. generally accepted accounting principles.[r.2]</b>","[5.18, 90.98, 3.84]",positive,"[37.27, 0.07, 62.66]",negative,"[76.11, 6.0, 17.88]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",78.23,381,The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Report of Management on Danaher Corporation’s Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.,"['The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Report of Management on Danaher Corporation’s Internal Control Over Financial Reporting.', 'Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit.']",<b>The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Report of Management on Danaher Corporation’s Internal Control Over Financial Reporting.[r.1]</b> <b>Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit.[r.2]</b> We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.,"[2.28, 94.88, 2.85]",positive,"[99.99, 0.0, 0.01]",neutral,"[88.64, 6.08, 5.28]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",78.18,584,"Management’s annual report on its internal control over financial reporting (as such term is defined in Rules 13a15(f) and 15d15(f) under the Exchange Act) and the independent registered public accounting firm’s audit report on the effectiveness of Danaher’s internal control over financial reporting are included in the Company’s financial statements for the year ended December 31, 2021 included in Item 8 of this Annual Report on Form 10K, under the headings Report of Management on Danaher Corporation’s Internal Control Over Financial Reporting and Report of Independent Registered Public Accounting Firm, respectively, and are incorporated herein by reference.","['Management’s annual report on its internal control over financial reporting (as such term is defined in Rules 13a15(f) and 15d15(f) under the Exchange Act) and the independent registered public accounting firm’s audit report on the effectiveness of Danaher’s internal control over financial reporting are included in the Company’s financial statements for the year ended December 31, 2021 included in Item 8 of this Annual Report on Form 10K, under the headings Report of Management on Danaher Corporation’s Internal Control', 'Over Financial Reporting and Report of Independent Registered Public Accounting Firm, respectively, and are incorporated herein by reference.']","<b>Management’s annual report on its internal control over financial reporting (as such term is defined in Rules 13a15(f) and 15d15(f) under the Exchange Act) and the independent registered public accounting firm’s audit report on the effectiveness of Danaher’s internal control over financial reporting are included in the Company’s financial statements for the year ended December 31, 2021 included in Item 8 of this Annual Report on Form 10K, under the headings Report of Management on Danaher Corporation’s Internal Control[r.1]</b> <b>Over Financial Reporting and Report of Independent Registered Public Accounting Firm, respectively, and are incorporated herein by reference.[r.2]</b>","[2.49, 94.96, 2.55]",positive,"[99.99, 0.0, 0.01]",neutral,"[94.24, 3.6, 2.16]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",78.17,589,"Other than the information below, the information required by this Item is incorporated by reference from the sections entitled Proposal 1–Election of Directors of Danaher, Corporate Governance and Other Information in the Proxy Statement for the Company’s 2022 annual meeting of shareholders and from the information under the caption Information About Our Executive Officers in Part I hereof. No nominee for director was selected pursuant to any arrangement or understanding between the nominee and any person other than the Company pursuant to which such person is or was to be selected as a director or nominee.","['Other than the information below, the information required by this Item is incorporated by reference from the sections entitled Proposal 1–Election of Directors of Danaher, Corporate Governance and Other Information in the Proxy Statement for the Company’s 2022 annual meeting of shareholders and from the information under the caption Information About Our Executive Officers in Part I hereof.']","<b>Other than the information below, the information required by this Item is incorporated by reference from the sections entitled Proposal 1–Election of Directors of Danaher, Corporate Governance and Other Information in the Proxy Statement for the Company’s 2022 annual meeting of shareholders and from the information under the caption Information About Our Executive Officers in Part I hereof.[r.1]</b> No nominee for director was selected pursuant to any arrangement or understanding between the nominee and any person other than the Company pursuant to which such person is or was to be selected as a director or nominee.","[2.69, 95.23, 2.08]",positive,"[99.99, 0.0, 0.01]",neutral,"[89.79, 3.13, 7.08]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",77.82,355,"Management’s discussion and analysis of the Company’s financial condition and results of operations is based upon the Company’s Consolidated Financial Statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. The Company bases these estimates and judgments on historical experience, the current economic environment and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ materially from these estimates and judgments.","['Management’s discussion and analysis of the Company’s financial condition and results of operations is based upon the Company’s Consolidated Financial Statements, which have been prepared in accordance with accounting principles generally accepted in the United States.', 'The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities.']","<b>Management’s discussion and analysis of the Company’s financial condition and results of operations is based upon the Company’s Consolidated Financial Statements, which have been prepared in accordance with accounting principles generally accepted in the United States.[r.1]</b> <b>The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities.[r.2]</b> The Company bases these estimates and judgments on historical experience, the current economic environment and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ materially from these estimates and judgments.","[16.41, 80.79, 2.81]",positive,"[99.99, 0.01, 0.01]",neutral,"[88.07, 5.04, 6.89]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",77.61,594,The information required by this Item is incorporated by reference from the section entitled Director Independence and Related Person Transactions in the Proxy Statement for the Company’s 2022 annual meeting of shareholders.,['The information required by this Item is incorporated by reference from the section entitled Director Independence and Related Person Transactions in the Proxy Statement for the Company’s 2022 annual meeting of shareholders.'],<b>The information required by this Item is incorporated by reference from the section entitled Director Independence and Related Person Transactions in the Proxy Statement for the Company’s 2022 annual meeting of shareholders.[r.1]</b>,"[2.79, 95.17, 2.04]",positive,"[99.99, 0.0, 0.01]",neutral,"[93.71, 4.02, 2.27]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",77.53,303,"The amount of income taxes the Company pays is subject to ongoing audits by federal, state and nonU.S. tax authorities, which often result in proposed assessments. Management performs a comprehensive review of its global tax positions on a quarterly basis. Based on these reviews, which take into account the results of discussions and resolutions of matters with certain tax authorities and the other factors referenced in the prior paragraph, reserves for contingent tax liabilities are accrued or adjusted as necessary. For a discussion of risks related to these and other tax matters, refer to Item 1A. Risk Factors.",['Management performs a comprehensive review of its global tax positions on a quarterly basis.'],"The amount of income taxes the Company pays is subject to ongoing audits by federal, state and nonU.S. tax authorities, which often result in proposed assessments. <b>Management performs a comprehensive review of its global tax positions on a quarterly basis.[r.1]</b> Based on these reviews, which take into account the results of discussions and resolutions of matters with certain tax authorities and the other factors referenced in the prior paragraph, reserves for contingent tax liabilities are accrued or adjusted as necessary. For a discussion of risks related to these and other tax matters, refer to Item 1A. Risk Factors.","[2.55, 94.6, 2.86]",positive,"[99.99, 0.0, 0.01]",neutral,"[84.97, 3.61, 11.42]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",77.11,159,"Any inability to maintain reliable information technology systems and appropriate controls with respect to global data privacy and security requirements and prevent data breaches can result in adverse regulatory and business consequences and litigation. As a global organization, we are subject to data privacy and security laws, regulations, and customerimposed controls in numerous jurisdictions as a result of having access to and processing confidential, personal and/or sensitive data in the course of our business. Please see Item 1. Business—Regulatory Matters for additional information. For example, entities that are found to be in violation of HIPAA as the result of a breach of unsecured patient health information, a complaint about privacy practices or an audit by HHS, may be subject to significant civil, criminal and administrative fines and penalties and/or additional reporting and oversight obligations. Failure to comply with the requirements of GDPR and the applicable national data protection laws of the EU member states may result in fines of up to €20 million or up to 4% of total worldwide annual turnover for the preceding financial year, whichever is higher, and other administrative penalties. Several other countries such as China and Russia have passed, and other countries are considering passing, laws that require some or all personal data relating to their citizens to be maintained on local servers and impose additional data transfer restrictions. A broad California privacy law came into effect in January 2020 with some of the same features as the GDPR, which has already prompted other states to enact or consider enacting similar laws. Government enforcement actions can be costly and interrupt the regular operation of our business, and data breaches or violations of data privacy laws can result in civil and criminal, monetary and nonmonetary penalties and damage to customer, patient, business partner and employee relationships and to our reputation, any of which may adversely affect our business and financial statements. In addition, compliance with the varying data privacy regulations across the U.S. and around the world has required significant expenditures and may require additional expenditures, and may require further changes in our products or business models that increase competition or reduce revenue.",[],"Any inability to maintain reliable information technology systems and appropriate controls with respect to global data privacy and security requirements and prevent data breaches can result in adverse regulatory and business consequences and litigation. As a global organization, we are subject to data privacy and security laws, regulations, and customerimposed controls in numerous jurisdictions as a result of having access to and processing confidential, personal and/or sensitive data in the course of our business. Please see Item 1. Business—Regulatory Matters for additional information. For example, entities that are found to be in violation of HIPAA as the result of a breach of unsecured patient health information, a complaint about privacy practices or an audit by HHS, may be subject to significant civil, criminal and administrative fines and penalties and/or additional reporting and oversight obligations. Failure to comply with the requirements of GDPR and the applicable national data protection laws of the EU member states may result in fines of up to €20 million or up to 4% of total worldwide annual turnover for the preceding financial year, whichever is higher, and other administrative penalties. Several other countries such as China and Russia have passed, and other countries are considering passing, laws that require some or all personal data relating to their citizens to be maintained on local servers and impose additional data transfer restrictions. A broad California privacy law came into effect in January 2020 with some of the same features as the GDPR, which has already prompted other states to enact or consider enacting similar laws. Government enforcement actions can be costly and interrupt the regular operation of our business, and data breaches or violations of data privacy laws can result in civil and criminal, monetary and nonmonetary penalties and damage to customer, patient, business partner and employee relationships and to our reputation, any of which may adversely affect our business and financial statements. In addition, compliance with the varying data privacy regulations across the U.S. and around the world has required significant expenditures and may require additional expenditures, and may require further changes in our products or business models that increase competition or reduce revenue.","[86.49, 12.08, 1.43]",neutral,"[0.85, 0.09, 99.07]",negative,"[37.13, 2.13, 60.74]",negative
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",76.99,583,"The Company’s management, with the participation of the Company’s President and Chief Executive Officer, and Executive Vice President and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a15(e) and 15d15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)) as of the end of the period covered by this report. Based on such evaluation, the Company’s President and Chief Executive Officer, and Executive Vice President and Chief Financial Officer, have concluded that, as of the end of such period, the Company’s disclosure controls and procedures were effective.","['The Company’s management, with the participation of the Company’s President and Chief Executive Officer, and Executive Vice President and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a15(e) and 15d15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)) as of the end of the period covered by this report.', 'Based on such evaluation, the Company’s President and Chief Executive Officer, and Executive Vice President and Chief Financial Officer, have concluded that, as of the end of such period, the Company’s disclosure controls and procedures were effective.']","<b>The Company’s management, with the participation of the Company’s President and Chief Executive Officer, and Executive Vice President and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a15(e) and 15d15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)) as of the end of the period covered by this report.[r.1]</b> <b>Based on such evaluation, the Company’s President and Chief Executive Officer, and Executive Vice President and Chief Financial Officer, have concluded that, as of the end of such period, the Company’s disclosure controls and procedures were effective.[r.2]</b>","[2.08, 79.96, 17.97]",positive,"[2.27, 97.67, 0.06]",positive,"[84.17, 14.7, 1.12]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",76.96,386,"We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2021, based on criteria established in Internal ControlIntegrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated February 23, 2022 expressed an unqualified opinion thereon.","['We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2021, based on criteria established in Internal ControlIntegrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated February 23, 2022 expressed an unqualified opinion thereon.']","<b>We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2021, based on criteria established in Internal ControlIntegrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated February 23, 2022 expressed an unqualified opinion thereon.[r.1]</b>","[1.24, 91.1, 7.66]",positive,"[99.99, 0.0, 0.01]",neutral,"[76.08, 4.53, 19.39]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",76.58,326,"Management assesses the Company’s liquidity in terms of its ability to generate cash to fund its operating, investing and financing activities. The Company continues to generate substantial cash from operating activities and believes that its operating cash flow, cash on hand and other sources of liquidity will be sufficient to allow it to continue investing in existing businesses (including capital expenditures), consummating strategic acquisitions and investments, paying interest and servicing debt, paying dividends, funding restructuring activities and managing its capital structure on a shortterm and longterm basis.","['Management assesses the Company’s liquidity in terms of its ability to generate cash to fund its operating, investing and financing activities.', 'The Company continues to generate substantial cash from operating activities and believes that its operating cash flow, cash on hand and other sources of liquidity will be sufficient to allow it to continue investing in existing businesses (including capital expenditures), consummating strategic acquisitions and investments, paying interest and servicing debt, paying dividends, funding restructuring activities and managing its capital structure on a shortterm and longterm basis.']","<b>Management assesses the Company’s liquidity in terms of its ability to generate cash to fund its operating, investing and financing activities.[r.1]</b> <b>The Company continues to generate substantial cash from operating activities and believes that its operating cash flow, cash on hand and other sources of liquidity will be sufficient to allow it to continue investing in existing businesses (including capital expenditures), consummating strategic acquisitions and investments, paying interest and servicing debt, paying dividends, funding restructuring activities and managing its capital structure on a shortterm and longterm basis.[r.2]</b>","[0.88, 19.53, 79.59]",negative,"[0.75, 99.21, 0.04]",positive,"[37.63, 61.97, 0.41]",positive
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",76.57,593,"The information required by this Item is incorporated by reference from the sections entitled Beneficial Ownership of Danaher Common Stock by Directors, Officers and Principal Shareholders, Summary of Employment Agreements and Plans and Compensation Tables and Information in the Proxy Statement for the Company’s 2022 annual meeting of shareholders.","['The information required by this Item is incorporated by reference from the sections entitled Beneficial Ownership of Danaher Common Stock by Directors, Officers and Principal Shareholders, Summary of Employment Agreements and Plans and Compensation Tables and Information in the Proxy Statement for the Company’s 2022 annual meeting of shareholders.']","<b>The information required by this Item is incorporated by reference from the sections entitled Beneficial Ownership of Danaher Common Stock by Directors, Officers and Principal Shareholders, Summary of Employment Agreements and Plans and Compensation Tables and Information in the Proxy Statement for the Company’s 2022 annual meeting of shareholders.[r.1]</b>","[4.47, 93.45, 2.08]",positive,"[99.99, 0.0, 0.01]",neutral,"[93.59, 3.74, 2.67]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",76.4,79,"Performance Management. Performance for Growth (P4G), our annual performance management program, supports our high performance culture by seeking to ensure that highperforming associates are recognized and rewarded for their contributions. P4G guides associates and their managers in setting clear personal ◦ ◦ performance goals aligned to our strategic priorities. Annual reviews under the program assess performance against these formal, annual objectives and against our leadership anchors.","['P4G guides associates and their managers in setting clear personal ◦ ◦ performance goals aligned to our strategic priorities.', 'Performance for Growth (P4G), our annual performance management program, supports our high performance culture by seeking to ensure that highperforming associates are recognized and rewarded for their contributions.']","Performance Management. <b>Performance for Growth (P4G), our annual performance management program, supports our high performance culture by seeking to ensure that highperforming associates are recognized and rewarded for their contributions.[r.2]</b> <b>P4G guides associates and their managers in setting clear personal ◦ ◦ performance goals aligned to our strategic priorities.[r.1]</b> Annual reviews under the program assess performance against these formal, annual objectives and against our leadership anchors.","[1.23, 74.24, 24.53]",positive,"[99.87, 0.12, 0.01]",neutral,"[28.08, 71.46, 0.47]",positive
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",76.35,137,"In 2021 approximately 62% of our sales were derived from customers outside the U.S. In addition, many of our manufacturing operations, suppliers and employees are located outside the U.S. Since our growth strategy depends in part on our ability to further penetrate markets outside the U.S. and increase the localization of our products and services, we expect to continue to increase our sales and presence outside the U.S., particularly in the highgrowth markets. Our nonU.S. business (and particularly our business in highgrowth markets) is subject to risks that include public health crises and epidemics, such as COVID19 interruption in the transportation of materials to us and finished goods to our customers differences in terms of sale, including longer payment terms than are typical in the U.S. local product preferences or requirements changes in a country’s or region’s political, legal, social or economic conditions, such as the devaluation of particular currencies trade protection measures, tariffs, embargoes and import or export restrictions and requirements unexpected changes in laws or regulatory requirements, including changes in tax laws capital controls and limitations on ownership and on repatriation of earnings and cash the potential for nationalization of enterprises changes in local healthcare delivery, payment and reimbursement policies and programs complex data privacy and cybersecurity requirements limitations on legal rights and our ability to enforce such rights, including differing protection of intellectual property difficulty in staffing and managing widespread operations workforce instability and differing labor or employment regulations difficulties in implementing restructuring actions on a timely or comprehensive basis and greater uncertainty, risk, expense and delay in commercializing products in certain foreign jurisdictions, including with respect to product and other regulatory approvals.","['Our nonU.S. business (and particularly our business in highgrowth markets) is subject to risks that include public health crises and epidemics, such as COVID19 interruption in the transportation of materials to us and finished goods to our customers differences in terms of sale, including longer payment terms than are typical in the U.S. local product preferences or requirements changes in a country’s or region’s political, legal, social or economic conditions, such as the devaluation of particular currencies trade protection measures, tariffs, embargoes and import or export restrictions and requirements unexpected changes in laws or regulatory requirements, including changes in tax laws capital controls and limitations on ownership and on repatriation of earnings and cash the potential for nationalization of enterprises changes in local healthcare delivery, payment and reimbursement policies and programs complex data privacy and cybersecurity requirements limitations on legal rights and our ability to enforce such rights, including differing protection of intellectual property difficulty in staffing and managing widespread operations workforce instability and differing labor or employment regulations difficulties in implementing restructuring actions on a timely or comprehensive basis and greater uncertainty, risk, expense and delay in commercializing products in certain foreign jurisdictions, including with respect to product and other regulatory approvals.']","In 2021 approximately 62% of our sales were derived from customers outside the U.S. In addition, many of our manufacturing operations, suppliers and employees are located outside the U.S. Since our growth strategy depends in part on our ability to further penetrate markets outside the U.S. and increase the localization of our products and services, we expect to continue to increase our sales and presence outside the U.S., particularly in the highgrowth markets. <b>Our nonU.S. business (and particularly our business in highgrowth markets) is subject to risks that include public health crises and epidemics, such as COVID19 interruption in the transportation of materials to us and finished goods to our customers differences in terms of sale, including longer payment terms than are typical in the U.S. local product preferences or requirements changes in a country’s or region’s political, legal, social or economic conditions, such as the devaluation of particular currencies trade protection measures, tariffs, embargoes and import or export restrictions and requirements unexpected changes in laws or regulatory requirements, including changes in tax laws capital controls and limitations on ownership and on repatriation of earnings and cash the potential for nationalization of enterprises changes in local healthcare delivery, payment and reimbursement policies and programs complex data privacy and cybersecurity requirements limitations on legal rights and our ability to enforce such rights, including differing protection of intellectual property difficulty in staffing and managing widespread operations workforce instability and differing labor or employment regulations difficulties in implementing restructuring actions on a timely or comprehensive basis and greater uncertainty, risk, expense and delay in commercializing products in certain foreign jurisdictions, including with respect to product and other regulatory approvals.[r.1]</b>","[12.34, 78.32, 9.34]",positive,"[0.6, 99.33, 0.07]",positive,"[66.39, 11.94, 21.67]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",76.27,35,Danaher strives to create shareholder value primarily through three strategic priorities strengthening our competitive advantage through consistent application of DBS tools enhancing our portfolio in attractive science and technology markets through strategic capital allocation and consistently attracting and retaining exceptional talent.,['Danaher strives to create shareholder value primarily through three strategic priorities strengthening our competitive advantage through consistent application of DBS tools enhancing our portfolio in attractive science and technology markets through strategic capital allocation and consistently attracting and retaining exceptional talent.'],<b>Danaher strives to create shareholder value primarily through three strategic priorities strengthening our competitive advantage through consistent application of DBS tools enhancing our portfolio in attractive science and technology markets through strategic capital allocation and consistently attracting and retaining exceptional talent.[r.1]</b>,"[1.0, 5.98, 93.02]",negative,"[0.01, 99.97, 0.02]",positive,"[8.76, 91.06, 0.18]",positive
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",76.24,363,"Income Taxes—For a description of the Company’s income tax accounting policies, refer to Notes 1 and 7 to the Consolidated Financial Statements. The Company establishes valuation allowances for its deferred tax assets if it is more likely than not that some or all of the deferred tax asset will not be realized. This requires management to make judgments and estimates regarding (1) the timing and amount of the reversal of taxable temporary differences, (2) expected future taxable income, and (3) the impact of tax planning strategies. Future changes to tax rates would also impact the amounts of deferred tax assets and liabilities and could have an adverse impact on the Company’s financial statements.","['This requires management to make judgments and estimates regarding (1) the timing and amount of the reversal of taxable temporary differences, (2) expected future taxable income, and (3) the impact of tax planning strategies.']","Income Taxes—For a description of the Company’s income tax accounting policies, refer to Notes 1 and 7 to the Consolidated Financial Statements. The Company establishes valuation allowances for its deferred tax assets if it is more likely than not that some or all of the deferred tax asset will not be realized. <b>This requires management to make judgments and estimates regarding (1) the timing and amount of the reversal of taxable temporary differences, (2) expected future taxable income, and (3) the impact of tax planning strategies.[r.1]</b> Future changes to tax rates would also impact the amounts of deferred tax assets and liabilities and could have an adverse impact on the Company’s financial statements.","[38.92, 58.72, 2.36]",positive,"[99.96, 0.01, 0.03]",neutral,"[62.71, 4.39, 32.9]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",76.23,590,"Danaher has adopted a code of business conduct and ethics for directors, officers (including Danaher’s principal executive officer, principal financial officer and principal accounting officer) and employees, known as the Code of Conduct. The Code of Conduct is available in the Investors section of Danaher’s website at www.danaher.com.","['Danaher has adopted a code of business conduct and ethics for directors, officers (including Danaher’s principal executive officer, principal financial officer and principal accounting officer) and employees, known as the Code of Conduct.']","<b>Danaher has adopted a code of business conduct and ethics for directors, officers (including Danaher’s principal executive officer, principal financial officer and principal accounting officer) and employees, known as the Code of Conduct.[r.1]</b> The Code of Conduct is available in the Investors section of Danaher’s website at www.danaher.com.","[2.64, 94.68, 2.68]",positive,"[99.98, 0.01, 0.01]",neutral,"[87.11, 11.86, 1.04]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",76.21,271,"Core sales growth (and the related measure of core sales including Cytiva) should be considered in addition to, and not as a replacement for or superior to, sales, and may not be comparable to similarly titled measures reported by other companies. Management believes that reporting these nonGAAP financial measures provides useful information to investors by helping identify underlying growth trends in Danaher’s business and facilitating comparisons of Danaher’s revenue performance with its performance in prior and future periods and to Danaher’s peers. Management also uses these nonGAAP financial measures to measure the Company’s operating and financial performance, and uses core sales growth as one of the performance measures in the Company’s executive shortterm cash incentive program. The Company excludes the effect of currency translation from these measures because currency translation is not under management’s control, is subject to volatility and can obscure underlying business trends, and excludes the effect of acquisitions (other than Cytiva sales, in the case of core sales growth including Cytiva) and divestiturerelated items because the nature, size, timing and number of acquisitions and divestitures can vary dramatically from periodtoperiod and between the Company and its peers and can also obscure underlying business trends and make comparisons of longterm performance difficult.","['Management also uses these nonGAAP financial measures to measure the Company’s operating and financial performance, and uses core sales growth as one of the performance measures in the Company’s executive shortterm cash incentive program.', 'Management believes that reporting these nonGAAP financial measures provides useful information to investors by helping identify underlying growth trends in Danaher’s business and facilitating comparisons of Danaher’s revenue performance with its performance in prior and future periods and to Danaher’s peers.']","Core sales growth (and the related measure of core sales including Cytiva) should be considered in addition to, and not as a replacement for or superior to, sales, and may not be comparable to similarly titled measures reported by other companies. <b>Management believes that reporting these nonGAAP financial measures provides useful information to investors by helping identify underlying growth trends in Danaher’s business and facilitating comparisons of Danaher’s revenue performance with its performance in prior and future periods and to Danaher’s peers.[r.2]</b> <b>Management also uses these nonGAAP financial measures to measure the Company’s operating and financial performance, and uses core sales growth as one of the performance measures in the Company’s executive shortterm cash incentive program.[r.1]</b> The Company excludes the effect of currency translation from these measures because currency translation is not under management’s control, is subject to volatility and can obscure underlying business trends, and excludes the effect of acquisitions (other than Cytiva sales, in the case of core sales growth including Cytiva) and divestiturerelated items because the nature, size, timing and number of acquisitions and divestitures can vary dramatically from periodtoperiod and between the Company and its peers and can also obscure underlying business trends and make comparisons of longterm performance difficult.","[11.92, 84.49, 3.58]",positive,"[99.8, 0.18, 0.02]",neutral,"[68.9, 11.56, 19.54]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",76.18,106,"Data Privacy and Security Laws As a global organization, we are subject to data privacy and security laws, regulations, and customerimposed controls in numerous jurisdictions as a result of having access to and processing confidential, personal and/or sensitive data in the course of our business. For example, in the United States, HIPAA privacy and security rules require certain of our operations to maintain controls to protect the availability and confidentiality of patient health information, individual states regulate data breach and security requirements and multiple governmental bodies assert authority over aspects of the protection of personal privacy. In particular, the California Consumer Privacy Act (CCPA), which came into effect in January 2020 has some of the same features as the GDPR (discussed below), and has already prompted several other states to enact or consider enacting similar laws. The EU General Data Protection Regulation that became effective in May 2018 (GDPR) has imposed significantly stricter requirements in how we collect, transmit, process and retain personal data, including, among other things, in certain circumstances a requirement for almost immediate notice of data breaches to supervisory authorities with significant fines for noncompliance. Several other countries such as China and Russia have passed, and other countries are considering passing, laws that require personal data relating to their citizens to be maintained on local servers and impose additional data transfer restrictions. For a discussion of risks related to these laws, refer to Item 1A. Risk Factors.","['The EU General Data Protection Regulation that became effective in May 2018 (GDPR) has imposed significantly stricter requirements in how we collect, transmit, process and retain personal data, including, among other things, in certain circumstances a requirement for almost immediate notice of data breaches to supervisory authorities with significant fines for noncompliance.', 'In particular, the California Consumer Privacy Act (CCPA), which came into effect in January 2020 has some of the same features as the GDPR (discussed below), and has already prompted several other states to enact or consider enacting similar laws.']","Data Privacy and Security Laws As a global organization, we are subject to data privacy and security laws, regulations, and customerimposed controls in numerous jurisdictions as a result of having access to and processing confidential, personal and/or sensitive data in the course of our business. For example, in the United States, HIPAA privacy and security rules require certain of our operations to maintain controls to protect the availability and confidentiality of patient health information, individual states regulate data breach and security requirements and multiple governmental bodies assert authority over aspects of the protection of personal privacy. <b>In particular, the California Consumer Privacy Act (CCPA), which came into effect in January 2020 has some of the same features as the GDPR (discussed below), and has already prompted several other states to enact or consider enacting similar laws.[r.2]</b> <b>The EU General Data Protection Regulation that became effective in May 2018 (GDPR) has imposed significantly stricter requirements in how we collect, transmit, process and retain personal data, including, among other things, in certain circumstances a requirement for almost immediate notice of data breaches to supervisory authorities with significant fines for noncompliance.[r.1]</b> Several other countries such as China and Russia have passed, and other countries are considering passing, laws that require personal data relating to their citizens to be maintained on local servers and impose additional data transfer restrictions. For a discussion of risks related to these laws, refer to Item 1A. Risk Factors.","[6.62, 90.06, 3.32]",positive,"[99.97, 0.02, 0.01]",neutral,"[72.1, 5.76, 22.14]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",76.11,429,"Pension and Postretirement Benefit Plans—The Company measures its pension and postretirement plans’ assets and its obligations that determine the respective plan’s funded status as of the end of the Company’s fiscal year, and recognizes an asset for a plan’s overfunded status or a liability for a plan’s underfunded status in its balance sheet. Changes in the funded status of the plans are recognized in the year in which the changes occur and reported in comprehensive income (loss). Refer to Note 16 for additional information on the Company’s pension and postretirement plans including a discussion of the actuarial assumptions, the Company’s policy for recognizing the associated gains and losses and the method used to estimate service and interest cost components.","['Pension and Postretirement Benefit Plans—The Company measures its pension and postretirement plans’ assets and its obligations that determine the respective plan’s funded status as of the end of the Company’s fiscal year, and recognizes an asset for a plan’s overfunded status or a liability for a plan’s underfunded status in its balance sheet.', 'Refer to Note 16 for additional information on the Company’s pension and postretirement plans including a discussion of the actuarial assumptions, the Company’s policy for recognizing the associated gains and losses and the method used to estimate service and interest cost components.']","<b>Pension and Postretirement Benefit Plans—The Company measures its pension and postretirement plans’ assets and its obligations that determine the respective plan’s funded status as of the end of the Company’s fiscal year, and recognizes an asset for a plan’s overfunded status or a liability for a plan’s underfunded status in its balance sheet.[r.1]</b> Changes in the funded status of the plans are recognized in the year in which the changes occur and reported in comprehensive income (loss). <b>Refer to Note 16 for additional information on the Company’s pension and postretirement plans including a discussion of the actuarial assumptions, the Company’s policy for recognizing the associated gains and losses and the method used to estimate service and interest cost components.[r.2]</b>","[5.56, 92.24, 2.19]",positive,"[99.99, 0.0, 0.01]",neutral,"[83.27, 4.56, 12.18]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",76.05,380,"We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2021 and 2020, the related consolidated statements of earnings, comprehensive income, stockholders’ equity and cash flows for each of the three years in the period ended December 31, 2021, and the related notes and financial statement schedule listed in the Index at Item 15(a) and our report dated February 23, 2022 expressed an unqualified opinion thereon.","['We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2021 and 2020, the related consolidated statements of earnings, comprehensive income, stockholders’ equity and cash flows for each of the three years in the period ended December 31, 2021, and the related notes and financial statement schedule listed in the Index at Item 15(a) and our report dated February 23, 2022 expressed an unqualified opinion thereon.']","<b>We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2021 and 2020, the related consolidated statements of earnings, comprehensive income, stockholders’ equity and cash flows for each of the three years in the period ended December 31, 2021, and the related notes and financial statement schedule listed in the Index at Item 15(a) and our report dated February 23, 2022 expressed an unqualified opinion thereon.[r.1]</b>","[2.19, 94.44, 3.37]",positive,"[99.99, 0.0, 0.01]",neutral,"[83.37, 3.37, 13.26]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.99,537,"The U.S. pension plan’s goal is to maintain between 60% and 70% of its assets in equity portfolios, which are invested in individual equity securities or funds that are expected to mirror broad market returns for equity securities or in assets with characteristics similar to equity investments, such as venture capital funds and partnerships. Asset holdings are periodically rebalanced when equity holdings are outside this range. The balance of the U.S. plan asset portfolio is invested in bond funds, real estate funds, various absolute and real return funds and private equity funds. NonU.S. plan assets are invested in various insurance contracts, equity and debt securities as determined by the administrator of each plan. The value of the plan assets directly affects the funded status of the Company’s pension plans recorded in the Consolidated Financial Statements.","['The U.S. pension plan’s goal is to maintain between 60% and 70% of its assets in equity portfolios, which are invested in individual equity securities or funds that are expected to mirror broad market returns for equity securities or in assets with characteristics similar to equity investments, such as venture capital funds and partnerships.', 'NonU.S. plan assets are invested in various insurance contracts, equity and debt securities as determined by the administrator of each plan.', 'The balance of the U.S. plan asset portfolio is invested in bond funds, real estate funds, various absolute and real return funds and private equity funds.']","<b>The U.S. pension plan’s goal is to maintain between 60% and 70% of its assets in equity portfolios, which are invested in individual equity securities or funds that are expected to mirror broad market returns for equity securities or in assets with characteristics similar to equity investments, such as venture capital funds and partnerships.[r.1]</b> Asset holdings are periodically rebalanced when equity holdings are outside this range. <b>The balance of the U.S. plan asset portfolio is invested in bond funds, real estate funds, various absolute and real return funds and private equity funds.[r.3]</b> <b>NonU.S. plan assets are invested in various insurance contracts, equity and debt securities as determined by the administrator of each plan.[r.2]</b> The value of the plan assets directly affects the funded status of the Company’s pension plans recorded in the Consolidated Financial Statements.","[6.09, 91.89, 2.02]",positive,"[99.99, 0.0, 0.01]",neutral,"[92.08, 3.93, 3.99]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.95,529,"The Company has noncontributory defined benefit pension plans which cover certain of its U.S. employees. During 2012, all remaining benefit accruals under the U.S. plans ceased. Defined benefit plans from acquisitions subsequent to 2012 are ceased as soon as practical. The Company also has noncontributory defined benefit pension plans which cover certain of its nonU.S. employees, and under certain of these plans, benefit accruals continue. In general, the Company’s policy is to fund these plans based on considerations relating to legal requirements, underlying asset returns, the plan’s funded status, the anticipated tax deductibility of the contribution, local practices, market conditions, interest rates and other factors. In addition to providing pension benefits, the Company provides certain health care and life insurance benefits for some of its retired employees in the United States. Certain employees may become eligible for these benefits as they reach normal retirement age while working for the Company.","['The Company also has noncontributory defined benefit pension plans which cover certain of its nonU.S. employees, and under certain of these plans, benefit accruals continue.', 'In general, the Company’s policy is to fund these plans based on considerations relating to legal requirements, underlying asset returns, the plan’s funded status, the anticipated tax deductibility of the contribution, local practices, market conditions, interest rates and other factors.']","The Company has noncontributory defined benefit pension plans which cover certain of its U.S. employees. During 2012, all remaining benefit accruals under the U.S. plans ceased. Defined benefit plans from acquisitions subsequent to 2012 are ceased as soon as practical. <b>The Company also has noncontributory defined benefit pension plans which cover certain of its nonU.S. employees, and under certain of these plans, benefit accruals continue.[r.1]</b> <b>In general, the Company’s policy is to fund these plans based on considerations relating to legal requirements, underlying asset returns, the plan’s funded status, the anticipated tax deductibility of the contribution, local practices, market conditions, interest rates and other factors.[r.2]</b> In addition to providing pension benefits, the Company provides certain health care and life insurance benefits for some of its retired employees in the United States. Certain employees may become eligible for these benefits as they reach normal retirement age while working for the Company.","[2.54, 94.58, 2.88]",positive,"[99.98, 0.0, 0.01]",neutral,"[80.71, 6.71, 12.58]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.85,585,"There have been no changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a15(f) and 15d15(f) under the Exchange Act) that occurred during the Company’s most recent completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.","['There have been no changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a15(f) and 15d15(f) under the Exchange Act) that occurred during the Company’s most recent completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.']","<b>There have been no changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a15(f) and 15d15(f) under the Exchange Act) that occurred during the Company’s most recent completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.[r.1]</b>","[20.19, 77.1, 2.72]",positive,"[99.97, 0.01, 0.02]",neutral,"[74.29, 3.73, 21.99]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.83,5,"Part III incorporates certain information by reference from the Registrant’s proxy statement for its 2022 annual meeting of shareholders to be filed pursuant to Regulation 14A within 120 days after Registrant’s fiscal yearend. With the exception of the sections of the 2022 Proxy Statement specifically incorporated herein by reference, the 2022 Proxy Statement is not deemed to be filed as part of this Form 10K.",['Part III incorporates certain information by reference from the Registrant’s proxy statement for its 2022 annual meeting of shareholders to be filed pursuant to Regulation 14A within 120 days after Registrant’s fiscal yearend.'],"<b>Part III incorporates certain information by reference from the Registrant’s proxy statement for its 2022 annual meeting of shareholders to be filed pursuant to Regulation 14A within 120 days after Registrant’s fiscal yearend.[r.1]</b> With the exception of the sections of the 2022 Proxy Statement specifically incorporated herein by reference, the 2022 Proxy Statement is not deemed to be filed as part of this Form 10K.","[2.46, 95.47, 2.07]",positive,"[99.99, 0.0, 0.01]",neutral,"[77.16, 3.29, 19.55]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.76,202,"The U.S. Congress, government agencies in nonU.S. jurisdictions where we do business, and the Organisation for Economic Cooperation and Development (OECD) have focused on issues related to the taxation of multinational corporations. One example is in the area of base erosion and profit shifting, for which the OECD has released several components of its comprehensive plan that have been adopted and expanded by many taxing authorities to address perceived tax abuse and inconsistencies between tax jurisdictions. As a result, the tax laws in the U.S. and other countries in which we do business could change on a prospective or retroactive basis, and any such changes could adversely affect our business and financial statements.","['The U.S. Congress, government agencies in nonU.S. jurisdictions where we do business, and the Organisation for Economic Cooperation and Development (OECD) have focused on issues related to the taxation of multinational corporations.', 'One example is in the area of base erosion and profit shifting, for which the OECD has released several components of its comprehensive plan that have been adopted and expanded by many taxing authorities to address perceived tax abuse and inconsistencies between tax jurisdictions.']","<b>The U.S. Congress, government agencies in nonU.S. jurisdictions where we do business, and the Organisation for Economic Cooperation and Development (OECD) have focused on issues related to the taxation of multinational corporations.[r.1]</b> <b>One example is in the area of base erosion and profit shifting, for which the OECD has released several components of its comprehensive plan that have been adopted and expanded by many taxing authorities to address perceived tax abuse and inconsistencies between tax jurisdictions.[r.2]</b> As a result, the tax laws in the U.S. and other countries in which we do business could change on a prospective or retroactive basis, and any such changes could adversely affect our business and financial statements.","[33.21, 62.67, 4.12]",positive,"[96.98, 0.05, 2.97]",neutral,"[49.45, 4.96, 45.59]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.73,500,"Accounting standards define fair value based on an exit price model, establish a framework for measuring fair value where the Company’s assets and liabilities are required to be carried at fair value and provide for certain disclosures related to the valuation methods used within a valuation hierarchy as established within the accounting standards. This hierarchy prioritizes the inputs into three broad levels as follows. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, or other observable characteristics for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from, or corroborated by, observable market data through correlation. Level 3 inputs are unobservable inputs based on the Company’s assumptions. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety.","['Accounting standards define fair value based on an exit price model, establish a framework for measuring fair value where the Company’s assets and liabilities are required to be carried at fair value and provide for certain disclosures related to the valuation methods used within a valuation hierarchy as established within the accounting standards.', 'A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety.']","<b>Accounting standards define fair value based on an exit price model, establish a framework for measuring fair value where the Company’s assets and liabilities are required to be carried at fair value and provide for certain disclosures related to the valuation methods used within a valuation hierarchy as established within the accounting standards.[r.1]</b> This hierarchy prioritizes the inputs into three broad levels as follows. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, or other observable characteristics for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from, or corroborated by, observable market data through correlation. Level 3 inputs are unobservable inputs based on the Company’s assumptions. <b>A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety.[r.2]</b>","[4.33, 93.66, 2.01]",positive,"[99.99, 0.0, 0.01]",neutral,"[80.07, 5.55, 14.37]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.71,430,"Accounting Standards Recently Adopted—In October 2021, the Financial Accounting Standards Board (FASB) issued ASU No. 202108, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The ASU requires companies to apply the definition of a performance obligation under ASC 606 to recognize and measure contract assets and contract liabilities (i.e., deferred revenue) relating to contracts with customers acquired in a business combination. Prior to the adoption of this ASU, an acquirer generally recognized assets acquired and liabilities assumed in a business combination, including contract assets and contract liabilities arising from revenue contracts with customers, at fair value on the acquisition date. The ASU results in the acquirer recording acquired contract assets and liabilities on the same basis that would have been recorded by the acquiree before the acquisition under ASC 606. The ASU is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. The Company early adopted the ASU effective January 1, 2021 and did not apply the standard to immaterial transactions that occurred in 2021. The impact of the adoption of the ASU was not significant.","['Accounting Standards Recently Adopted—In October 2021, the Financial Accounting Standards Board (FASB) issued ASU No. 202108, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.', 'Prior to the adoption of this ASU, an acquirer generally recognized assets acquired and liabilities assumed in a business combination, including contract assets and contract liabilities arising from revenue contracts with customers, at fair value on the acquisition date.']","<b>Accounting Standards Recently Adopted—In October 2021, the Financial Accounting Standards Board (FASB) issued ASU No. 202108, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.[r.1]</b> The ASU requires companies to apply the definition of a performance obligation under ASC 606 to recognize and measure contract assets and contract liabilities (i.e., deferred revenue) relating to contracts with customers acquired in a business combination. <b>Prior to the adoption of this ASU, an acquirer generally recognized assets acquired and liabilities assumed in a business combination, including contract assets and contract liabilities arising from revenue contracts with customers, at fair value on the acquisition date.[r.2]</b> The ASU results in the acquirer recording acquired contract assets and liabilities on the same basis that would have been recorded by the acquiree before the acquisition under ASC 606. The ASU is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. The Company early adopted the ASU effective January 1, 2021 and did not apply the standard to immaterial transactions that occurred in 2021. The impact of the adoption of the ASU was not significant.","[3.2, 94.18, 2.62]",positive,"[99.99, 0.0, 0.01]",neutral,"[71.5, 7.35, 21.16]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.63,122,"While the pandemic continues we may experience continued adverse impacts on certain elements of our business and financial statements. Even to the extent COVID19 conditions begin to improve, the duration and sustainability of any such improvements will be uncertain and continuing adverse impacts and/or the degree of improvement may vary dramatically by geography and line of business. The actions Danaher’s businesses take in response to any improvements in conditions may vary widely by geography and line of business and will likely be made with incomplete information pose the risk that such actions may prove to be premature, incorrect or insufficient and could have an adverse impact on our business and financial statements.",[],"While the pandemic continues we may experience continued adverse impacts on certain elements of our business and financial statements. Even to the extent COVID19 conditions begin to improve, the duration and sustainability of any such improvements will be uncertain and continuing adverse impacts and/or the degree of improvement may vary dramatically by geography and line of business. The actions Danaher’s businesses take in response to any improvements in conditions may vary widely by geography and line of business and will likely be made with incomplete information pose the risk that such actions may prove to be premature, incorrect or insufficient and could have an adverse impact on our business and financial statements.","[78.88, 19.25, 1.87]",neutral,"[1.82, 0.1, 98.07]",negative,"[40.69, 3.21, 56.1]",negative
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.54,395,"Auditing the Company's accounting for its acquisition of Aldevron was complex due to the estimation uncertainty in determining the fair value of intangible assets other than goodwill. The estimation uncertainty was primarily due to the sensitivity of the respective assets’ fair value to underlying assumptions about the future performance of Aldevron and other related valuation assumptions. The significant assumptions used to estimate the value of these assets included discount rates and certain assumptions that form the basis of the forecasted results of the acquired business including earnings before interest, taxes, depreciation and amortization (EBITDA), revenue, revenue growth rates, royalty rates and technology obsolescence rates. These assumptions are forward looking and could be affected by future economic and market conditions.","[""Auditing the Company's accounting for its acquisition of Aldevron was complex due to the estimation uncertainty in determining the fair value of intangible assets other than goodwill.""]","<b>Auditing the Company's accounting for its acquisition of Aldevron was complex due to the estimation uncertainty in determining the fair value of intangible assets other than goodwill.[r.1]</b> The estimation uncertainty was primarily due to the sensitivity of the respective assets’ fair value to underlying assumptions about the future performance of Aldevron and other related valuation assumptions. The significant assumptions used to estimate the value of these assets included discount rates and certain assumptions that form the basis of the forecasted results of the acquired business including earnings before interest, taxes, depreciation and amortization (EBITDA), revenue, revenue growth rates, royalty rates and technology obsolescence rates. These assumptions are forward looking and could be affected by future economic and market conditions.","[21.13, 75.79, 3.09]",positive,"[99.22, 0.01, 0.77]",neutral,"[59.69, 5.09, 35.22]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.42,417,"Revenue Recognition—The Company derives revenues primarily from the sale of Life Sciences, Diagnostics and Environmental & Applied Solutions products and services. Revenue is recognized when control of the promised products or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products or services (the transaction price). A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers. For equipment and consumables sold by the Company, control transfers to the customer at a point in time. To indicate the transfer of control, the Company must have a present right to payment, legal title must have passed to the customer, the customer must have the significant risks and rewards of ownership, and where acceptance is not a formality, the customer must have accepted the product or service. The Company’s principal terms of sale are FOB Shipping Point, or equivalent, and, as such, the Company primarily transfers control and records revenue for product sales upon shipment. Sales arrangements with delivery terms that are not FOB Shipping Point are not recognized upon shipment and the transfer of control for revenue recognition is evaluated based on the associated shipping terms and customer obligations. If a performance obligation to the customer with respect to a sales transaction remains to be fulfilled following shipment (typically installation or acceptance by the customer), revenue recognition for that performance obligation is deferred until such commitments have been fulfilled. Returns for products sold are estimated and recorded as a reduction of revenue at the time of sale. Customer allowances and rebates, consisting primarily of volume discounts and other shortterm incentive programs, are recorded as a reduction of revenue at the time of sale because these allowances reflect a reduction in the transaction price. Product returns, customer allowances and rebates are estimated based on historical experience and known trends. For extended warranty and service, control transfers to the customer over the term of the arrangement. Revenue for extended warranty and service is recognized based upon the period of time elapsed under the arrangement. Revenue for other longterm contracts is generally recognized based upon the costtocost measure of progress, provided that the Company meets the criteria associated with transferring control of the good or service over time.","['To indicate the transfer of control, the Company must have a present right to payment, legal title must have passed to the customer, the customer must have the significant risks and rewards of ownership, and where acceptance is not a formality, the customer must have accepted the product or service.']","Revenue Recognition—The Company derives revenues primarily from the sale of Life Sciences, Diagnostics and Environmental & Applied Solutions products and services. Revenue is recognized when control of the promised products or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products or services (the transaction price). A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers. For equipment and consumables sold by the Company, control transfers to the customer at a point in time. <b>To indicate the transfer of control, the Company must have a present right to payment, legal title must have passed to the customer, the customer must have the significant risks and rewards of ownership, and where acceptance is not a formality, the customer must have accepted the product or service.[r.1]</b> The Company’s principal terms of sale are FOB Shipping Point, or equivalent, and, as such, the Company primarily transfers control and records revenue for product sales upon shipment. Sales arrangements with delivery terms that are not FOB Shipping Point are not recognized upon shipment and the transfer of control for revenue recognition is evaluated based on the associated shipping terms and customer obligations. If a performance obligation to the customer with respect to a sales transaction remains to be fulfilled following shipment (typically installation or acceptance by the customer), revenue recognition for that performance obligation is deferred until such commitments have been fulfilled. Returns for products sold are estimated and recorded as a reduction of revenue at the time of sale. Customer allowances and rebates, consisting primarily of volume discounts and other shortterm incentive programs, are recorded as a reduction of revenue at the time of sale because these allowances reflect a reduction in the transaction price. Product returns, customer allowances and rebates are estimated based on historical experience and known trends. For extended warranty and service, control transfers to the customer over the term of the arrangement. Revenue for extended warranty and service is recognized based upon the period of time elapsed under the arrangement. Revenue for other longterm contracts is generally recognized based upon the costtocost measure of progress, provided that the Company meets the criteria associated with transferring control of the good or service over time.","[14.73, 82.1, 3.17]",positive,"[99.99, 0.01, 0.01]",neutral,"[78.48, 6.84, 14.68]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.42,428,"Accounting for StockBased Compensation—The Company accounts for stockbased compensation by measuring the cost of employee services received in exchange for all equity awards granted, including stock options, restricted stock units (RSUs) and performance stock units (PSUs), based on the fair value of the award as of the grant date. Equitybased compensation expense is recognized net of an estimated forfeiture rate on a straightline basis over the requisite service period of the award, except that in the case of RSUs, compensation expense is recognized using an accelerated attribution method. Refer to Note 19 for additional information on the stockbased compensation plans in which certain employees of the Company participate.","['Accounting for StockBased Compensation—The Company accounts for stockbased compensation by measuring the cost of employee services received in exchange for all equity awards granted, including stock options, restricted stock units (RSUs) and performance stock units (PSUs), based on the fair value of the award as of the grant date.', 'Equitybased compensation expense is recognized net of an estimated forfeiture rate on a straightline basis over the requisite service period of the award, except that in the case of RSUs, compensation expense is recognized using an accelerated attribution method.']","<b>Accounting for StockBased Compensation—The Company accounts for stockbased compensation by measuring the cost of employee services received in exchange for all equity awards granted, including stock options, restricted stock units (RSUs) and performance stock units (PSUs), based on the fair value of the award as of the grant date.[r.1]</b> <b>Equitybased compensation expense is recognized net of an estimated forfeiture rate on a straightline basis over the requisite service period of the award, except that in the case of RSUs, compensation expense is recognized using an accelerated attribution method.[r.2]</b> Refer to Note 19 for additional information on the stockbased compensation plans in which certain employees of the Company participate.","[3.26, 94.49, 2.25]",positive,"[99.99, 0.0, 0.01]",neutral,"[87.08, 8.14, 4.78]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.42,210,"We cannot provide assurance that our internal controls and compliance systems, including our Code of Conduct, always protect us from acts committed by employees, agents or business partners of ours (or of businesses we acquire or partner with) that violate laws, including the laws governing payments to government officials, bribery, fraud, kickbacks and false claims, pricing, sales and marketing practices, conflicts of interest, competition, employment practices and workplace behavior, export and import compliance, economic and trade sanctions, money laundering and data privacy. In particular, the U.S. Foreign Corrupt Practices Act, the UK Bribery Act and similar antibribery laws in other jurisdictions generally prohibit companies and their intermediaries from making improper payments to government officials for the purpose of obtaining or retaining business, and we operate in many parts of the world that have experienced governmental corruption to some degree. Any such improper actions or allegations of such acts could damage our reputation and subject us to civil or criminal investigations and related shareholder lawsuits, could lead to substantial civil and criminal, monetary and nonmonetary penalties and could cause us to incur significant legal and investigatory fees. In addition, the government may seek to hold us liable for violations committed by companies in which we invest or that we acquire. We also rely on our suppliers to adhere to our Supplier Code of Conduct, and violations of such code of conduct could adversely affect our business and financial statements.","['We cannot provide assurance that our internal controls and compliance systems, including our Code of Conduct, always protect us from acts committed by employees, agents or business partners of ours (or of businesses we acquire or partner with) that violate laws, including the laws governing payments to government officials, bribery, fraud, kickbacks and false claims, pricing, sales and marketing practices, conflicts of interest, competition, employment practices and workplace behavior, export and import compliance, economic and trade sanctions, money laundering and data privacy.']","<b>We cannot provide assurance that our internal controls and compliance systems, including our Code of Conduct, always protect us from acts committed by employees, agents or business partners of ours (or of businesses we acquire or partner with) that violate laws, including the laws governing payments to government officials, bribery, fraud, kickbacks and false claims, pricing, sales and marketing practices, conflicts of interest, competition, employment practices and workplace behavior, export and import compliance, economic and trade sanctions, money laundering and data privacy.[r.1]</b> In particular, the U.S. Foreign Corrupt Practices Act, the UK Bribery Act and similar antibribery laws in other jurisdictions generally prohibit companies and their intermediaries from making improper payments to government officials for the purpose of obtaining or retaining business, and we operate in many parts of the world that have experienced governmental corruption to some degree. Any such improper actions or allegations of such acts could damage our reputation and subject us to civil or criminal investigations and related shareholder lawsuits, could lead to substantial civil and criminal, monetary and nonmonetary penalties and could cause us to incur significant legal and investigatory fees. In addition, the government may seek to hold us liable for violations committed by companies in which we invest or that we acquire. We also rely on our suppliers to adhere to our Supplier Code of Conduct, and violations of such code of conduct could adversely affect our business and financial statements.","[56.08, 41.74, 2.18]",neutral,"[20.97, 0.12, 78.91]",negative,"[23.0, 0.88, 76.13]",negative
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.39,175,"We have implemented significant restructuring activities across our businesses to adjust our cost structure, and we may engage in similar restructuring activities in the future. These restructuring activities and our regular ongoing cost reduction activities (including in connection with the integration of acquired businesses) reduce our available talent, assets and other resources and can slow improvements in our products and services, adversely affect our ability to respond to customers, limit our ability to increase production quickly if demand for our products increases and trigger adverse public attention. In addition, delays or failures in implementing planned restructuring activities or other productivity improvements, unexpected costs or failure to meet targeted improvements on the anticipated timeline or at all may diminish the expected operational or financial benefits from such actions. Any of the circumstances described above could adversely impact our business and financial statements.","['These restructuring activities and our regular ongoing cost reduction activities (including in connection with the integration of acquired businesses) reduce our available talent, assets and other resources and can slow improvements in our products and services, adversely affect our ability to respond to customers, limit our ability to increase production quickly if demand for our products increases and trigger adverse public attention.', 'We have implemented significant restructuring activities across our businesses to adjust our cost structure, and we may engage in similar restructuring activities in the future.', 'In addition, delays or failures in implementing planned restructuring activities or other productivity improvements, unexpected costs or failure to meet targeted improvements on the anticipated timeline or at all may diminish the expected operational or financial benefits from such actions.']","<b>We have implemented significant restructuring activities across our businesses to adjust our cost structure, and we may engage in similar restructuring activities in the future.[r.2]</b> <b>These restructuring activities and our regular ongoing cost reduction activities (including in connection with the integration of acquired businesses) reduce our available talent, assets and other resources and can slow improvements in our products and services, adversely affect our ability to respond to customers, limit our ability to increase production quickly if demand for our products increases and trigger adverse public attention.[r.1]</b> <b>In addition, delays or failures in implementing planned restructuring activities or other productivity improvements, unexpected costs or failure to meet targeted improvements on the anticipated timeline or at all may diminish the expected operational or financial benefits from such actions.[r.3]</b> Any of the circumstances described above could adversely impact our business and financial statements.","[94.52, 4.45, 1.02]",neutral,"[0.11, 0.07, 99.82]",negative,"[33.43, 3.34, 63.23]",negative
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.38,416,"Goodwill and Other Intangible Assets—Goodwill and other intangible assets result from the Company’s acquisition of existing businesses. In accordance with accounting standards related to business combinations, goodwill is not amortized however, certain finitelived identifiable intangible assets, primarily customer relationships and acquired technology, are amortized over their estimated useful lives. Intangible assets with indefinite lives are not amortized. Inprocess research and development (IPR&D) is initially capitalized at fair value and when the IPR&D project is complete, the asset is considered a finitelived intangible asset and amortized over its estimated useful life. If an IPR&D project is abandoned, an impairment loss equal to the value of the intangible asset is recorded in the period of abandonment. The Company reviews identified intangible assets and goodwill for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. The Company also tests intangible assets with indefinite lives and goodwill for impairment at least annually. Refer to Notes 2 and 11 for additional information about the Company’s goodwill and other intangible assets.","['Inprocess research and development (IPR&D) is initially capitalized at fair value and when the IPR&D project is complete, the asset is considered a finitelived intangible asset and amortized over its estimated useful life.']","Goodwill and Other Intangible Assets—Goodwill and other intangible assets result from the Company’s acquisition of existing businesses. In accordance with accounting standards related to business combinations, goodwill is not amortized however, certain finitelived identifiable intangible assets, primarily customer relationships and acquired technology, are amortized over their estimated useful lives. Intangible assets with indefinite lives are not amortized. <b>Inprocess research and development (IPR&D) is initially capitalized at fair value and when the IPR&D project is complete, the asset is considered a finitelived intangible asset and amortized over its estimated useful life.[r.1]</b> If an IPR&D project is abandoned, an impairment loss equal to the value of the intangible asset is recorded in the period of abandonment. The Company reviews identified intangible assets and goodwill for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. The Company also tests intangible assets with indefinite lives and goodwill for impairment at least annually. Refer to Notes 2 and 11 for additional information about the Company’s goodwill and other intangible assets.","[6.67, 91.48, 1.86]",positive,"[99.98, 0.0, 0.01]",neutral,"[52.98, 5.33, 41.69]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.37,387,These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.,['These financial statements are the responsibility of the Company’s management.'],<b>These financial statements are the responsibility of the Company’s management.[r.1]</b> Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.,"[2.73, 94.91, 2.37]",positive,"[99.99, 0.0, 0.01]",neutral,"[88.46, 5.48, 6.06]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.34,376,"The Company completed the acquisition of Aldevron on August 30, 2021. Since the Company has not yet fully incorporated the internal controls and procedures of Aldevron into the Company’s internal control over financial reporting, management excluded Aldevron from its assessment of the effectiveness of the Company’s internal control over financial reporting as of December 31, 2021. Aldevron constituted 12% of the Company’s total assets as of December 31, 2021 and less than 1% of the Company’s total revenues for the year then ended.","['Since the Company has not yet fully incorporated the internal controls and procedures of Aldevron into the Company’s internal control over financial reporting, management excluded Aldevron from its assessment of the effectiveness of the Company’s internal control over financial reporting as of December 31, 2021.']","The Company completed the acquisition of Aldevron on August 30, 2021. <b>Since the Company has not yet fully incorporated the internal controls and procedures of Aldevron into the Company’s internal control over financial reporting, management excluded Aldevron from its assessment of the effectiveness of the Company’s internal control over financial reporting as of December 31, 2021.[r.1]</b> Aldevron constituted 12% of the Company’s total assets as of December 31, 2021 and less than 1% of the Company’s total revenues for the year then ended.","[63.43, 34.4, 2.17]",neutral,"[99.98, 0.0, 0.01]",neutral,"[70.68, 5.46, 23.87]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.34,569,"In connection with the Envista Disposition, Envista adopted a stockbased compensation plan, which provided for stockbased awards denominated in shares of Envista common stock. Envista employees who participated in the Danaher stock compensation program prior to the Separation continued to participate in such program solely with respect to outstanding compensation awards received prior to the Separation, until the SplitOff (at which time such awards were terminated and replaced with awards denominated in Envista common stock under the Envista stock compensation plan). Stockbased compensation expense for Envista is included in results from discontinued operations.","['In connection with the Envista Disposition, Envista adopted a stockbased compensation plan, which provided for stockbased awards denominated in shares of Envista common stock.', 'Envista employees who participated in the Danaher stock compensation program prior to the Separation continued to participate in such program solely with respect to outstanding compensation awards received prior to the Separation, until the SplitOff (at which time such awards were terminated and replaced with awards denominated in Envista common stock under the Envista stock compensation plan).']","<b>In connection with the Envista Disposition, Envista adopted a stockbased compensation plan, which provided for stockbased awards denominated in shares of Envista common stock.[r.1]</b> <b>Envista employees who participated in the Danaher stock compensation program prior to the Separation continued to participate in such program solely with respect to outstanding compensation awards received prior to the Separation, until the SplitOff (at which time such awards were terminated and replaced with awards denominated in Envista common stock under the Envista stock compensation plan).[r.2]</b> Stockbased compensation expense for Envista is included in results from discontinued operations.","[10.41, 87.51, 2.08]",positive,"[99.99, 0.0, 0.01]",neutral,"[84.23, 5.05, 10.72]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.31,362,"Contingent Liabilities—As discussed in Item 3. Legal Proceedings and Notes 8 and 18 to the Consolidated Financial Statements, the Company is, from time to time, subject to a variety of litigation and similar contingent liabilities incidental to its business (or the business operations of previously owned entities). The Company recognizes a liability for any legal contingency or contract settlement expense that is known or probable of occurrence and reasonably estimable. These assessments require judgments concerning matters such as litigation developments and outcomes, the anticipated outcome of negotiations, the number of future claims, the cost of both pending and future claims and the value of the elements in the outcome. In addition, because most contingencies are resolved over long periods of time, liabilities may change in the future due to various factors, including those discussed in Note 18 to the Consolidated Financial Statements. If the reserves established by the Company with respect to these contingent liabilities are inadequate, the Company would be required to incur an expense equal to the amount of the loss incurred in excess of the reserves, which would adversely affect the Company’s financial statements.",[],"Contingent Liabilities—As discussed in Item 3. Legal Proceedings and Notes 8 and 18 to the Consolidated Financial Statements, the Company is, from time to time, subject to a variety of litigation and similar contingent liabilities incidental to its business (or the business operations of previously owned entities). The Company recognizes a liability for any legal contingency or contract settlement expense that is known or probable of occurrence and reasonably estimable. These assessments require judgments concerning matters such as litigation developments and outcomes, the anticipated outcome of negotiations, the number of future claims, the cost of both pending and future claims and the value of the elements in the outcome. In addition, because most contingencies are resolved over long periods of time, liabilities may change in the future due to various factors, including those discussed in Note 18 to the Consolidated Financial Statements. If the reserves established by the Company with respect to these contingent liabilities are inadequate, the Company would be required to incur an expense equal to the amount of the loss incurred in excess of the reserves, which would adversely affect the Company’s financial statements.","[20.97, 76.8, 2.24]",positive,"[99.95, 0.01, 0.05]",neutral,"[61.47, 3.54, 35.0]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.24,586,"Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012, which amended the Exchange Act to add Section 13(r) thereof, an issuer is required to disclose in its annual or quarterly reports, as applicable, whether, during the relevant reporting period, it or any entity acting on its behalf knowingly engaged in certain activities, transactions or dealings related to parties subject to sanctions administered by the Office of Foreign Assets Control (OFAC) within the U.S. Department of the Treasury, even if those transactions are authorized by law.","['Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012, which amended the Exchange Act to add Section 13(r) thereof, an issuer is required to disclose in its annual or quarterly reports, as applicable, whether, during the relevant reporting period, it or any entity acting on its behalf knowingly engaged in certain activities, transactions or dealings related to parties subject to sanctions administered by the Office of Foreign Assets Control (OFAC) within the U.S. Department of the Treasury, even if those transactions are authorized by law.']","<b>Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012, which amended the Exchange Act to add Section 13(r) thereof, an issuer is required to disclose in its annual or quarterly reports, as applicable, whether, during the relevant reporting period, it or any entity acting on its behalf knowingly engaged in certain activities, transactions or dealings related to parties subject to sanctions administered by the Office of Foreign Assets Control (OFAC) within the U.S. Department of the Treasury, even if those transactions are authorized by law.[r.1]</b>","[9.6, 88.52, 1.88]",positive,"[99.99, 0.0, 0.01]",neutral,"[86.81, 1.8, 11.39]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.14,383,"Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.","['Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances.']","<b>Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances.[r.1]</b> We believe that our audit provides a reasonable basis for our opinion.","[1.87, 81.71, 16.42]",positive,"[99.98, 0.01, 0.01]",neutral,"[68.95, 28.37, 2.68]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.1,494,"The Company estimates the fair value of its reporting units primarily using a market approach, based on current trading multiples of EBITDA for companies operating in businesses similar to each of the Company’s reporting units, in addition to recent available market sale transactions of comparable businesses. In determining the estimated fair value of each reporting unit, the Company also applies a control premium. If the estimated fair value of the reporting unit is less than its carrying value, the Company must perform additional analysis to determine if the reporting unit’s goodwill has been impaired.","['The Company estimates the fair value of its reporting units primarily using a market approach, based on current trading multiples of EBITDA for companies operating in businesses similar to each of the Company’s reporting units, in addition to recent available market sale transactions of comparable businesses.', 'In determining the estimated fair value of each reporting unit, the Company also applies a control premium.']","<b>The Company estimates the fair value of its reporting units primarily using a market approach, based on current trading multiples of EBITDA for companies operating in businesses similar to each of the Company’s reporting units, in addition to recent available market sale transactions of comparable businesses.[r.1]</b> <b>In determining the estimated fair value of each reporting unit, the Company also applies a control premium.[r.2]</b> If the estimated fair value of the reporting unit is less than its carrying value, the Company must perform additional analysis to determine if the reporting unit’s goodwill has been impaired.","[42.31, 53.84, 3.85]",positive,"[99.65, 0.01, 0.34]",neutral,"[74.41, 5.2, 20.4]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.05,552,"The Company records a liability in the Consolidated Financial Statements for loss contingencies when a loss is known or considered probable and the amount can be reasonably estimated. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a loss does not meet the known or probable level but is reasonably possible it is disclosed and if the loss or range of loss can be reasonably estimated, the estimated loss or range of loss is disclosed. The Company’s reserves consist of specific reserves for individual claims and additional amounts for anticipated developments of these claims as well as for incurred but not yet reported claims. The specific reserves for individual known claims are quantified with the assistance of legal counsel and outside risk professionals where appropriate. In addition, outside risk professionals assist in the determination of reserves for incurred but not yet reported claims through evaluation of the Company’s specific loss history, actual claims reported and industry trends together with statistical and other factors. Reserve estimates may be adjusted as additional information regarding a claim becomes known. Because most contingencies are resolved over long periods of time, new developments (including litigation developments, the discovery of new facts, changes in legislation and outcomes of similar cases), changes in assumptions or changes in the Company’s strategy in any given period can require the Company to adjust the loss contingency estimates that have been recorded in the financial statements, record estimates for liabilities or assets previously not susceptible of reasonable estimates or pay cash settlements or judgments. While the Company actively pursues financial recoveries from insurance providers and indemnifying parties, it does not recognize any recoveries until realized or until such time as a sustained pattern of collections is established related to historical matters of a similar nature and magnitude. If the Company’s selfinsurance and litigation reserves prove inadequate, it would be required to incur an expense equal to the amount of the loss incurred in excess of the reserves, which would adversely affect the Company’s Consolidated Financial Statements.","['The Company records a liability in the Consolidated Financial Statements for loss contingencies when a loss is known or considered probable and the amount can be reasonably estimated.', 'Because most contingencies are resolved over long periods of time, new developments (including litigation developments, the discovery of new facts, changes in legislation and outcomes of similar cases), changes in assumptions or changes in the Company’s strategy in any given period can require the Company to adjust the loss contingency estimates that have been recorded in the financial statements, record estimates for liabilities or assets previously not susceptible of reasonable estimates or pay cash settlements or judgments.']","<b>The Company records a liability in the Consolidated Financial Statements for loss contingencies when a loss is known or considered probable and the amount can be reasonably estimated.[r.1]</b> If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a loss does not meet the known or probable level but is reasonably possible it is disclosed and if the loss or range of loss can be reasonably estimated, the estimated loss or range of loss is disclosed. The Company’s reserves consist of specific reserves for individual claims and additional amounts for anticipated developments of these claims as well as for incurred but not yet reported claims. The specific reserves for individual known claims are quantified with the assistance of legal counsel and outside risk professionals where appropriate. In addition, outside risk professionals assist in the determination of reserves for incurred but not yet reported claims through evaluation of the Company’s specific loss history, actual claims reported and industry trends together with statistical and other factors. Reserve estimates may be adjusted as additional information regarding a claim becomes known. <b>Because most contingencies are resolved over long periods of time, new developments (including litigation developments, the discovery of new facts, changes in legislation and outcomes of similar cases), changes in assumptions or changes in the Company’s strategy in any given period can require the Company to adjust the loss contingency estimates that have been recorded in the financial statements, record estimates for liabilities or assets previously not susceptible of reasonable estimates or pay cash settlements or judgments.[r.2]</b> While the Company actively pursues financial recoveries from insurance providers and indemnifying parties, it does not recognize any recoveries until realized or until such time as a sustained pattern of collections is established related to historical matters of a similar nature and magnitude. If the Company’s selfinsurance and litigation reserves prove inadequate, it would be required to incur an expense equal to the amount of the loss incurred in excess of the reserves, which would adversely affect the Company’s Consolidated Financial Statements.","[10.85, 87.01, 2.14]",positive,"[99.97, 0.01, 0.02]",neutral,"[64.53, 5.44, 30.03]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.02,36,"Danaher measures its progress against these strategic priorities over the longterm based primarily on financial metrics relating to revenue growth, profitability, cash flow and capital returns, as well as certain nonfinancial metrics. To further the strategic objectives set forth above, the Company also acquires businesses and makes investments that either complement its existing business portfolio or expand its portfolio into new and attractive markets. Given the rapid pace of technological development and the specialized expertise typical of Danaher’s served markets, acquisitions, strategic alliances and investments provide the Company access to important new technologies and domain expertise. Danaher believes there are many acquisition and investment opportunities available within its targeted markets. The extent to which we identify, consummate and effectively integrate appropriate acquisitions and consummate appropriate investments affects our overall growth and operating results. Danaher also continually assesses the strategic fit of its existing businesses and may dispose of businesses that are deemed not to fit with its strategic plan.",[],"Danaher measures its progress against these strategic priorities over the longterm based primarily on financial metrics relating to revenue growth, profitability, cash flow and capital returns, as well as certain nonfinancial metrics. To further the strategic objectives set forth above, the Company also acquires businesses and makes investments that either complement its existing business portfolio or expand its portfolio into new and attractive markets. Given the rapid pace of technological development and the specialized expertise typical of Danaher’s served markets, acquisitions, strategic alliances and investments provide the Company access to important new technologies and domain expertise. Danaher believes there are many acquisition and investment opportunities available within its targeted markets. The extent to which we identify, consummate and effectively integrate appropriate acquisitions and consummate appropriate investments affects our overall growth and operating results. Danaher also continually assesses the strategic fit of its existing businesses and may dispose of businesses that are deemed not to fit with its strategic plan.","[0.94, 76.68, 22.38]",positive,"[78.34, 21.61, 0.05]",neutral,"[53.36, 45.47, 1.17]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.02,573,"The amount of stockbased compensation expense recognized during a period is also based on the portion of the awards that are ultimately expected to vest. The Company estimates prevesting forfeitures at the time of grant by analyzing historical data and revises those estimates in subsequent periods if actual forfeitures differ from those estimates. Ultimately, the total expense recognized over the vesting period will equal the fair value of awards that actually vest.",[],"The amount of stockbased compensation expense recognized during a period is also based on the portion of the awards that are ultimately expected to vest. The Company estimates prevesting forfeitures at the time of grant by analyzing historical data and revises those estimates in subsequent periods if actual forfeitures differ from those estimates. Ultimately, the total expense recognized over the vesting period will equal the fair value of awards that actually vest.","[3.31, 94.12, 2.57]",positive,"[99.99, 0.01, 0.01]",neutral,"[82.61, 10.16, 7.23]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",75.01,424,"Productivity Improvement and Restructuring—The Company periodically initiates productivity improvement and restructuring activities to appropriately position the Company’s cost base relative to prevailing economic conditions and associated customer demand as well as in connection with certain acquisitions. Costs associated with productivity improvement and restructuring actions can include onetime termination benefits and related charges in addition to facility closure, contract termination and other related activities. The Company records the cost of the productivity improvement and restructuring activities when the associated liability is incurred.","['Productivity Improvement and Restructuring—The Company periodically initiates productivity improvement and restructuring activities to appropriately position the Company’s cost base relative to prevailing economic conditions and associated customer demand as well as in connection with certain acquisitions.', 'The Company records the cost of the productivity improvement and restructuring activities when the associated liability is incurred.']","<b>Productivity Improvement and Restructuring—The Company periodically initiates productivity improvement and restructuring activities to appropriately position the Company’s cost base relative to prevailing economic conditions and associated customer demand as well as in connection with certain acquisitions.[r.1]</b> Costs associated with productivity improvement and restructuring actions can include onetime termination benefits and related charges in addition to facility closure, contract termination and other related activities. <b>The Company records the cost of the productivity improvement and restructuring activities when the associated liability is incurred.[r.2]</b>","[14.86, 82.58, 2.56]",positive,"[94.91, 5.02, 0.07]",neutral,"[80.48, 11.43, 8.08]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.99,401,"Common stockbased award activity Common stock issued in connection with acquisitions Common stock issued in connection with LYONs’ conversions Issuance of common stock Sale of Envista Holdings Corporation common stock Balance, end of period Retained earnings Balance, beginning of period Adoption of accounting standards Net earnings Common stock dividends declared Mandatory Convertible Preferred Stock dividends declared Tendered common stock in exchange offer for Envista Holdings Corporation common stock Balance, end of period Accumulated other comprehensive income (loss) Balance, beginning of period Other comprehensive income (loss) Balance, end of period Noncontrolling interests Balance, beginning of period Activity related to Envista Holdings Corporation, net Change in noncontrolling interests Balance, end of period Total stockholders’ equity, end of period $ $ $ $ $ $ $ $ $ $ $ $ $ 3,268  $ —  3,268  $ 9  $ — 9  $ 9,698  $ 335  23  34  —  —  10,090  $ 27,159  $ —  6,433  (601) (164) —  32,827  $ (368) $ (659) (1,027) $ 11  $ —  (1) 10  $ 45,177  $ 1,600  $ 1,668  3,268  $ 8  $ 1  9  $ 7,565  $ 351  —  53  1,729  —  9,698  $ 24,166  $ (8) 3,646  (509) (136) —  27,159  $ (3,068) $ 2,700  (368) $ 11  $ —  —  11  $ 39,777  $ —  1,600  1,600 8  —  8 5,834  315  —  33  1,443  (60) 7,565 25,162  —  3,008  (484) (68) (3,452) 24,166 (2,791) (277) (3,068) 12  (3) 2  11  30,282 See the accompanying Notes to the Consolidated Financial Statements.","['Common stockbased award activity Common stock issued in connection with acquisitions Common stock issued in connection with LYONs’ conversions Issuance of common stock Sale of Envista Holdings Corporation common stock Balance, end of period Retained earnings Balance, beginning of period Adoption of accounting standards Net earnings Common stock dividends declared Mandatory Convertible Preferred Stock dividends declared Tendered common stock in exchange offer for Envista Holdings Corporation common stock Balance, end of period Accumulated other comprehensive income (loss) Balance, beginning of period Other comprehensive income (loss) Balance, end of period Noncontrolling interests Balance, beginning of period Activity related to Envista Holdings Corporation, net Change in noncontrolling interests Balance, end of period Total stockholders’ equity, end of period $ $ $ $ $ $ $ $ $ $ $ $ $ 3,268  $ —  3,268  $ 9  $ — 9  $ 9,698  $ 335  23  34  —  —  10,090  $ 27,159  $ —  6,433  (601) (164) —  32,827  $ (368) $ (659) (1,027) $ 11  $ —  (1) 10  $ 45,177  $ 1,600  $ 1,668  3,268  $ 8  $ 1  9  $ 7,565  $ 351  —  53  1,729  —  9,698  $ 24,166  $ (8) 3,646  (509) (136) —  27,159  $ (3,068) $ 2,700  (368) $ 11  $ —  —  11  $ 39,777  $ —  1,600  1,600 8  —  8 5,834  315  —  33  1,443  (60) 7,565 25,162  —  3,008  (484) (68) (3,452) 24,166 (2,791) (277) (3,068) 12  (3) 2  11  30,282 See the accompanying Notes to the Consolidated Financial Statements.']","<b>Common stockbased award activity Common stock issued in connection with acquisitions Common stock issued in connection with LYONs’ conversions Issuance of common stock Sale of Envista Holdings Corporation common stock Balance, end of period Retained earnings Balance, beginning of period Adoption of accounting standards Net earnings Common stock dividends declared Mandatory Convertible Preferred Stock dividends declared Tendered common stock in exchange offer for Envista Holdings Corporation common stock Balance, end of period Accumulated other comprehensive income (loss) Balance, beginning of period Other comprehensive income (loss) Balance, end of period Noncontrolling interests Balance, beginning of period Activity related to Envista Holdings Corporation, net Change in noncontrolling interests Balance, end of period Total stockholders’ equity, end of period $ $ $ $ $ $ $ $ $ $ $ $ $ 3,268  $ —  3,268  $ 9  $ — 9  $ 9,698  $ 335  23  34  —  —  10,090  $ 27,159  $ —  6,433  (601) (164) —  32,827  $ (368) $ (659) (1,027) $ 11  $ —  (1) 10  $ 45,177  $ 1,600  $ 1,668  3,268  $ 8  $ 1  9  $ 7,565  $ 351  —  53  1,729  —  9,698  $ 24,166  $ (8) 3,646  (509) (136) —  27,159  $ (3,068) $ 2,700  (368) $ 11  $ —  —  11  $ 39,777  $ —  1,600  1,600 8  —  8 5,834  315  —  33  1,443  (60) 7,565 25,162  —  3,008  (484) (68) (3,452) 24,166 (2,791) (277) (3,068) 12  (3) 2  11  30,282 See the accompanying Notes to the Consolidated Financial Statements.[r.1]</b>","[9.61, 88.16, 2.23]",positive,"[99.99, 0.01, 0.01]",neutral,"[85.34, 3.77, 10.89]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.97,9,"Certain statements included or incorporated by reference in this Annual Report, in other documents we file with or furnish to the Securities and Exchange Commission (SEC), in our press releases, webcasts, conference calls, materials delivered to shareholders and other communications, are forwardlooking statements within the meaning of the U.S. federal securities laws. All statements other than historical factual information are forwardlooking statements, including without limitation statements regarding projections of revenue, expenses, profit, profit margins, pricing, tax rates, tax provisions, cash flows, pension and benefit obligations and funding requirements, our liquidity position or other projected financial measures management’s plans and strategies for future operations, including statements relating to anticipated operating performance, cost reductions, restructuring activities, new product and service developments, competitive strengths or market position, acquisitions and the integration thereof, divestitures, spinoffs, splitoffs or other distributions, strategic opportunities, securities offerings, stock repurchases, dividends and executive compensation growth, declines and other trends in markets we sell into new or modified laws, regulations and accounting pronouncements future regulatory approvals and the timing and conditionality thereof outstanding claims, legal proceedings, tax audits and assessments and other contingent liabilities future foreign currency exchange rates and fluctuations in those rates the potential or anticipated direct or indirect impact of COVID19 on our business, results of operations and/or financial condition general economic and capital markets conditions the anticipated timing of any of the foregoing assumptions underlying any of the foregoing and any other statements that address events or developments that Danaher intends or believes will or may occur in the future. Terminology such as believe, anticipate, should, could, intend, will, plan, expect, estimate, project, target, may, possible, potential, forecast and positioned and similar references to future periods are intended to identify forwardlooking statements, although not all forwardlooking statements are accompanied by such words. Forwardlooking statements are based on assumptions and assessments made by our management in light of their experience and perceptions of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. These forwardlooking statements are subject to a number of risks and uncertainties, including but not limited to the risks and uncertainties set forth below and under Item 1A. Risk Factors in this Annual Report.","['All statements other than historical factual information are forwardlooking statements, including without limitation statements regarding projections of revenue, expenses, profit, profit margins, pricing, tax rates, tax provisions, cash flows, pension and benefit obligations and funding requirements, our liquidity position or other projected financial measures management’s plans and strategies for future operations, including statements relating to anticipated operating performance, cost reductions, restructuring activities, new product and service developments, competitive strengths or market position, acquisitions and the integration thereof, divestitures, spinoffs, splitoffs or other distributions, strategic opportunities, securities offerings, stock repurchases, dividends and executive compensation growth, declines and other trends in markets we sell into new or modified laws, regulations and accounting pronouncements future regulatory approvals and the timing and conditionality thereof outstanding claims, legal proceedings, tax audits and assessments and other contingent liabilities future foreign currency exchange rates and fluctuations in those rates the potential or anticipated direct or indirect impact of COVID19 on our business, results of operations and/or financial condition general economic and capital markets conditions the anticipated timing of any of the foregoing assumptions underlying any of the foregoing and any other statements that address events or developments that Danaher intends or believes will or may occur in the future.', 'Certain statements included or incorporated by reference in this Annual Report, in other documents we file with or furnish to the Securities and Exchange Commission (SEC), in our press releases, webcasts, conference calls, materials delivered to shareholders and other communications, are forwardlooking statements within the meaning of the U.S. federal securities laws.']","<b>Certain statements included or incorporated by reference in this Annual Report, in other documents we file with or furnish to the Securities and Exchange Commission (SEC), in our press releases, webcasts, conference calls, materials delivered to shareholders and other communications, are forwardlooking statements within the meaning of the U.S. federal securities laws.[r.2]</b> <b>All statements other than historical factual information are forwardlooking statements, including without limitation statements regarding projections of revenue, expenses, profit, profit margins, pricing, tax rates, tax provisions, cash flows, pension and benefit obligations and funding requirements, our liquidity position or other projected financial measures management’s plans and strategies for future operations, including statements relating to anticipated operating performance, cost reductions, restructuring activities, new product and service developments, competitive strengths or market position, acquisitions and the integration thereof, divestitures, spinoffs, splitoffs or other distributions, strategic opportunities, securities offerings, stock repurchases, dividends and executive compensation growth, declines and other trends in markets we sell into new or modified laws, regulations and accounting pronouncements future regulatory approvals and the timing and conditionality thereof outstanding claims, legal proceedings, tax audits and assessments and other contingent liabilities future foreign currency exchange rates and fluctuations in those rates the potential or anticipated direct or indirect impact of COVID19 on our business, results of operations and/or financial condition general economic and capital markets conditions the anticipated timing of any of the foregoing assumptions underlying any of the foregoing and any other statements that address events or developments that Danaher intends or believes will or may occur in the future.[r.1]</b> Terminology such as believe, anticipate, should, could, intend, will, plan, expect, estimate, project, target, may, possible, potential, forecast and positioned and similar references to future periods are intended to identify forwardlooking statements, although not all forwardlooking statements are accompanied by such words. Forwardlooking statements are based on assumptions and assessments made by our management in light of their experience and perceptions of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. These forwardlooking statements are subject to a number of risks and uncertainties, including but not limited to the risks and uncertainties set forth below and under Item 1A. Risk Factors in this Annual Report.","[4.58, 93.29, 2.12]",positive,"[99.98, 0.01, 0.01]",neutral,"[79.81, 4.84, 15.35]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.94,561,"Issuance of common stock attributable to stockbased compensation Common stock issued in connection with acquisitions Common stock issued in connection with LYONs’ conversions Other issuance of common stock Balance, end of period 3.4  —  3.4 851.3  3.4  0.1  0.9  —  855.7 1.7  1.7  3.4 835.5  4.5  —  0.4  10.9  851.3 —  1.7  1.7 817.9  4.6  —  0.9  12.1  835.5 In May 2020, the Company completed the underwritten public offering of 10.9 million shares of Danaher common stock at a price to the public of $163.00 per share (the 2020 Common Stock Offering), resulting in net proceeds of approximately $1.7 billion, after deducting expenses and the underwriters’ discount of $54 million. Simultaneously, the Company completed the underwritten public offering of 1.72 million shares of its 5.0% MCPS Series B, without par value and with a liquidation preference of $1,000 per share (the 2020 MCPS Offering), resulting in net proceeds of approximately $1.7 billion, after deducting expenses and the underwriters’ discount of $49 million. The Company has used the net proceeds from the 2020 Common Stock Offering and the 2020 MCPS Offering for general corporate purposes.","['Issuance of common stock attributable to stockbased compensation Common stock issued in connection with acquisitions Common stock issued in connection with LYONs’ conversions Other issuance of common stock Balance, end of period 3.4  —  3.4 851.3  3.4  0.1  0.9  —  855.7 1.7  1.7  3.4 835.5  4.5  —  0.4  10.9  851.3 —  1.7  1.7 817.9  4.6  —  0.9  12.1  835.5']","<b>Issuance of common stock attributable to stockbased compensation Common stock issued in connection with acquisitions Common stock issued in connection with LYONs’ conversions Other issuance of common stock Balance, end of period 3.4  —  3.4 851.3  3.4  0.1  0.9  —  855.7 1.7  1.7  3.4 835.5  4.5  —  0.4  10.9  851.3 —  1.7  1.7 817.9  4.6  —  0.9  12.1  835.5[r.1]</b> In May 2020, the Company completed the underwritten public offering of 10.9 million shares of Danaher common stock at a price to the public of $163.00 per share (the 2020 Common Stock Offering), resulting in net proceeds of approximately $1.7 billion, after deducting expenses and the underwriters’ discount of $54 million. Simultaneously, the Company completed the underwritten public offering of 1.72 million shares of its 5.0% MCPS Series B, without par value and with a liquidation preference of $1,000 per share (the 2020 MCPS Offering), resulting in net proceeds of approximately $1.7 billion, after deducting expenses and the underwriters’ discount of $49 million. The Company has used the net proceeds from the 2020 Common Stock Offering and the 2020 MCPS Offering for general corporate purposes.","[2.08, 94.19, 3.73]",positive,"[99.99, 0.01, 0.01]",neutral,"[87.06, 9.43, 3.51]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.91,302,"The Company’s effective tax rate can be affected by changes in the mix of earnings in countries with different statutory tax rates (including as a result of business acquisitions and dispositions), changes in the valuation of deferred tax assets and liabilities, accruals related to contingent tax liabilities and periodtoperiod changes in such accruals, the results of audits and examinations of previously filed tax returns (as further discussed below), the expiration of statutes of limitations, the implementation of tax planning strategies, tax rulings, court decisions, settlements with tax authorities, changes in tax laws and regulations, and legislative policy changes that may result from the OECD’s initiative on Base Erosion and Profit Shifting. For a description of the tax treatment of earnings that are planned to be reinvested indefinitely outside the United States, refer to —Liquidity and Capital Resources—Cash and Cash Requirements below.","['The Company’s effective tax rate can be affected by changes in the mix of earnings in countries with different statutory tax rates (including as a result of business acquisitions and dispositions), changes in the valuation of deferred tax assets and liabilities, accruals related to contingent tax liabilities and periodtoperiod changes in such accruals, the results of audits and examinations of previously filed tax returns (as further discussed below), the expiration of statutes of limitations, the implementation of tax planning strategies, tax rulings, court decisions, settlements with tax authorities, changes in tax laws and regulations, and legislative policy changes that may result from the OECD’s initiative on Base Erosion and Profit Shifting.']","<b>The Company’s effective tax rate can be affected by changes in the mix of earnings in countries with different statutory tax rates (including as a result of business acquisitions and dispositions), changes in the valuation of deferred tax assets and liabilities, accruals related to contingent tax liabilities and periodtoperiod changes in such accruals, the results of audits and examinations of previously filed tax returns (as further discussed below), the expiration of statutes of limitations, the implementation of tax planning strategies, tax rulings, court decisions, settlements with tax authorities, changes in tax laws and regulations, and legislative policy changes that may result from the OECD’s initiative on Base Erosion and Profit Shifting.[r.1]</b> For a description of the tax treatment of earnings that are planned to be reinvested indefinitely outside the United States, refer to —Liquidity and Capital Resources—Cash and Cash Requirements below.","[8.93, 89.2, 1.87]",positive,"[99.98, 0.01, 0.01]",neutral,"[84.68, 4.2, 11.12]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.86,502,"The Company’s investments in equity securities consist of investments in publicly traded equity securities and investments in nonmarketable equity securities. The publicly traded securities are classified as Level 1 in the fair value hierarchy as they are measured based on quotes in active markets. For the nonmarketable equity securities, the Company estimates the fair value of the investments in equity securities based on the measurement alternative and adjusts for impairments and observable price changes with a same or similar security from the same issuer within net earnings (the Fair Value Alternative). The Company’s investments in these equity securities are not classified in the fair value hierarchy due to the use of these measurement methods. Additionally, the Company is a limited partner in partnerships that invest primarily in earlystage companies. While the partnerships record these investments at fair value, the Company’s investments in the partnerships are accounted for under the equity method of accounting and are not subject to fair value measurement disclosures. As of December 31, 2021 and 2020, the Company’s equity method investments included investments in partnerships with a carrying value of approximately $1.3 billion and $453 million, respectively. During the years ended December 31, 2021 and 2020, the Company recorded net realized and unrealized gains of $401 million and $18 million, respectively, related to changes in the fair value of the Company’s investments in equity securities and the Company’s equity in earnings of the partnerships that reflect the changes in fair value of the investments of the partnerships. Refer to Note 9 for additional information on gains and losses on the Company’s investments, including investments in the partnerships. No significant realized or unrealized gains or losses were recorded in 2019 with respect to these investments.","['While the partnerships record these investments at fair value, the Company’s investments in the partnerships are accounted for under the equity method of accounting and are not subject to fair value measurement disclosures.']","The Company’s investments in equity securities consist of investments in publicly traded equity securities and investments in nonmarketable equity securities. The publicly traded securities are classified as Level 1 in the fair value hierarchy as they are measured based on quotes in active markets. For the nonmarketable equity securities, the Company estimates the fair value of the investments in equity securities based on the measurement alternative and adjusts for impairments and observable price changes with a same or similar security from the same issuer within net earnings (the Fair Value Alternative). The Company’s investments in these equity securities are not classified in the fair value hierarchy due to the use of these measurement methods. Additionally, the Company is a limited partner in partnerships that invest primarily in earlystage companies. <b>While the partnerships record these investments at fair value, the Company’s investments in the partnerships are accounted for under the equity method of accounting and are not subject to fair value measurement disclosures.[r.1]</b> As of December 31, 2021 and 2020, the Company’s equity method investments included investments in partnerships with a carrying value of approximately $1.3 billion and $453 million, respectively. During the years ended December 31, 2021 and 2020, the Company recorded net realized and unrealized gains of $401 million and $18 million, respectively, related to changes in the fair value of the Company’s investments in equity securities and the Company’s equity in earnings of the partnerships that reflect the changes in fair value of the investments of the partnerships. Refer to Note 9 for additional information on gains and losses on the Company’s investments, including investments in the partnerships. No significant realized or unrealized gains or losses were recorded in 2019 with respect to these investments.","[10.07, 86.53, 3.4]",positive,"[99.99, 0.0, 0.01]",neutral,"[77.57, 5.89, 16.54]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.86,570,"The equity compensation awards granted by the Company generally vest only if the employee is employed by the Company (or in the case of directors, the director continues to serve on the Company Board) on the vesting date or in other limited circumstances, including following a qualifying retirement. To cover the exercise of options and vesting of RSUs and PSUs, the Company generally issues new shares from its authorized but unissued share pool, although it may instead issue treasury shares in certain circumstances.","['The equity compensation awards granted by the Company generally vest only if the employee is employed by the Company (or in the case of directors, the director continues to serve on the Company Board) on the vesting date or in other limited circumstances, including following a qualifying retirement.', 'To cover the exercise of options and vesting of RSUs and PSUs, the Company generally issues new shares from its authorized but unissued share pool, although it may instead issue treasury shares in certain circumstances.']","<b>The equity compensation awards granted by the Company generally vest only if the employee is employed by the Company (or in the case of directors, the director continues to serve on the Company Board) on the vesting date or in other limited circumstances, including following a qualifying retirement.[r.1]</b> <b>To cover the exercise of options and vesting of RSUs and PSUs, the Company generally issues new shares from its authorized but unissued share pool, although it may instead issue treasury shares in certain circumstances.[r.2]</b>","[2.42, 95.3, 2.28]",positive,"[99.99, 0.0, 0.01]",neutral,"[92.49, 3.78, 3.74]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.84,77,"We have leveraged DBS with the goal of driving progress on diversity representation and inclusive culture, including by requiring all of our operating companies to implement a DI Policy Deployment initiative in each of 2021 and 2022. Our DI initiatives focus on broadening our candidate pools, sourcing diverse slates in the hiring process, developing people leaders’ competency in and accountability for DI and implementing and sustaining programs (such as our Associate Resource Groups for Women, Black, Latinx, LGBTQ and Asian descent associates and friends/allies) that offer mentorship, support and engagement to help our associates succeed and thrive. As of December 31, 2021, (1) 37% of our total associates were female and females represented 31%, 33% and 39% of our executives/senior leaders, managers and individual contributors, respectively and (2) 39% of our total U.S. associates were People of Color and People of Color represented 22%, 31% and 41% of our U.S. executives/senior leaders, managers and individual contributors, respectively. ◦ In support of our DI commitment, we conduct regular pay reviews from a race (in the United States) and gender (globally) perspective that serve to proactively identify and address potential pay differences, and in 2020 we achieved base pay equity for women and for racial and ethnic minorities in the U.S.","['We have leveraged DBS with the goal of driving progress on diversity representation and inclusive culture, including by requiring all of our operating companies to implement a DI Policy Deployment initiative in each of 2021 and 2022.']","<b>We have leveraged DBS with the goal of driving progress on diversity representation and inclusive culture, including by requiring all of our operating companies to implement a DI Policy Deployment initiative in each of 2021 and 2022.[r.1]</b> Our DI initiatives focus on broadening our candidate pools, sourcing diverse slates in the hiring process, developing people leaders’ competency in and accountability for DI and implementing and sustaining programs (such as our Associate Resource Groups for Women, Black, Latinx, LGBTQ and Asian descent associates and friends/allies) that offer mentorship, support and engagement to help our associates succeed and thrive. As of December 31, 2021, (1) 37% of our total associates were female and females represented 31%, 33% and 39% of our executives/senior leaders, managers and individual contributors, respectively and (2) 39% of our total U.S. associates were People of Color and People of Color represented 22%, 31% and 41% of our U.S. executives/senior leaders, managers and individual contributors, respectively. ◦ In support of our DI commitment, we conduct regular pay reviews from a race (in the United States) and gender (globally) perspective that serve to proactively identify and address potential pay differences, and in 2020 we achieved base pay equity for women and for racial and ethnic minorities in the U.S.","[1.04, 70.83, 28.12]",positive,"[0.03, 99.95, 0.02]",positive,"[46.48, 53.09, 0.42]",positive
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.83,554,"In addition to environmental compliance costs, the Company from time to time incurs costs related to remedial efforts or alleged environmental damage associated with past or current waste disposal practices or other hazardous materials handling practices. For example, generators of hazardous substances found in disposal sites at which environmental problems are alleged to exist, as well as the current and former owners of those sites and certain other classes of persons, are subject to claims brought by state and federal regulatory agencies pursuant to statutory authority. The Company has received notification from the U.S. Environmental Protection Agency, and from state and nonU.S. environmental agencies, that conditions at certain sites where the Company and others previously disposed of hazardous wastes and/or are or were property owners require clean up and other possible remedial action, including sites where the Company has been identified as a potentially responsible party under U.S. federal and state environmental laws. The Company has projects underway at a number of current and former facilities, in both the United States and abroad, to investigate and remediate environmental contamination resulting from past operations. Remediation activities generally relate to soil and/or groundwater contamination and may include preremedial activities such as factfinding and investigation, risk assessment, feasibility study and/or design, as well as remediation actions such as contaminant removal, monitoring and/or installation, operation and maintenance of longerterm remediation systems. The Company is also from time to time party to personal injury, property damage or other claims brought by private parties alleging injury or damage due to the presence of, or exposure to, hazardous substances. The Company can also become subject to additional remedial, compliance or personal injury costs due to future events such as changes in existing laws or regulations, changes in agency direction or enforcement policies, developments in remediation technologies, changes in the conduct of the Company’s operations and changes in accounting rules.","['The Company has received notification from the U.S. Environmental Protection Agency, and from state and nonU.S. environmental agencies, that conditions at certain sites where the Company and others previously disposed of hazardous wastes and/or are or were property owners require clean up and other possible remedial action, including sites where the Company has been identified as a potentially responsible party under U.S. federal and state environmental laws.']","In addition to environmental compliance costs, the Company from time to time incurs costs related to remedial efforts or alleged environmental damage associated with past or current waste disposal practices or other hazardous materials handling practices. For example, generators of hazardous substances found in disposal sites at which environmental problems are alleged to exist, as well as the current and former owners of those sites and certain other classes of persons, are subject to claims brought by state and federal regulatory agencies pursuant to statutory authority. <b>The Company has received notification from the U.S. Environmental Protection Agency, and from state and nonU.S. environmental agencies, that conditions at certain sites where the Company and others previously disposed of hazardous wastes and/or are or were property owners require clean up and other possible remedial action, including sites where the Company has been identified as a potentially responsible party under U.S. federal and state environmental laws.[r.1]</b> The Company has projects underway at a number of current and former facilities, in both the United States and abroad, to investigate and remediate environmental contamination resulting from past operations. Remediation activities generally relate to soil and/or groundwater contamination and may include preremedial activities such as factfinding and investigation, risk assessment, feasibility study and/or design, as well as remediation actions such as contaminant removal, monitoring and/or installation, operation and maintenance of longerterm remediation systems. The Company is also from time to time party to personal injury, property damage or other claims brought by private parties alleging injury or damage due to the presence of, or exposure to, hazardous substances. The Company can also become subject to additional remedial, compliance or personal injury costs due to future events such as changes in existing laws or regulations, changes in agency direction or enforcement policies, developments in remediation technologies, changes in the conduct of the Company’s operations and changes in accounting rules.","[16.63, 81.1, 2.27]",positive,"[99.87, 0.01, 0.12]",neutral,"[63.75, 2.65, 33.6]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.79,542,"Venture capital, partnerships and other private investments are valued using the NAV based on the information provided by the asset fund managers, which reflects the plan’s share of the fair value of the net assets of the investment. Depending on the nature of the assets, the underlying investments are valued using a combination of either discounted cash flows, earnings and market multiples, thirdparty appraisals or through reference to the quoted market prices of the underlying investments held by the venture, partnership or private entity where available. Valuation adjustments reflect changes in operating results, financial condition, or prospects of the applicable portfolio company.","['Venture capital, partnerships and other private investments are valued using the NAV based on the information provided by the asset fund managers, which reflects the plan’s share of the fair value of the net assets of the investment.']","<b>Venture capital, partnerships and other private investments are valued using the NAV based on the information provided by the asset fund managers, which reflects the plan’s share of the fair value of the net assets of the investment.[r.1]</b> Depending on the nature of the assets, the underlying investments are valued using a combination of either discounted cash flows, earnings and market multiples, thirdparty appraisals or through reference to the quoted market prices of the underlying investments held by the venture, partnership or private entity where available. Valuation adjustments reflect changes in operating results, financial condition, or prospects of the applicable portfolio company.","[2.39, 95.34, 2.27]",positive,"[99.99, 0.0, 0.01]",neutral,"[89.74, 6.9, 3.36]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.78,37,"DBS is not only the set of business processes and tools our operating companies use on a daily basis, but is more broadly our culture. As reflected in our logo, DBS features five core values (the Core Values) 1. The Best Team Wins 2. Customers Talk, We Listen 3. Kaizen is our Way of Life 4.",[],"DBS is not only the set of business processes and tools our operating companies use on a daily basis, but is more broadly our culture. As reflected in our logo, DBS features five core values (the Core Values) 1. The Best Team Wins 2. Customers Talk, We Listen 3. Kaizen is our Way of Life 4.","[1.6, 93.63, 4.77]",positive,"[99.99, 0.01, 0.01]",neutral,"[19.62, 80.07, 0.32]",positive
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.77,406,"Use of Estimates—The preparation of these financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. The Company bases these estimates on historical experience, the current economic environment and on various other assumptions that are believed to be reasonable under the circumstances. However, uncertainties associated with these estimates exist and actual results may differ materially from these estimates.","['Use of Estimates—The preparation of these financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities.']","<b>Use of Estimates—The preparation of these financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities.[r.1]</b> The Company bases these estimates on historical experience, the current economic environment and on various other assumptions that are believed to be reasonable under the circumstances. However, uncertainties associated with these estimates exist and actual results may differ materially from these estimates.","[13.83, 82.97, 3.2]",positive,"[99.98, 0.0, 0.01]",neutral,"[71.74, 4.88, 23.37]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.77,301,Income tax expense and deferred tax assets and liabilities reflect management’s assessment of future taxes expected to be paid on items reflected in the Company’s Consolidated Financial Statements. The Company records the tax effect of discrete items and items that are reported net of their tax effects in the period in which they occur.,['Income tax expense and deferred tax assets and liabilities reflect management’s assessment of future taxes expected to be paid on items reflected in the Company’s Consolidated Financial Statements.'],<b>Income tax expense and deferred tax assets and liabilities reflect management’s assessment of future taxes expected to be paid on items reflected in the Company’s Consolidated Financial Statements.[r.1]</b> The Company records the tax effect of discrete items and items that are reported net of their tax effects in the period in which they occur.,"[9.02, 89.41, 1.57]",positive,"[99.99, 0.0, 0.01]",neutral,"[86.26, 3.98, 9.76]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.73,389,"The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.","['The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments.', 'The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.']","<b>The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments.[r.1]</b> <b>The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.[r.2]</b>","[8.45, 89.79, 1.76]",positive,"[99.99, 0.0, 0.01]",neutral,"[75.27, 5.98, 18.75]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.66,427,"Accumulated Other Comprehensive Income (Loss)—Accumulated other comprehensive income (loss) refers to certain gains and losses that under U.S. GAAP are included in comprehensive income (loss) but are excluded from net earnings as these amounts are initially recorded as an adjustment to stockholders’ equity. Foreign currency translation adjustments are generally not adjusted for income taxes as they relate to indefinite investments in nonU.S. subsidiaries. Foreign currency translation adjustments generally relate to indefinite investments in nonU.S. subsidiaries, net of any tax impacts. Cash flow hedge adjustments reflect the gains or losses on the derivative contract designated as the hedging instrument. Pension and postretirement plan benefit adjustments relate to unrecognized prior service credits and actuarial losses. Refer to Notes 15, 16 and 19 for additional information.",['Accumulated Other Comprehensive Income (Loss)—Accumulated other comprehensive income (loss) refers to certain gains and losses that under U.S. GAAP are included in comprehensive income (loss) but are excluded from net earnings as these amounts are initially recorded as an adjustment to stockholders’ equity.'],"<b>Accumulated Other Comprehensive Income (Loss)—Accumulated other comprehensive income (loss) refers to certain gains and losses that under U.S. GAAP are included in comprehensive income (loss) but are excluded from net earnings as these amounts are initially recorded as an adjustment to stockholders’ equity.[r.1]</b> Foreign currency translation adjustments are generally not adjusted for income taxes as they relate to indefinite investments in nonU.S. subsidiaries. Foreign currency translation adjustments generally relate to indefinite investments in nonU.S. subsidiaries, net of any tax impacts. Cash flow hedge adjustments reflect the gains or losses on the derivative contract designated as the hedging instrument. Pension and postretirement plan benefit adjustments relate to unrecognized prior service credits and actuarial losses. Refer to Notes 15, 16 and 19 for additional information.","[15.9, 82.03, 2.08]",positive,"[99.98, 0.0, 0.01]",neutral,"[59.34, 3.5, 37.16]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.65,484,"The Company estimates the fair value of investments in equity securities using the Fair Value Alternative and records adjustments to fair value within net earnings. Additionally, the Company is a limited partner in partnerships that invest primarily in early stage companies. While the partnerships record these investments at fair value, the Company’s investments in the partnerships are accounted for under the equity method of accounting. The investment gains (losses) include realized and unrealized gains and losses related to changes in the fair value of the Company’s investments in equity securities and the Company’s equity in earnings of the partnerships that reflect the changes in fair value of the investments of the partnerships.",['The investment gains (losses) include realized and unrealized gains and losses related to changes in the fair value of the Company’s investments in equity securities and the Company’s equity in earnings of the partnerships that reflect the changes in fair value of the investments of the partnerships.'],"The Company estimates the fair value of investments in equity securities using the Fair Value Alternative and records adjustments to fair value within net earnings. Additionally, the Company is a limited partner in partnerships that invest primarily in early stage companies. While the partnerships record these investments at fair value, the Company’s investments in the partnerships are accounted for under the equity method of accounting. <b>The investment gains (losses) include realized and unrealized gains and losses related to changes in the fair value of the Company’s investments in equity securities and the Company’s equity in earnings of the partnerships that reflect the changes in fair value of the investments of the partnerships.[r.1]</b>","[7.12, 89.74, 3.14]",positive,"[99.98, 0.01, 0.01]",neutral,"[82.41, 6.58, 11.01]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.64,121,"The direct impact of COVID19 and the preventive and precautionary measures implemented as a result thereof have adversely affected, and may continue to adversely affect, certain elements of our Company (including to a different degree our operations, commercial organizations, supply chains and distribution systems). Please see Management’s Discussion and Analysis of Financial Condition and Results of Operations for a discussion of how COVID19 impacted our results of operations and financial position in 2021. Without limiting the foregoing, we have experienced and/or may in the future experience constraints on the movement of our products through the supply chain capacity constraints and price increases in our own supply chain, including with respect to freight services adverse impacts on our workforce and/or key employees including labor availability adverse impacts on customer orders and purchases and unpredictable reductions in demand for our products adverse impacts on our collections of accounts receivable, including delays in collections and increases in uncollectible receivables unpredictable increases in demand for certain products and increased cybersecurity attack activity.","['The direct impact of COVID19 and the preventive and precautionary measures implemented as a result thereof have adversely affected, and may continue to adversely affect, certain elements of our Company (including to a different degree our operations, commercial organizations, supply chains and distribution systems).']","<b>The direct impact of COVID19 and the preventive and precautionary measures implemented as a result thereof have adversely affected, and may continue to adversely affect, certain elements of our Company (including to a different degree our operations, commercial organizations, supply chains and distribution systems).[r.1]</b> Please see Management’s Discussion and Analysis of Financial Condition and Results of Operations for a discussion of how COVID19 impacted our results of operations and financial position in 2021. Without limiting the foregoing, we have experienced and/or may in the future experience constraints on the movement of our products through the supply chain capacity constraints and price increases in our own supply chain, including with respect to freight services adverse impacts on our workforce and/or key employees including labor availability adverse impacts on customer orders and purchases and unpredictable reductions in demand for our products adverse impacts on our collections of accounts receivable, including delays in collections and increases in uncollectible receivables unpredictable increases in demand for certain products and increased cybersecurity attack activity.","[91.63, 6.33, 2.04]",neutral,"[0.51, 0.1, 99.39]",negative,"[48.35, 2.67, 48.97]",negative
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.63,357,"Acquired Intangibles—The Company’s business acquisitions, including the Cytiva and Aldevron acquisitions, typically result in the recognition of goodwill, developed technology and other intangible assets, which affect the amount of future period amortization expense and possible impairment charges that the Company may incur. The fair values of acquired intangibles are determined using information available near the acquisition date based on estimates and assumptions that are deemed reasonable by the Company. Significant assumptions include the discount rates and certain assumptions that form the basis of the forecasted results of the acquired business including earnings before interest, taxes, depreciation and amortization (EBITDA), revenue, revenue growth rates, royalty rates and technology obsolescence rates. These assumptions are forward looking and could be affected by future economic and market conditions. The Company engages thirdparty valuation specialists who review the Company’s critical assumptions and calculations of the fair value of acquired intangible assets in connection with significant acquisitions. In connection with acquisitions during the year ended December 31, 2021, the Company recognized aggregate goodwill of approximately $7.2 billion and intangible assets of approximately $4.0 billion. Refer to Notes 1, 2 and 11 to the Consolidated Financial Statements for a description of the Company’s policies relating to goodwill, acquired intangibles and acquisitions.","['Refer to Notes 1, 2 and 11 to the Consolidated Financial Statements for a description of the Company’s policies relating to goodwill, acquired intangibles and acquisitions.', 'Acquired Intangibles—The Company’s business acquisitions, including the Cytiva and Aldevron acquisitions, typically result in the recognition of goodwill, developed technology and other intangible assets, which affect the amount of future period amortization expense and possible impairment charges that the Company may incur.', 'The Company engages thirdparty valuation specialists who review the Company’s critical assumptions and calculations of the fair value of acquired intangible assets in connection with significant acquisitions.']","<b>Acquired Intangibles—The Company’s business acquisitions, including the Cytiva and Aldevron acquisitions, typically result in the recognition of goodwill, developed technology and other intangible assets, which affect the amount of future period amortization expense and possible impairment charges that the Company may incur.[r.2]</b> The fair values of acquired intangibles are determined using information available near the acquisition date based on estimates and assumptions that are deemed reasonable by the Company. Significant assumptions include the discount rates and certain assumptions that form the basis of the forecasted results of the acquired business including earnings before interest, taxes, depreciation and amortization (EBITDA), revenue, revenue growth rates, royalty rates and technology obsolescence rates. These assumptions are forward looking and could be affected by future economic and market conditions. <b>The Company engages thirdparty valuation specialists who review the Company’s critical assumptions and calculations of the fair value of acquired intangible assets in connection with significant acquisitions.[r.3]</b> In connection with acquisitions during the year ended December 31, 2021, the Company recognized aggregate goodwill of approximately $7.2 billion and intangible assets of approximately $4.0 billion. <b>Refer to Notes 1, 2 and 11 to the Consolidated Financial Statements for a description of the Company’s policies relating to goodwill, acquired intangibles and acquisitions.[r.1]</b>","[4.15, 93.34, 2.51]",positive,"[99.98, 0.01, 0.01]",neutral,"[81.61, 8.96, 9.43]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.56,323,"The Company is exposed to potential credit losses in the event of nonperformance by counterparties to its financial instruments. Financial instruments that potentially subject the Company to credit risk consist of cash and temporary investments, receivables from customers and derivatives. The Company places cash and temporary investments with various highquality financial institutions throughout the world and exposure is limited at any one institution. Although the Company typically does not obtain collateral or other security to secure these obligations, it does regularly monitor the thirdparty depository institutions that hold its cash and cash equivalents. The Company’s emphasis is primarily on safety and liquidity of principal and secondarily on maximizing yield on those funds.",['The Company’s emphasis is primarily on safety and liquidity of principal and secondarily on maximizing yield on those funds.'],"The Company is exposed to potential credit losses in the event of nonperformance by counterparties to its financial instruments. Financial instruments that potentially subject the Company to credit risk consist of cash and temporary investments, receivables from customers and derivatives. The Company places cash and temporary investments with various highquality financial institutions throughout the world and exposure is limited at any one institution. Although the Company typically does not obtain collateral or other security to secure these obligations, it does regularly monitor the thirdparty depository institutions that hold its cash and cash equivalents. <b>The Company’s emphasis is primarily on safety and liquidity of principal and secondarily on maximizing yield on those funds.[r.1]</b>","[2.54, 94.01, 3.45]",positive,"[45.98, 0.08, 53.93]",negative,"[76.59, 6.34, 17.07]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.53,253,"Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is designed to provide material information relevant to an assessment of Danaher’s financial condition and results of operations, including an evaluation of the amounts and certainty of cash flows from operations and from outside sources. The MD&A is designed to focus specifically on material events and uncertainties known to management that are reasonably likely to cause reported financial information not to be necessarily indicative of future operating results or of future financial condition. This includes descriptions and amounts of matters that have had a material impact on reported operations, as well as matters that are reasonably likely based on management’s assessment to have a material impact on future operations. The Company’s MD&A is divided into five sections Overview Results of Operations Liquidity and Capital Resources Critical Accounting Estimates New Accounting Standards This discussion and analysis should be read together with Danaher’s audited financial statements and related Notes thereto as of December 31, 2021 and 2020 and for each of the three years in the period ended December 31, 2021 included in this Annual Report. Management's discussion and analysis of financial condition and results of operations for 2019 is included in Item 7 of the Company’s Annual Report on Form 10K with respect to the year ended December 31, 2020 filed with the Securities and Exchange Commission and should be referred to for information regarding this period.","[""Management's discussion and analysis of financial condition and results of operations for 2019 is included in Item 7 of the Company’s Annual Report on Form 10K with respect to the year ended December 31, 2020 filed with the Securities and Exchange Commission and should be referred to for information regarding this period."", 'Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is designed to provide material information relevant to an assessment of Danaher’s financial condition and results of operations, including an evaluation of the amounts and certainty of cash flows from operations and from outside sources.']","<b>Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is designed to provide material information relevant to an assessment of Danaher’s financial condition and results of operations, including an evaluation of the amounts and certainty of cash flows from operations and from outside sources.[r.2]</b> The MD&A is designed to focus specifically on material events and uncertainties known to management that are reasonably likely to cause reported financial information not to be necessarily indicative of future operating results or of future financial condition. This includes descriptions and amounts of matters that have had a material impact on reported operations, as well as matters that are reasonably likely based on management’s assessment to have a material impact on future operations. The Company’s MD&A is divided into five sections Overview Results of Operations Liquidity and Capital Resources Critical Accounting Estimates New Accounting Standards This discussion and analysis should be read together with Danaher’s audited financial statements and related Notes thereto as of December 31, 2021 and 2020 and for each of the three years in the period ended December 31, 2021 included in this Annual Report. <b>Management's discussion and analysis of financial condition and results of operations for 2019 is included in Item 7 of the Company’s Annual Report on Form 10K with respect to the year ended December 31, 2020 filed with the Securities and Exchange Commission and should be referred to for information regarding this period.[r.1]</b>","[4.36, 93.57, 2.07]",positive,"[99.99, 0.0, 0.01]",neutral,"[85.48, 6.91, 7.6]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.48,81,"Safety and Risk Management. Associate safety is deeply embedded in our culture. Our Environment, Health and Safety (EHS) Policy establishes the core principles upon which our EHS management programs are built, and associates use our DBSbased 4E toolkit to identify, assess and control hazards related to ergonomics, energetics, exposures and environment. In addition, we evaluate and manage risks relating to our human capital strategy as part of Danaher’s enterprise risk management program. Key quantitative measures that we use to assess performance in this category include total recordable incident rate (defined as the number of workrelated injuries or illness cases serious enough to require treatment beyond first aid, per 100 associates) and days away, restricted or transferred (defined as the number of workrelated injuries or illness cases that result in an employee working with physical restrictions, being away from work or unable to do their job or transferring to other work, per 100 associates).","['In addition, we evaluate and manage risks relating to our human capital strategy as part of Danaher’s enterprise risk management program.']","Safety and Risk Management. Associate safety is deeply embedded in our culture. Our Environment, Health and Safety (EHS) Policy establishes the core principles upon which our EHS management programs are built, and associates use our DBSbased 4E toolkit to identify, assess and control hazards related to ergonomics, energetics, exposures and environment. <b>In addition, we evaluate and manage risks relating to our human capital strategy as part of Danaher’s enterprise risk management program.[r.1]</b> Key quantitative measures that we use to assess performance in this category include total recordable incident rate (defined as the number of workrelated injuries or illness cases serious enough to require treatment beyond first aid, per 100 associates) and days away, restricted or transferred (defined as the number of workrelated injuries or illness cases that result in an employee working with physical restrictions, being away from work or unable to do their job or transferring to other work, per 100 associates).","[11.4, 85.43, 3.17]",positive,"[99.99, 0.0, 0.01]",neutral,"[66.91, 5.98, 27.11]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.46,591,"Danaher intends to disclose any amendment to the Code of Conduct that relates to any element of the code of ethics definition enumerated in Item 406(b) of Regulation SK, and any waiver from a provision of the Code of Conduct granted to any director, principal executive officer, principal financial officer, principal accounting officer, or any of its other executive officers, in the Investors section of its website, at www.danaher.com, within four business days following the date of such amendment or waiver.","['Danaher intends to disclose any amendment to the Code of Conduct that relates to any element of the code of ethics definition enumerated in Item 406(b) of Regulation SK, and any waiver from a provision of the Code of Conduct granted to any director, principal executive officer, principal financial officer, principal accounting officer, or any of its other executive officers, in the Investors section of its website, at www.danaher.com, within four business days following the date of such amendment or waiver.']","<b>Danaher intends to disclose any amendment to the Code of Conduct that relates to any element of the code of ethics definition enumerated in Item 406(b) of Regulation SK, and any waiver from a provision of the Code of Conduct granted to any director, principal executive officer, principal financial officer, principal accounting officer, or any of its other executive officers, in the Investors section of its website, at www.danaher.com, within four business days following the date of such amendment or waiver.[r.1]</b>","[4.27, 93.68, 2.06]",positive,"[99.99, 0.01, 0.01]",neutral,"[93.89, 3.48, 2.64]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.43,413,"Land and improvements Buildings Machinery and equipment Customerleased equipment Gross property, plant and equipment Less accumulated depreciation Property, plant and equipment, net $ $ 203  $ 1,676  3,610  1,766  7,255  (3,465) 3,790  $ 192  1,522  2,881  1,849  6,444  (3,182) 3,262 Investments—Investments over which the Company has a significant influence but not a controlling interest, are accounted for using the equity method of accounting which requires the Company to record its initial investment at cost and adjust the balance each period for the Company’s share of the investee’s income or loss and dividends paid. The Company also invests in startup companies where the Company has neither control of nor significant influence over the investee. The Company measures these nonmarketable equity securities at fair value and recognizes changes in fair value in net earnings. For securities without readily available fair values, the Company has elected the measurement alternative to record these investments at cost and to adjust for impairments and observable price changes with a same or similar security from the same issuer within net earnings (the Fair Value Alternative). Additionally, the Company is a limited partner in partnerships that invest in startup companies. While the partnerships record these investments at fair value, the Company’s investment in the partnerships is accounted for under the equity method of accounting. The Company made minority investments in nonmarketable equity securities and equity method investments totaling $934 million, $342 million and $241 million in 2021, 2020 and 2019, respectively, including investments in partnerships of $662 million, $172 million and $189 million in 2021, 2020 and 2019, respectively. The Company recorded net realized and unrealized gains related to changes in the fair value of these investments in other income (expense), net, in the Consolidated Statements of Earnings. Refer to Notes 9 and 12 for additional information about the Company’s investments.","['The Company recorded net realized and unrealized gains related to changes in the fair value of these investments in other income (expense), net, in the Consolidated Statements of Earnings.']","Land and improvements Buildings Machinery and equipment Customerleased equipment Gross property, plant and equipment Less accumulated depreciation Property, plant and equipment, net $ $ 203  $ 1,676  3,610  1,766  7,255  (3,465) 3,790  $ 192  1,522  2,881  1,849  6,444  (3,182) 3,262 Investments—Investments over which the Company has a significant influence but not a controlling interest, are accounted for using the equity method of accounting which requires the Company to record its initial investment at cost and adjust the balance each period for the Company’s share of the investee’s income or loss and dividends paid. The Company also invests in startup companies where the Company has neither control of nor significant influence over the investee. The Company measures these nonmarketable equity securities at fair value and recognizes changes in fair value in net earnings. For securities without readily available fair values, the Company has elected the measurement alternative to record these investments at cost and to adjust for impairments and observable price changes with a same or similar security from the same issuer within net earnings (the Fair Value Alternative). Additionally, the Company is a limited partner in partnerships that invest in startup companies. While the partnerships record these investments at fair value, the Company’s investment in the partnerships is accounted for under the equity method of accounting. The Company made minority investments in nonmarketable equity securities and equity method investments totaling $934 million, $342 million and $241 million in 2021, 2020 and 2019, respectively, including investments in partnerships of $662 million, $172 million and $189 million in 2021, 2020 and 2019, respectively. <b>The Company recorded net realized and unrealized gains related to changes in the fair value of these investments in other income (expense), net, in the Consolidated Statements of Earnings.[r.1]</b> Refer to Notes 9 and 12 for additional information about the Company’s investments.","[2.28, 94.3, 3.42]",positive,"[99.99, 0.01, 0.01]",neutral,"[81.48, 6.41, 12.11]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.42,391,"Due to the inherent uncertainty in predicting the resolution of some of these tax matters, auditing the Company’s uncertain tax positions and the related unrecognized tax benefits is complex and required the use of tax subject matter resources to determine whether the more likely than not criteria was met.","['Due to the inherent uncertainty in predicting the resolution of some of these tax matters, auditing the Company’s uncertain tax positions and the related unrecognized tax benefits is complex and required the use of tax subject matter resources to determine whether the more likely than not criteria was met.']","<b>Due to the inherent uncertainty in predicting the resolution of some of these tax matters, auditing the Company’s uncertain tax positions and the related unrecognized tax benefits is complex and required the use of tax subject matter resources to determine whether the more likely than not criteria was met.[r.1]</b>","[63.06, 34.87, 2.07]",neutral,"[99.98, 0.01, 0.02]",neutral,"[52.43, 3.06, 44.51]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.4,432,"In November 2021, the FASB issued ASU No. 202110 Government Assistance (Topic 832), which requires annual disclosures of transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. These required disclosures include information on the nature of transactions and related accounting policies used to account for transactions, detail on the line items on the balance sheet and income statement affected by these transactions including amounts applicable to each line, and significant terms and conditions of the transactions including commitments and contingencies. The ASU is effective for fiscal years beginning after December 15, 2021. The Company receives various forms of government assistance, primarily through grants related to the development of new products and the expansion of production capacity. During 2021, certain agencies of the U.S. government, including the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services, agreed to finance an expansion of production capacity related to chromatography, liquid cell culture media, buffers and cell culture powder media and singleuse consumables at certain of the Company’s Life Sciences businesses and the development of diagnostics testing technologies and the expansion of testing production capacity at certain of the Company’s Diagnostics businesses. The Company’s businesses may enter into similar agreements in the future. In consideration of this financing the U.S. government has certain rights, including rights with respect to the allocation of certain of the incremental production capacity associated with such expansion and/or rights in intellectual property produced with its financial assistance. The amount awarded pursuant to these grants in 2021 totaled $568 million and will be paid over periods ranging from one year to four years. In 2021, the Company received aggregate payments related to government grants of $73 million that offset operating expenses and capital expenditures of $41 million and $32 million, respectively. The Company is still assessing the impact of this ASU and the required disclosures, however, management anticipates the adoption of this ASU will not have a significant impact on the Company’s financial statements.","['These required disclosures include information on the nature of transactions and related accounting policies used to account for transactions, detail on the line items on the balance sheet and income statement affected by these transactions including amounts applicable to each line, and significant terms and conditions of the transactions including commitments and contingencies.', 'The Company is still assessing the impact of this ASU and the required disclosures, however, management anticipates the adoption of this ASU will not have a significant impact on the Company’s financial statements.']","In November 2021, the FASB issued ASU No. 202110 Government Assistance (Topic 832), which requires annual disclosures of transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. <b>These required disclosures include information on the nature of transactions and related accounting policies used to account for transactions, detail on the line items on the balance sheet and income statement affected by these transactions including amounts applicable to each line, and significant terms and conditions of the transactions including commitments and contingencies.[r.1]</b> The ASU is effective for fiscal years beginning after December 15, 2021. The Company receives various forms of government assistance, primarily through grants related to the development of new products and the expansion of production capacity. During 2021, certain agencies of the U.S. government, including the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services, agreed to finance an expansion of production capacity related to chromatography, liquid cell culture media, buffers and cell culture powder media and singleuse consumables at certain of the Company’s Life Sciences businesses and the development of diagnostics testing technologies and the expansion of testing production capacity at certain of the Company’s Diagnostics businesses. The Company’s businesses may enter into similar agreements in the future. In consideration of this financing the U.S. government has certain rights, including rights with respect to the allocation of certain of the incremental production capacity associated with such expansion and/or rights in intellectual property produced with its financial assistance. The amount awarded pursuant to these grants in 2021 totaled $568 million and will be paid over periods ranging from one year to four years. In 2021, the Company received aggregate payments related to government grants of $73 million that offset operating expenses and capital expenditures of $41 million and $32 million, respectively. <b>The Company is still assessing the impact of this ASU and the required disclosures, however, management anticipates the adoption of this ASU will not have a significant impact on the Company’s financial statements.[r.2]</b>","[1.69, 92.12, 6.19]",positive,"[99.98, 0.01, 0.01]",neutral,"[83.32, 6.91, 9.77]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.4,365,"In addition, certain of the Company’s tax returns are currently under review by tax authorities including in Denmark and the United States (refer to —Results of Operations—Income Taxes and Note 7 to the Consolidated Financial Statements). Management believes the positions taken in these returns are in accordance with the relevant tax laws. However, the outcome of these audits is uncertain and could result in the Company being required to record charges for prior year tax obligations which could have a material adverse impact to the Company’s financial statements, including its effective tax rate.",[],"In addition, certain of the Company’s tax returns are currently under review by tax authorities including in Denmark and the United States (refer to —Results of Operations—Income Taxes and Note 7 to the Consolidated Financial Statements). Management believes the positions taken in these returns are in accordance with the relevant tax laws. However, the outcome of these audits is uncertain and could result in the Company being required to record charges for prior year tax obligations which could have a material adverse impact to the Company’s financial statements, including its effective tax rate.","[72.06, 26.1, 1.85]",neutral,"[97.83, 0.02, 2.16]",neutral,"[48.84, 2.21, 48.94]",negative
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.39,546,"A limited number of the Company’s subsidiaries participate in multiemployer defined benefit and contribution plans, primarily outside of the United States, that require the Company to periodically contribute funds to the plan. The risks of participating in a multiemployer plan differ from the risks of participating in a singleemployer plan in the following respects (1) assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers, (2) if a participating employer ceases contributing to the plan, the unfunded obligations of the plan may be required to be borne by the remaining participating employers and (3) if the Company elects to stop participating in the plan, the Company may be required to pay the plan an amount based on the unfunded status of the plan. None of the multiemployer plans in which the Company’s subsidiaries participate are considered to be quantitatively or qualitatively significant, either individually or in the aggregate. In addition, contributions made to these plans during 2021, 2020 and 2019 were not significant, either individually or in the aggregate.","['The risks of participating in a multiemployer plan differ from the risks of participating in a singleemployer plan in the following respects (1) assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers, (2) if a participating employer ceases contributing to the plan, the unfunded obligations of the plan may be required to be borne by the remaining participating employers and (3) if the Company elects to stop participating in the plan, the Company may be required to pay the plan an amount based on the unfunded status of the plan.']","A limited number of the Company’s subsidiaries participate in multiemployer defined benefit and contribution plans, primarily outside of the United States, that require the Company to periodically contribute funds to the plan. <b>The risks of participating in a multiemployer plan differ from the risks of participating in a singleemployer plan in the following respects (1) assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers, (2) if a participating employer ceases contributing to the plan, the unfunded obligations of the plan may be required to be borne by the remaining participating employers and (3) if the Company elects to stop participating in the plan, the Company may be required to pay the plan an amount based on the unfunded status of the plan.[r.1]</b> None of the multiemployer plans in which the Company’s subsidiaries participate are considered to be quantitatively or qualitatively significant, either individually or in the aggregate. In addition, contributions made to these plans during 2021, 2020 and 2019 were not significant, either individually or in the aggregate.","[5.95, 91.59, 2.46]",positive,"[99.99, 0.0, 0.01]",neutral,"[59.73, 4.46, 35.81]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.39,493,"As discussed in Note 2, goodwill arises from the purchase price for acquired businesses exceeding the fair value of tangible and intangible assets acquired less assumed liabilities and noncontrolling interests. Management assesses the goodwill of each of its reporting units for impairment at least annually at the beginning of the fourth quarter and as triggering events occur that indicate that it is more likely than not that an impairment exists. The Company elected to bypass the optional qualitative goodwill assessment allowed by applicable accounting standards and performed a quantitative impairment test for all reporting units as this was determined to be the most effective method to assess for impairment across the reporting units.",['Management assesses the goodwill of each of its reporting units for impairment at least annually at the beginning of the fourth quarter and as triggering events occur that indicate that it is more likely than not that an impairment exists.'],"As discussed in Note 2, goodwill arises from the purchase price for acquired businesses exceeding the fair value of tangible and intangible assets acquired less assumed liabilities and noncontrolling interests. <b>Management assesses the goodwill of each of its reporting units for impairment at least annually at the beginning of the fourth quarter and as triggering events occur that indicate that it is more likely than not that an impairment exists.[r.1]</b> The Company elected to bypass the optional qualitative goodwill assessment allowed by applicable accounting standards and performed a quantitative impairment test for all reporting units as this was determined to be the most effective method to assess for impairment across the reporting units.","[7.65, 69.43, 22.92]",positive,"[99.99, 0.01, 0.01]",neutral,"[75.28, 12.06, 12.66]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.38,107,"For a discussion of the environmental laws and regulations that the Company’s operations, products and services are subject to and other environmental contingencies, refer to Note 18 to the Consolidated Financial Statements included in this Annual Report. For a discussion of risks related to compliance with environmental and health and safety laws and risks related to past or future releases of, or exposures to, hazardous substances, refer to Item 1A. Risk Factors.","['For a discussion of the environmental laws and regulations that the Company’s operations, products and services are subject to and other environmental contingencies, refer to Note 18 to the Consolidated Financial Statements included in this Annual Report.']","<b>For a discussion of the environmental laws and regulations that the Company’s operations, products and services are subject to and other environmental contingencies, refer to Note 18 to the Consolidated Financial Statements included in this Annual Report.[r.1]</b> For a discussion of risks related to compliance with environmental and health and safety laws and risks related to past or future releases of, or exposures to, hazardous substances, refer to Item 1A. Risk Factors.","[4.0, 93.83, 2.18]",positive,"[99.99, 0.0, 0.01]",neutral,"[67.84, 2.85, 29.31]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.32,331,"Cash flows from operating activities can fluctuate significantly from periodtoperiod as working capital needs and the timing of payments for income taxes, restructuring activities and productivity improvement initiatives, pension funding and other items impact reported cash flows.","['Cash flows from operating activities can fluctuate significantly from periodtoperiod as working capital needs and the timing of payments for income taxes, restructuring activities and productivity improvement initiatives, pension funding and other items impact reported cash flows.']","<b>Cash flows from operating activities can fluctuate significantly from periodtoperiod as working capital needs and the timing of payments for income taxes, restructuring activities and productivity improvement initiatives, pension funding and other items impact reported cash flows.[r.1]</b>","[95.45, 2.98, 1.57]",neutral,"[70.33, 0.16, 29.51]",neutral,"[81.21, 3.93, 14.86]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.31,367,"Valuation of Investments in Equity Securities—For a description of the Company’s investments in equity securities and partnerships refer to Notes 1, 9 and 12 to the Consolidated Financial Statements. The Company invests in publiclytraded securities, nonmarketable securities of earlystage companies and equity method investments, including partnerships that invest primarily in earlystage companies.","['Valuation of Investments in Equity Securities—For a description of the Company’s investments in equity securities and partnerships refer to Notes 1, 9 and 12 to the Consolidated Financial Statements.']","<b>Valuation of Investments in Equity Securities—For a description of the Company’s investments in equity securities and partnerships refer to Notes 1, 9 and 12 to the Consolidated Financial Statements.[r.1]</b> The Company invests in publiclytraded securities, nonmarketable securities of earlystage companies and equity method investments, including partnerships that invest primarily in earlystage companies.","[1.87, 95.28, 2.85]",positive,"[99.99, 0.0, 0.01]",neutral,"[92.55, 5.26, 2.18]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.29,327,"The Company has relied primarily on borrowings under its commercial paper program to address liquidity requirements that exceed the capacity provided by its operating cash flows and cash on hand, while also accessing the capital markets from time to time including to secure financing for more significant acquisitions. Subject to any limitations that may result from the COVID19 pandemic or other market disruptions (such as the disruptions in the financial and capital markets that occurred at times in 2020), the Company anticipates following the same approach in the future.",[],"The Company has relied primarily on borrowings under its commercial paper program to address liquidity requirements that exceed the capacity provided by its operating cash flows and cash on hand, while also accessing the capital markets from time to time including to secure financing for more significant acquisitions. Subject to any limitations that may result from the COVID19 pandemic or other market disruptions (such as the disruptions in the financial and capital markets that occurred at times in 2020), the Company anticipates following the same approach in the future.","[2.2, 79.12, 18.68]",positive,"[99.98, 0.01, 0.01]",neutral,"[75.22, 17.19, 7.58]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.27,359,"As of December 31, 2021, the Company had five reporting units for goodwill impairment testing. Reporting units resulting from recent acquisitions generally present the highest risk of impairment. Management believes the impairment risk associated with these reporting units generally decreases as these businesses are integrated into the Company and better positioned for potential future earnings growth. The Company’s annual goodwill impairment analysis in 2021 indicated that in all instances, the fair values of the Company’s reporting units exceeded their carrying values and consequently did not result in an impairment charge. The excess of the estimated fair value over carrying value (expressed as a percentage of carrying value for the respective reporting unit) for each of the Company’s reporting units as of the annual testing date ranged from approximately 175% to approximately 1,200%. To evaluate the sensitivity of the fair value calculations used in the goodwill impairment test, the Company applied a hypothetical 10% decrease to the fair values of each reporting unit and compared those hypothetical values to the reporting unit carrying values. Based on this hypothetical 10% decrease, the excess of the estimated fair value over carrying value (expressed as a percentage of carrying value for the respective reporting unit) for each of the Company’s reporting units ranged from approximately 145% to approximately 1,100%.",['Management believes the impairment risk associated with these reporting units generally decreases as these businesses are integrated into the Company and better positioned for potential future earnings growth.'],"As of December 31, 2021, the Company had five reporting units for goodwill impairment testing. Reporting units resulting from recent acquisitions generally present the highest risk of impairment. <b>Management believes the impairment risk associated with these reporting units generally decreases as these businesses are integrated into the Company and better positioned for potential future earnings growth.[r.1]</b> The Company’s annual goodwill impairment analysis in 2021 indicated that in all instances, the fair values of the Company’s reporting units exceeded their carrying values and consequently did not result in an impairment charge. The excess of the estimated fair value over carrying value (expressed as a percentage of carrying value for the respective reporting unit) for each of the Company’s reporting units as of the annual testing date ranged from approximately 175% to approximately 1,200%. To evaluate the sensitivity of the fair value calculations used in the goodwill impairment test, the Company applied a hypothetical 10% decrease to the fair values of each reporting unit and compared those hypothetical values to the reporting unit carrying values. Based on this hypothetical 10% decrease, the excess of the estimated fair value over carrying value (expressed as a percentage of carrying value for the respective reporting unit) for each of the Company’s reporting units ranged from approximately 145% to approximately 1,100%.","[86.03, 9.38, 4.6]",neutral,"[0.06, 99.86, 0.08]",positive,"[68.37, 12.76, 18.87]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.21,163,"Climate change resulting from increased concentrations of carbon dioxide and other greenhouse gases in the atmosphere could present risks to our operations. Physical risk resulting from acute changes (such as hurricane, tornado, wildfire or flooding) or chronic changes (such as droughts, heat waves or sea level changes) in climate patterns can adversely impact our facilities and operations and disrupt our supply chains and distribution systems. Concern over climate change can also result in new or additional legal or regulatory requirements designed to reduce greenhouse gas emissions and/or mitigate the effects of climate change on the environment (such as taxation of, or caps on the use of, carbonbased energy). Any such new or additional legal or regulatory requirements may increase the costs associated with, or disrupt, sourcing, manufacturing and distribution of our products, which may adversely affect our business and financial statements. In addition, any failure to adequately address stakeholder expectations with respect to environmental, social and governance (ESG) matters may result in the loss of business, adverse reputational impacts, diluted market valuations and challenges in attracting and retaining customers and talented employees.","['In addition, any failure to adequately address stakeholder expectations with respect to environmental, social and governance (ESG) matters may result in the loss of business, adverse reputational impacts, diluted market valuations and challenges in attracting and retaining customers and talented employees.']","Climate change resulting from increased concentrations of carbon dioxide and other greenhouse gases in the atmosphere could present risks to our operations. Physical risk resulting from acute changes (such as hurricane, tornado, wildfire or flooding) or chronic changes (such as droughts, heat waves or sea level changes) in climate patterns can adversely impact our facilities and operations and disrupt our supply chains and distribution systems. Concern over climate change can also result in new or additional legal or regulatory requirements designed to reduce greenhouse gas emissions and/or mitigate the effects of climate change on the environment (such as taxation of, or caps on the use of, carbonbased energy). Any such new or additional legal or regulatory requirements may increase the costs associated with, or disrupt, sourcing, manufacturing and distribution of our products, which may adversely affect our business and financial statements. <b>In addition, any failure to adequately address stakeholder expectations with respect to environmental, social and governance (ESG) matters may result in the loss of business, adverse reputational impacts, diluted market valuations and challenges in attracting and retaining customers and talented employees.[r.1]</b>","[86.61, 11.92, 1.47]",neutral,"[0.17, 0.07, 99.75]",negative,"[29.29, 2.11, 68.6]",negative
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.17,377,"The Company’s independent registered public accounting firm has issued an audit report on the effectiveness of the Company’s internal control over financial reporting. This report dated February 23, 2022 appears on pages 58 and 59 of this Form 10K.",['The Company’s independent registered public accounting firm has issued an audit report on the effectiveness of the Company’s internal control over financial reporting.'],"<b>The Company’s independent registered public accounting firm has issued an audit report on the effectiveness of the Company’s internal control over financial reporting.[r.1]</b> This report dated February 23, 2022 appears on pages 58 and 59 of this Form 10K.","[1.37, 90.42, 8.21]",positive,"[99.99, 0.01, 0.01]",neutral,"[92.3, 5.82, 1.87]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.17,120,"Our global operations expose us to risks associated with public health crises, including epidemics and pandemics such as COVID19. The global spread of COVID19 has led to unprecedented restrictions on, and disruptions in, business and personal activities, including as a result of preventive and precautionary measures that we, other businesses, our communities and governments are taking to mitigate the spread. For example, national, state and local governments have implemented and may continue to implement safety precautions, including quarantines, border closures, increased border controls, travel restrictions, shelter in place orders, shutdowns, governmentordered vaccine mandates and other measures. These measures can disrupt normal business operations and can have significant negative impacts on businesses and financial markets worldwide.",[],"Our global operations expose us to risks associated with public health crises, including epidemics and pandemics such as COVID19. The global spread of COVID19 has led to unprecedented restrictions on, and disruptions in, business and personal activities, including as a result of preventive and precautionary measures that we, other businesses, our communities and governments are taking to mitigate the spread. For example, national, state and local governments have implemented and may continue to implement safety precautions, including quarantines, border closures, increased border controls, travel restrictions, shelter in place orders, shutdowns, governmentordered vaccine mandates and other measures. These measures can disrupt normal business operations and can have significant negative impacts on businesses and financial markets worldwide.","[86.43, 11.78, 1.79]",neutral,"[0.55, 0.1, 99.35]",negative,"[30.85, 2.1, 67.05]",negative
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.17,151,"We continually assess the strategic fit of our existing businesses and may divest, spinoff, splitoff or otherwise dispose of businesses that are deemed not to fit with our strategic plan or are not achieving the desired return on investment. For example, in 2015 Danaher separated and splitoff to Danaher shareholders the majority of its former communications business in a Reverse Morris Trust transaction with NetScout Systems, Inc. (the Communications Disposition), in 2016 Danaher separated and spunoff to Danaher shareholders its former Test & Measurement segment, Industrial Technologies segment (excluding the product identification businesses) and retail/commercial petroleum business (collectively known as Fortive Corporation) (the Fortive Disposition), and in 2019 Danaher consummated the separation and initial public offering (IPO) and subsequent splitoff of its Dental segment, known as Envista Holdings Corporation (the Envista Disposition). Transactions such as these pose risks and challenges that could negatively impact our business and financial statements. For example, when we decide to sell or otherwise dispose of a business or assets, we may be unable to do so on satisfactory terms within our anticipated timeframe or at all, and even after reaching a definitive agreement to sell or dispose a business the sale is typically subject to satisfaction of preclosing conditions which may not become satisfied. In addition, divestitures or other dispositions can dilute the Company’s earnings per share, have other adverse financial, tax and accounting impacts and distract management, and disputes can arise with buyers. In addition, we have retained responsibility for and/or have agreed to indemnify buyers against some known and unknown contingent liabilities related to a number of businesses we or our predecessors have sold or disposed. The resolution of these contingencies has not had a material effect on our business or financial statements but we cannot be certain that this favorable pattern will continue.","['We continually assess the strategic fit of our existing businesses and may divest, spinoff, splitoff or otherwise dispose of businesses that are deemed not to fit with our strategic plan or are not achieving the desired return on investment.']","<b>We continually assess the strategic fit of our existing businesses and may divest, spinoff, splitoff or otherwise dispose of businesses that are deemed not to fit with our strategic plan or are not achieving the desired return on investment.[r.1]</b> For example, in 2015 Danaher separated and splitoff to Danaher shareholders the majority of its former communications business in a Reverse Morris Trust transaction with NetScout Systems, Inc. (the Communications Disposition), in 2016 Danaher separated and spunoff to Danaher shareholders its former Test & Measurement segment, Industrial Technologies segment (excluding the product identification businesses) and retail/commercial petroleum business (collectively known as Fortive Corporation) (the Fortive Disposition), and in 2019 Danaher consummated the separation and initial public offering (IPO) and subsequent splitoff of its Dental segment, known as Envista Holdings Corporation (the Envista Disposition). Transactions such as these pose risks and challenges that could negatively impact our business and financial statements. For example, when we decide to sell or otherwise dispose of a business or assets, we may be unable to do so on satisfactory terms within our anticipated timeframe or at all, and even after reaching a definitive agreement to sell or dispose a business the sale is typically subject to satisfaction of preclosing conditions which may not become satisfied. In addition, divestitures or other dispositions can dilute the Company’s earnings per share, have other adverse financial, tax and accounting impacts and distract management, and disputes can arise with buyers. In addition, we have retained responsibility for and/or have agreed to indemnify buyers against some known and unknown contingent liabilities related to a number of businesses we or our predecessors have sold or disposed. The resolution of these contingencies has not had a material effect on our business or financial statements but we cannot be certain that this favorable pattern will continue.","[13.5, 83.52, 2.98]",positive,"[96.79, 0.07, 3.14]",neutral,"[45.15, 2.79, 52.06]",negative
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.16,118,"You should carefully consider the risks and uncertainties described below, together with the information included elsewhere in this Annual Report on Form 10K and other documents we file with the SEC. We have identified the risks and uncertainties described below as material, but they are not the only risks and uncertainties facing us. Our business is also subject to general risks and uncertainties that affect many other companies, such as market conditions, economic conditions, geopolitical events, changes in laws, regulations or accounting rules, fluctuations in interest rates, terrorism, wars or conflicts, major health concerns including pandemics, natural disasters or other disruptions of expected business conditions. Additional risks and uncertainties not currently known to us or that we currently believe are immaterial also may impair our business and financial statements, including our results of operations, liquidity and financial condition, and our stock price.",[],"You should carefully consider the risks and uncertainties described below, together with the information included elsewhere in this Annual Report on Form 10K and other documents we file with the SEC. We have identified the risks and uncertainties described below as material, but they are not the only risks and uncertainties facing us. Our business is also subject to general risks and uncertainties that affect many other companies, such as market conditions, economic conditions, geopolitical events, changes in laws, regulations or accounting rules, fluctuations in interest rates, terrorism, wars or conflicts, major health concerns including pandemics, natural disasters or other disruptions of expected business conditions. Additional risks and uncertainties not currently known to us or that we currently believe are immaterial also may impair our business and financial statements, including our results of operations, liquidity and financial condition, and our stock price.","[46.73, 51.23, 2.04]",positive,"[99.79, 0.01, 0.2]",neutral,"[47.39, 2.42, 50.19]",negative
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.14,501,"Availableforsale debt securities, which are included in other longterm assets in the accompanying Consolidated Balance Sheets, are measured at fair value using quoted prices reported by investment brokers and dealers based on the underlying terms of the security and comparison to similar securities traded on an active market. As of December 31, 2021 and 2020, availableforsale debt securities primarily include U.S. Treasury Notes and corporate debt securities.","['Availableforsale debt securities, which are included in other longterm assets in the accompanying Consolidated Balance Sheets, are measured at fair value using quoted prices reported by investment brokers and dealers based on the underlying terms of the security and comparison to similar securities traded on an active market.']","<b>Availableforsale debt securities, which are included in other longterm assets in the accompanying Consolidated Balance Sheets, are measured at fair value using quoted prices reported by investment brokers and dealers based on the underlying terms of the security and comparison to similar securities traded on an active market.[r.1]</b> As of December 31, 2021 and 2020, availableforsale debt securities primarily include U.S. Treasury Notes and corporate debt securities.","[3.38, 94.66, 1.96]",positive,"[99.99, 0.0, 0.01]",neutral,"[92.26, 4.73, 3.01]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.11,515,"If a change of control triggering event occurs with respect to any of the 2021 (prior to their repayment in the first quarter of 2021), 2027 and 2032 Yen Notes the 2022, Floating Rate 2022, 2024, 2025 (prior to their repayment in the fourth quarter of 2021), 2026, 2027 and 2030 Euronotes the 2025, 2045, 2050 and 2051 U.S. Notes the 2023 and 2028 CHF Bonds the 2022, 2024, 2029, 2039 and 2049 Biopharma Notes or the 2026, 2028, 2031, 2039 and 2049 Biopharma Euronotes, each holder of such notes may require the Company to repurchase some or all of such notes and bonds at a purchase price equal to 101% (100% in the case of the 2027 and 2032 Yen Notes) of the principal amount of the notes and bonds, plus accrued and unpaid interest (and in the case of the Yen Notes, certain swaprelated losses as applicable). A change of control triggering event means the occurrence of both a change of control and a rating event, each as defined in the applicable indenture or comparable governing document. Except in connection with a change of control triggering event, the Company does not have any credit rating downgrade triggers that would accelerate the maturity of a material amount of outstanding debt. Each holder of the 2027 and 2032 Yen Notes may also require the Company to repurchase some or all of its notes at a purchase price equal to 100% of the principal amount of the notes, plus accrued and unpaid interest and certain swaprelated losses as applicable, in certain circumstances whereby such holder comes into violation of economic sanctions laws as a result of holding such notes.",[],"If a change of control triggering event occurs with respect to any of the 2021 (prior to their repayment in the first quarter of 2021), 2027 and 2032 Yen Notes the 2022, Floating Rate 2022, 2024, 2025 (prior to their repayment in the fourth quarter of 2021), 2026, 2027 and 2030 Euronotes the 2025, 2045, 2050 and 2051 U.S. Notes the 2023 and 2028 CHF Bonds the 2022, 2024, 2029, 2039 and 2049 Biopharma Notes or the 2026, 2028, 2031, 2039 and 2049 Biopharma Euronotes, each holder of such notes may require the Company to repurchase some or all of such notes and bonds at a purchase price equal to 101% (100% in the case of the 2027 and 2032 Yen Notes) of the principal amount of the notes and bonds, plus accrued and unpaid interest (and in the case of the Yen Notes, certain swaprelated losses as applicable). A change of control triggering event means the occurrence of both a change of control and a rating event, each as defined in the applicable indenture or comparable governing document. Except in connection with a change of control triggering event, the Company does not have any credit rating downgrade triggers that would accelerate the maturity of a material amount of outstanding debt. Each holder of the 2027 and 2032 Yen Notes may also require the Company to repurchase some or all of its notes at a purchase price equal to 100% of the principal amount of the notes, plus accrued and unpaid interest and certain swaprelated losses as applicable, in certain circumstances whereby such holder comes into violation of economic sanctions laws as a result of holding such notes.","[15.91, 82.19, 1.9]",positive,"[99.98, 0.01, 0.01]",neutral,"[62.77, 3.28, 33.94]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.09,462,"Remaining performance obligations represent the aggregate transaction price allocated to performance obligations with an original contract term greater than one year which are fully or partially unsatisfied at the end of the period. Remaining performance obligations include noncancelable purchase orders, the nonlease portion of minimum purchase commitments under longterm consumable supply arrangements, extended warranty and service and other longterm contracts. These remaining performance obligations do not include revenue from contracts with customers with an original term of one year or less, revenue from longterm consumable supply arrangements with no minimum purchase requirements or revenue expected from purchases made in excess of the minimum purchase requirements or revenue from equipment leased to customers. While the remaining performance obligation disclosure is similar in concept to backlog, the definition of remaining performance obligations excludes leases and contracts that provide the customer with the right to cancel or terminate for convenience with no substantial penalty, even if historical experience indicates the likelihood of cancellation or termination is remote. Additionally, the Company has elected to exclude contracts with customers with an original term of one year or less from remaining performance obligations while these contracts are included within backlog.",[],"Remaining performance obligations represent the aggregate transaction price allocated to performance obligations with an original contract term greater than one year which are fully or partially unsatisfied at the end of the period. Remaining performance obligations include noncancelable purchase orders, the nonlease portion of minimum purchase commitments under longterm consumable supply arrangements, extended warranty and service and other longterm contracts. These remaining performance obligations do not include revenue from contracts with customers with an original term of one year or less, revenue from longterm consumable supply arrangements with no minimum purchase requirements or revenue expected from purchases made in excess of the minimum purchase requirements or revenue from equipment leased to customers. While the remaining performance obligation disclosure is similar in concept to backlog, the definition of remaining performance obligations excludes leases and contracts that provide the customer with the right to cancel or terminate for convenience with no substantial penalty, even if historical experience indicates the likelihood of cancellation or termination is remote. Additionally, the Company has elected to exclude contracts with customers with an original term of one year or less from remaining performance obligations while these contracts are included within backlog.","[22.15, 75.67, 2.18]",positive,"[99.97, 0.01, 0.03]",neutral,"[60.41, 5.56, 34.03]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.08,551,"While the Company maintains general, products, property, workers’ compensation, automobile, cargo, aviation, crime, cyber, fiduciary and directors’ and officers’ liability insurance (and has acquired rights under similar policies in connection with certain acquisitions) up to certain limits that cover certain of these claims, this insurance may be insufficient or unavailable to cover such losses. For general, products and property liability and most other insured risks, the Company purchases outside insurance coverage only for severe losses and must establish and maintain reserves with respect to amounts within the selfinsured retention. In addition, while the Company believes it is entitled to indemnification from thirdparties for some of these claims, these rights may also be insufficient or unavailable to cover such losses.","['While the Company maintains general, products, property, workers’ compensation, automobile, cargo, aviation, crime, cyber, fiduciary and directors’ and officers’ liability insurance (and has acquired rights under similar policies in connection with certain acquisitions) up to certain limits that cover certain of these claims, this insurance may be insufficient or unavailable to cover such losses.']","<b>While the Company maintains general, products, property, workers’ compensation, automobile, cargo, aviation, crime, cyber, fiduciary and directors’ and officers’ liability insurance (and has acquired rights under similar policies in connection with certain acquisitions) up to certain limits that cover certain of these claims, this insurance may be insufficient or unavailable to cover such losses.[r.1]</b> For general, products and property liability and most other insured risks, the Company purchases outside insurance coverage only for severe losses and must establish and maintain reserves with respect to amounts within the selfinsured retention. In addition, while the Company believes it is entitled to indemnification from thirdparties for some of these claims, these rights may also be insufficient or unavailable to cover such losses.","[15.76, 81.42, 2.82]",positive,"[99.94, 0.01, 0.06]",neutral,"[50.47, 2.76, 46.77]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.07,558,"As of December 31, 2021, the Company had approximately $703 million of guarantees consisting primarily of outstanding standby letters of credit, bank guarantees and performance and bid bonds. These guarantees have been provided in connection with certain arrangements with vendors, customers, insurance providers, financing counterparties and governmental entities to secure the Company’s obligations and/or performance requirements related to specific transactions. The Company believes that if the obligations under these instruments were triggered, it would not have a material effect on its Consolidated Financial Statements.",[],"As of December 31, 2021, the Company had approximately $703 million of guarantees consisting primarily of outstanding standby letters of credit, bank guarantees and performance and bid bonds. These guarantees have been provided in connection with certain arrangements with vendors, customers, insurance providers, financing counterparties and governmental entities to secure the Company’s obligations and/or performance requirements related to specific transactions. The Company believes that if the obligations under these instruments were triggered, it would not have a material effect on its Consolidated Financial Statements.","[8.48, 89.3, 2.23]",positive,"[99.99, 0.0, 0.01]",neutral,"[81.23, 8.35, 10.42]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.05,433,"The Company continually evaluates potential acquisitions that either strategically fit with the Company’s existing portfolio or expand the Company’s portfolio into a new and attractive business area. The Company has completed a number of acquisitions that have been accounted for as purchases and have resulted in the recognition of goodwill in the Company’s Consolidated Financial Statements. This goodwill arises because the purchase prices for these businesses exceeds the fair value of acquired identifiable net assets due to the purchase prices reflecting a number of factors including the future earnings and cash flow potential of these businesses, the multiple to earnings, cash flow and other factors at which similar businesses have been purchased by other acquirers, the competitive nature of the processes by which the Company acquired the businesses, the avoidance of the time and costs which would be required (and the associated risks that would be encountered) to enhance the Company’s existing product offerings to key target markets and enter into new and profitable businesses and the complementary strategic fit and resulting synergies these businesses bring to existing operations.",[],"The Company continually evaluates potential acquisitions that either strategically fit with the Company’s existing portfolio or expand the Company’s portfolio into a new and attractive business area. The Company has completed a number of acquisitions that have been accounted for as purchases and have resulted in the recognition of goodwill in the Company’s Consolidated Financial Statements. This goodwill arises because the purchase prices for these businesses exceeds the fair value of acquired identifiable net assets due to the purchase prices reflecting a number of factors including the future earnings and cash flow potential of these businesses, the multiple to earnings, cash flow and other factors at which similar businesses have been purchased by other acquirers, the competitive nature of the processes by which the Company acquired the businesses, the avoidance of the time and costs which would be required (and the associated risks that would be encountered) to enhance the Company’s existing product offerings to key target markets and enter into new and profitable businesses and the complementary strategic fit and resulting synergies these businesses bring to existing operations.","[1.57, 76.78, 21.65]",positive,"[0.44, 99.53, 0.03]",positive,"[67.78, 28.37, 3.85]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.05,568,"PSUs issued under the 2007 Omnibus Incentive Plan provide for the issuance of a share of the Company’s common stock at no cost to the holder, vest based on specified performance criteria, are subject to an additional holding period following vesting and are entitled to dividend equivalent rights. The PSU dividend equivalent rights are subject to the same vesting and payment restrictions as the related shares, and the shares underlying the PSUs are not considered issued and outstanding.","['The PSU dividend equivalent rights are subject to the same vesting and payment restrictions as the related shares, and the shares underlying the PSUs are not considered issued and outstanding.']","PSUs issued under the 2007 Omnibus Incentive Plan provide for the issuance of a share of the Company’s common stock at no cost to the holder, vest based on specified performance criteria, are subject to an additional holding period following vesting and are entitled to dividend equivalent rights. <b>The PSU dividend equivalent rights are subject to the same vesting and payment restrictions as the related shares, and the shares underlying the PSUs are not considered issued and outstanding.[r.1]</b>","[2.54, 95.3, 2.17]",positive,"[99.99, 0.0, 0.01]",neutral,"[78.58, 4.16, 17.26]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.03,123,"Please see Item 7 – Management’s Discussion and Analysis of Financial Condition and Results of Operations for a discussion of the Company products that are being used in the fight against COVID19. In an effort to optimize availability of needed medical and other supplies and products in connection with the pandemic, we may elect to or governments may require us or our customers to allocate manufacturing capacity (for example, pursuant to the U.S. Defense Production Act (DPA)) in a way that adversely affects our financial condition and results of operations, results in differential treatment of customers and/or adversely affects our reputation and customer relationships. For example, certain of our customers are or have been subject to DPA requirements relating to the production of COVID19 related products and have required certain of our businesses to also comply with these requirements under our supply agreements. Please also see the risk factor titled The U.S. government has certain rights with respect to incremental production capacity and/or the intellectual property we have developed using government financing for a discussion of the U.S. government’s rights in connection with funding they have provided certain of our businesses to finance capacity expansion for the production of certain COVID19 related products.",['Please also see the risk factor titled The U.S. government has certain rights with respect to incremental production capacity and/or the intellectual property we have developed using government financing for a discussion of the U.S. government’s rights in connection with funding they have provided certain of our businesses to finance capacity expansion for the production of certain COVID19 related products.'],"Please see Item 7 – Management’s Discussion and Analysis of Financial Condition and Results of Operations for a discussion of the Company products that are being used in the fight against COVID19. In an effort to optimize availability of needed medical and other supplies and products in connection with the pandemic, we may elect to or governments may require us or our customers to allocate manufacturing capacity (for example, pursuant to the U.S. Defense Production Act (DPA)) in a way that adversely affects our financial condition and results of operations, results in differential treatment of customers and/or adversely affects our reputation and customer relationships. For example, certain of our customers are or have been subject to DPA requirements relating to the production of COVID19 related products and have required certain of our businesses to also comply with these requirements under our supply agreements. <b>Please also see the risk factor titled The U.S. government has certain rights with respect to incremental production capacity and/or the intellectual property we have developed using government financing for a discussion of the U.S. government’s rights in connection with funding they have provided certain of our businesses to finance capacity expansion for the production of certain COVID19 related products.[r.1]</b>","[9.3, 87.27, 3.43]",positive,"[99.53, 0.02, 0.45]",neutral,"[52.77, 2.74, 44.49]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.03,550,"The Company is subject to or otherwise responsible for a variety of litigation and other legal and regulatory proceedings in the course of its business (or related to the business operations of previously owned entities), including claims or counterclaims for damages arising out of the use of products or services and claims relating to intellectual property matters, employment matters, tax matters, commercial disputes, breach of contract claims, competition and sales and trading practices, environmental matters, personal injury, insurance coverage, securities matters, fiduciary duties and acquisition or divestiturerelated matters, as well as regulatory subpoenas, requests for information, investigations and enforcement. The Company also from time to time becomes subject to lawsuits as a result of acquisitions or as a result of liabilities retained from, or representations, warranties or indemnities provided in connection with, businesses divested by the Company or its predecessors. The types of claims made in lawsuits include claims for compensatory damages, punitive and consequential damages (and in some cases, treble damages) and/or injunctive relief.","['The Company is subject to or otherwise responsible for a variety of litigation and other legal and regulatory proceedings in the course of its business (or related to the business operations of previously owned entities), including claims or counterclaims for damages arising out of the use of products or services and claims relating to intellectual property matters, employment matters, tax matters, commercial disputes, breach of contract claims, competition and sales and trading practices, environmental matters, personal injury, insurance coverage, securities matters, fiduciary duties and acquisition or divestiturerelated matters, as well as regulatory subpoenas, requests for information, investigations and enforcement.']","<b>The Company is subject to or otherwise responsible for a variety of litigation and other legal and regulatory proceedings in the course of its business (or related to the business operations of previously owned entities), including claims or counterclaims for damages arising out of the use of products or services and claims relating to intellectual property matters, employment matters, tax matters, commercial disputes, breach of contract claims, competition and sales and trading practices, environmental matters, personal injury, insurance coverage, securities matters, fiduciary duties and acquisition or divestiturerelated matters, as well as regulatory subpoenas, requests for information, investigations and enforcement.[r.1]</b> The Company also from time to time becomes subject to lawsuits as a result of acquisitions or as a result of liabilities retained from, or representations, warranties or indemnities provided in connection with, businesses divested by the Company or its predecessors. The types of claims made in lawsuits include claims for compensatory damages, punitive and consequential damages (and in some cases, treble damages) and/or injunctive relief.","[31.69, 66.38, 1.93]",positive,"[99.98, 0.0, 0.01]",neutral,"[63.89, 1.74, 34.38]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",74.01,382,We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.,['Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.'],We conducted our audit in accordance with the standards of the PCAOB. <b>Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.[r.1]</b>,"[1.55, 85.34, 13.11]",positive,"[99.99, 0.01, 0.01]",neutral,"[83.49, 10.84, 5.66]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.98,216,"From time to time, we become aware through our internal audits and other internal control procedures, employees or other parties of possible compliance matters, such as complaints or concerns relating to accounting, internal controls, financial reporting, auditing or ethical matters or relating to compliance with laws. When we become aware of such possible compliance matters, we investigate internally and take what we believe to be appropriate corrective action. Internal investigations can lead to the assertion of claims or the commencement of legal or regulatory proceedings against us and adversely affect our business and financial statements.","['From time to time, we become aware through our internal audits and other internal control procedures, employees or other parties of possible compliance matters, such as complaints or concerns relating to accounting, internal controls, financial reporting, auditing or ethical matters or relating to compliance with laws.']","<b>From time to time, we become aware through our internal audits and other internal control procedures, employees or other parties of possible compliance matters, such as complaints or concerns relating to accounting, internal controls, financial reporting, auditing or ethical matters or relating to compliance with laws.[r.1]</b> When we become aware of such possible compliance matters, we investigate internally and take what we believe to be appropriate corrective action. Internal investigations can lead to the assertion of claims or the commencement of legal or regulatory proceedings against us and adversely affect our business and financial statements.","[35.93, 61.88, 2.19]",positive,"[99.97, 0.01, 0.02]",neutral,"[58.21, 2.09, 39.7]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.96,314,"The Company is exposed to market risk from changes in interest rates, foreign currency exchange rates, equity prices and commodity prices as well as credit risk, each of which could impact its Consolidated Financial Statements. The Company generally addresses its exposure to these risks through its normal operating and financing activities. The Company also periodically uses derivative financial instruments to manage foreign exchange risks and interest rate risks. In addition, the Company’s broadbased business activities help to reduce the impact that volatility in any particular area or related areas may have on its financial statements as a whole.","['In addition, the Company’s broadbased business activities help to reduce the impact that volatility in any particular area or related areas may have on its financial statements as a whole.']","The Company is exposed to market risk from changes in interest rates, foreign currency exchange rates, equity prices and commodity prices as well as credit risk, each of which could impact its Consolidated Financial Statements. The Company generally addresses its exposure to these risks through its normal operating and financing activities. The Company also periodically uses derivative financial instruments to manage foreign exchange risks and interest rate risks. <b>In addition, the Company’s broadbased business activities help to reduce the impact that volatility in any particular area or related areas may have on its financial statements as a whole.[r.1]</b>","[2.27, 92.12, 5.61]",positive,"[93.07, 6.77, 0.16]",neutral,"[78.39, 12.28, 9.33]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.95,307,"During the year ended December 31, 2020, the Company settled the IRS audits of its federal income tax returns for 2012 through 2015. In the audit, the IRS proposed significant adjustments to the Company’s taxable income of approximately $2.7 billion related to the deferral of tax on certain premium income related to the Company’s selfinsurance programs. For income tax purposes, the recognition of certain premium income has been deferred in accordance with U.S. tax laws related to insurance. While the settlement of these matters was not material to the Company’s financial statements, the settlement does not preclude the IRS from proposing similar adjustments in future audits and the IRS has continued to examine the deferral of premium income related to selfinsurance programs in its examination of the Company’s federal income tax returns for 2016 through 2018. The examination is ongoing and to date, the IRS has not proposed any adjustments related to the Company’s selfinsurance programs. Due to the enactment of the TCJA in 2017 and the resulting reduction in the U.S. corporate tax rate for years after 2017, the Company remeasured its deferred tax liabilities related to the temporary differences associated with this deferred premium income from 35.0% to 21.0%. If the IRS proposes adjustments related to the Company’s selfinsurance premiums with respect to years prior to the adoption of the TCJA and the Company is unsuccessful in defending its position, any taxes owed to the IRS may be computed under the previous 35.0% statutory tax rate and the Company may be required to remeasure the related deferred tax liabilities from 21.0% to 35.0%, which in addition to any interest due on the amounts assessed, would require a charge to future earnings. Management believes the positions the Company has taken in its U.S. tax returns are in accordance with the relevant tax laws.","['Due to the enactment of the TCJA in 2017 and the resulting reduction in the U.S. corporate tax rate for years after 2017, the Company remeasured its deferred tax liabilities related to the temporary differences associated with this deferred premium income from 35.0% to 21.0%.']","During the year ended December 31, 2020, the Company settled the IRS audits of its federal income tax returns for 2012 through 2015. In the audit, the IRS proposed significant adjustments to the Company’s taxable income of approximately $2.7 billion related to the deferral of tax on certain premium income related to the Company’s selfinsurance programs. For income tax purposes, the recognition of certain premium income has been deferred in accordance with U.S. tax laws related to insurance. While the settlement of these matters was not material to the Company’s financial statements, the settlement does not preclude the IRS from proposing similar adjustments in future audits and the IRS has continued to examine the deferral of premium income related to selfinsurance programs in its examination of the Company’s federal income tax returns for 2016 through 2018. The examination is ongoing and to date, the IRS has not proposed any adjustments related to the Company’s selfinsurance programs. <b>Due to the enactment of the TCJA in 2017 and the resulting reduction in the U.S. corporate tax rate for years after 2017, the Company remeasured its deferred tax liabilities related to the temporary differences associated with this deferred premium income from 35.0% to 21.0%.[r.1]</b> If the IRS proposes adjustments related to the Company’s selfinsurance premiums with respect to years prior to the adoption of the TCJA and the Company is unsuccessful in defending its position, any taxes owed to the IRS may be computed under the previous 35.0% statutory tax rate and the Company may be required to remeasure the related deferred tax liabilities from 21.0% to 35.0%, which in addition to any interest due on the amounts assessed, would require a charge to future earnings. Management believes the positions the Company has taken in its U.S. tax returns are in accordance with the relevant tax laws.","[14.49, 81.26, 4.25]",positive,"[99.97, 0.01, 0.02]",neutral,"[76.9, 5.01, 18.09]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.91,468,"The Company operates and reports its results in three separate business segments consisting of the Life Sciences, Diagnostics and Environmental & Applied Solutions segments. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income and expense, loss on early extinguishment of borrowings, interest and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. The identifiable assets by segment are those used in each segment’s operations. Intersegment amounts are not significant and are eliminated to arrive at consolidated totals.",[],"The Company operates and reports its results in three separate business segments consisting of the Life Sciences, Diagnostics and Environmental & Applied Solutions segments. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income and expense, loss on early extinguishment of borrowings, interest and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. The identifiable assets by segment are those used in each segment’s operations. Intersegment amounts are not significant and are eliminated to arrive at consolidated totals.","[13.09, 85.03, 1.89]",positive,"[99.97, 0.02, 0.01]",neutral,"[66.5, 7.24, 26.26]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.89,369,"The Company’s investments in publicly traded securities are measured at fair value based on quotes in active markets. For investments in non marketable equity securities where the Company does not have influence over the investee, the Company has elected the measurement alternative and records these investments at cost and adjusts the carrying value for impairments and observable price changes with a same or similar security from the same issuer adjusted to reflect the specific rights and preferences of the securities, if applicable. Valuations of nonmarketable equity securities are complex and require judgment due to the absence of market prices, lack of liquidity and the risks inherent in earlystage companies. The uncertainty in the process of valuing securities for which a ready market does not exist may cause our estimated values of these securities to differ significantly from the values that would have been derived had a ready market for the securities existed, and those differences could be material.","['Valuations of nonmarketable equity securities are complex and require judgment due to the absence of market prices, lack of liquidity and the risks inherent in earlystage companies.']","The Company’s investments in publicly traded securities are measured at fair value based on quotes in active markets. For investments in non marketable equity securities where the Company does not have influence over the investee, the Company has elected the measurement alternative and records these investments at cost and adjusts the carrying value for impairments and observable price changes with a same or similar security from the same issuer adjusted to reflect the specific rights and preferences of the securities, if applicable. <b>Valuations of nonmarketable equity securities are complex and require judgment due to the absence of market prices, lack of liquidity and the risks inherent in earlystage companies.[r.1]</b> The uncertainty in the process of valuing securities for which a ready market does not exist may cause our estimated values of these securities to differ significantly from the values that would have been derived had a ready market for the securities existed, and those differences could be material.","[55.52, 42.01, 2.48]",neutral,"[99.94, 0.01, 0.06]",neutral,"[59.34, 4.84, 35.82]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.87,538,"The Company has certain investments that are valued using Net Asset Value (NAV) as the practical expedient. In addition, certain of the investments valued using NAV as the practical expedient have limits on their redemption to monthly, quarterly, semiannually or annually and require up to 90 days prior written notice. These investments valued using NAV consist of mutual funds, venture capital funds, partnerships, real estate, and other private investments, which allow the Company to allocate investments across a broad array of types of funds and diversify the portfolio.",[],"The Company has certain investments that are valued using Net Asset Value (NAV) as the practical expedient. In addition, certain of the investments valued using NAV as the practical expedient have limits on their redemption to monthly, quarterly, semiannually or annually and require up to 90 days prior written notice. These investments valued using NAV consist of mutual funds, venture capital funds, partnerships, real estate, and other private investments, which allow the Company to allocate investments across a broad array of types of funds and diversify the portfolio.","[1.5, 94.45, 4.06]",positive,"[99.99, 0.0, 0.01]",neutral,"[85.76, 12.91, 1.33]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.86,18,"Any inability to consummate acquisitions at our historical rate and appropriate prices, and to make appropriate investments that support our longterm strategy, could negatively impact our business. Our acquisition of businesses, investments, joint ventures and other strategic relationships could also negatively impact our business and financial statements and our indemnification rights may not fully protect us from liabilities related thereto.","['Our acquisition of businesses, investments, joint ventures and other strategic relationships could also negatively impact our business and financial statements and our indemnification rights may not fully protect us from liabilities related thereto.']","Any inability to consummate acquisitions at our historical rate and appropriate prices, and to make appropriate investments that support our longterm strategy, could negatively impact our business. <b>Our acquisition of businesses, investments, joint ventures and other strategic relationships could also negatively impact our business and financial statements and our indemnification rights may not fully protect us from liabilities related thereto.[r.1]</b>","[86.77, 11.98, 1.25]",neutral,"[0.21, 0.05, 99.74]",negative,"[19.16, 1.1, 79.74]",negative
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.83,423,"Income Taxes—The Company’s income tax expense represents the tax liability for the current year, the tax benefit or expense for the net change in deferred tax liabilities and assets during the year, as well as reserves for unrecognized tax benefits and return to provision adjustments. Deferred tax liabilities and assets are determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted rates expected to be in effect during the year in which the differences reverse. Deferred tax assets generally represent items that can be used as a tax deduction or credit in the Company’s tax return in future years for which the tax benefit has already been reflected on the Company’s Consolidated Statements of Earnings. The Company establishes valuation allowances for its deferred tax assets if it is more likely than not that some or all of the deferred tax asset will not be realized. Deferred tax liabilities generally represent items that have already been taken as a deduction on the Company’s tax return but have not yet been recognized as an expense in the Company’s Consolidated Statements of Earnings. The effect on deferred tax assets and liabilities due to a change in tax rates is recognized in income tax expense in the period that includes the enactment date. The Company provides for unrecognized tax benefits when, based upon the technical merits, it is more likely than not that an uncertain tax position will not be sustained upon examination.  Judgment is required in evaluating tax positions and determining income tax provisions.  The Company reevaluates the technical merits of its tax positions and may recognize an uncertain tax benefit in certain circumstances, including when (1) a tax audit is completed (2) applicable tax laws change, including a tax case ruling or legislative guidance or (3) the applicable statute of limitations expires. The Company recognizes potential accrued interest and penalties associated with unrecognized tax positions in income tax expense. Refer to Note 7 for additional information.",[],"Income Taxes—The Company’s income tax expense represents the tax liability for the current year, the tax benefit or expense for the net change in deferred tax liabilities and assets during the year, as well as reserves for unrecognized tax benefits and return to provision adjustments. Deferred tax liabilities and assets are determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted rates expected to be in effect during the year in which the differences reverse. Deferred tax assets generally represent items that can be used as a tax deduction or credit in the Company’s tax return in future years for which the tax benefit has already been reflected on the Company’s Consolidated Statements of Earnings. The Company establishes valuation allowances for its deferred tax assets if it is more likely than not that some or all of the deferred tax asset will not be realized. Deferred tax liabilities generally represent items that have already been taken as a deduction on the Company’s tax return but have not yet been recognized as an expense in the Company’s Consolidated Statements of Earnings. The effect on deferred tax assets and liabilities due to a change in tax rates is recognized in income tax expense in the period that includes the enactment date. The Company provides for unrecognized tax benefits when, based upon the technical merits, it is more likely than not that an uncertain tax position will not be sustained upon examination.  Judgment is required in evaluating tax positions and determining income tax provisions.  The Company reevaluates the technical merits of its tax positions and may recognize an uncertain tax benefit in certain circumstances, including when (1) a tax audit is completed (2) applicable tax laws change, including a tax case ruling or legislative guidance or (3) the applicable statute of limitations expires. The Company recognizes potential accrued interest and penalties associated with unrecognized tax positions in income tax expense. Refer to Note 7 for additional information.","[6.2, 91.66, 2.14]",positive,"[99.98, 0.01, 0.01]",neutral,"[68.54, 8.23, 23.23]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.81,541,"Common/collective trusts are valued based on the plan’s interest, represented by investment units, in the underlying investments held within the trust that are traded in an active market by the trustee.","['Common/collective trusts are valued based on the plan’s interest, represented by investment units, in the underlying investments held within the trust that are traded in an active market by the trustee.']","<b>Common/collective trusts are valued based on the plan’s interest, represented by investment units, in the underlying investments held within the trust that are traded in an active market by the trustee.[r.1]</b>","[1.41, 94.56, 4.04]",positive,"[99.99, 0.0, 0.01]",neutral,"[77.76, 21.21, 1.03]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.76,431,"Accounting Standards Not Yet Adopted—In August 2020, the FASB issued ASU No. 202006, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The ASU includes amendments to the guidance on convertible instruments and the derivative scope exception for contracts in an entity’s own equity and simplifies the accounting for convertible instruments which include beneficial conversion features or cash conversion features by removing certain separation models in Subtopic 47020. Additionally, the ASU will require entities to use the ifconverted method when calculating diluted earnings per share for convertible instruments. The ASU is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Management anticipates the adoption of this ASU will not have a significant impact on the Company’s financial statements.","['The ASU includes amendments to the guidance on convertible instruments and the derivative scope exception for contracts in an entity’s own equity and simplifies the accounting for convertible instruments which include beneficial conversion features or cash conversion features by removing certain separation models in Subtopic 47020.', 'Management anticipates the adoption of this ASU will not have a significant impact on the Company’s financial statements.']","Accounting Standards Not Yet Adopted—In August 2020, the FASB issued ASU No. 202006, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. <b>The ASU includes amendments to the guidance on convertible instruments and the derivative scope exception for contracts in an entity’s own equity and simplifies the accounting for convertible instruments which include beneficial conversion features or cash conversion features by removing certain separation models in Subtopic 47020.[r.1]</b> Additionally, the ASU will require entities to use the ifconverted method when calculating diluted earnings per share for convertible instruments. The ASU is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. <b>Management anticipates the adoption of this ASU will not have a significant impact on the Company’s financial statements.[r.2]</b>","[3.41, 93.92, 2.67]",positive,"[99.87, 0.12, 0.01]",neutral,"[70.44, 12.53, 17.03]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.74,393,"To evaluate whether the technical merits of some uncertain tax positions are more likely than not sustainable, our audit procedures included, among others, evaluation of applicable tax law, court cases, tax regulations and other regulatory guidance by our tax subject matter resources. We also involved tax subject matter resources in verifying our understanding of the relevant facts and analysis by reading relevant correspondence with the tax authority and reading thirdparty advice obtained by management. We also evaluated the adequacy of the Company’s disclosures included in Note 7 to the consolidated financial statements in relation to these matters.",[],"To evaluate whether the technical merits of some uncertain tax positions are more likely than not sustainable, our audit procedures included, among others, evaluation of applicable tax law, court cases, tax regulations and other regulatory guidance by our tax subject matter resources. We also involved tax subject matter resources in verifying our understanding of the relevant facts and analysis by reading relevant correspondence with the tax authority and reading thirdparty advice obtained by management. We also evaluated the adequacy of the Company’s disclosures included in Note 7 to the consolidated financial statements in relation to these matters.","[1.44, 91.07, 7.49]",positive,"[99.96, 0.01, 0.03]",neutral,"[84.9, 6.05, 9.05]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.74,476,"Included in deferred income taxes as of December 31, 2021 are tax benefits for U.S. and nonU.S. net operating loss carryforwards totaling $427 million ($172 million of which the Company does not expect to realize and have corresponding valuation allowances). Certain of the losses can be carried forward indefinitely and others can be carried forward to various dates from 2022 through 2041. In addition, the Company had general business and nonU.S. tax credit carryforwards of $117 million ($58 million of which the Company does not expect to realize and have corresponding valuation allowances) as of December 31, 2021, which can be carried forward to various dates from 2022 to 2031. In addition, as of December 31, 2021, the Company had $12 million of valuation allowances related to other deferred tax asset balances that are not more likely than not of being realized.",[],"Included in deferred income taxes as of December 31, 2021 are tax benefits for U.S. and nonU.S. net operating loss carryforwards totaling $427 million ($172 million of which the Company does not expect to realize and have corresponding valuation allowances). Certain of the losses can be carried forward indefinitely and others can be carried forward to various dates from 2022 through 2041. In addition, the Company had general business and nonU.S. tax credit carryforwards of $117 million ($58 million of which the Company does not expect to realize and have corresponding valuation allowances) as of December 31, 2021, which can be carried forward to various dates from 2022 to 2031. In addition, as of December 31, 2021, the Company had $12 million of valuation allowances related to other deferred tax asset balances that are not more likely than not of being realized.","[3.49, 93.65, 2.85]",positive,"[99.99, 0.01, 0.01]",neutral,"[57.81, 5.85, 36.35]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.72,470,"Noncurrent deferred tax assets and noncurrent deferred tax liabilities are included in other assets and other longterm liabilities, respectively, in the accompanying Consolidated Balance Sheets. Deferred income tax assets and liabilities as of December 31 were as follows ($ in millions) Deferred tax assets Allowance for doubtful accounts Inventories Pension and postretirement benefits Environmental and regulatory compliance Other accruals and prepayments Stockbased compensation expense Operating lease liabilities Tax credit and loss carryforwards Valuation allowances Total deferred tax asset Deferred tax liabilities Property, plant and equipment Insurance, including selfinsurance Basis difference in LYONs Operating lease rightofuse assets Goodwill and other intangibles Total deferred tax liability Net deferred tax liability $ $ 19  $ 93  105  38  348  76  252  544  (242) 1,233 (79) (520) —  (235) (3,962) (4,796) (3,563) $ 24  99  259  27  341  68  215  569  (264) 1,338 (50) (713) (11) (204) (3,814) (4,792) (3,454) The Company evaluates the future realizability of tax credits and loss carryforwards considering the anticipated future earnings of the Company’s subsidiaries as well as tax planning strategies in the associated jurisdictions. Deferred taxes associated with U.S. entities consist of net deferred tax liabilities of approximately $2.1 billion and $1.9 billion as of December 31, 2021 and 2020, respectively. Deferred taxes associated with nonU.S. entities consist of net deferred tax liabilities of approximately $1.5 billion and $1.6 billion as of December 31, 2021 and 2020, respectively. During 2021, the Company’s valuation allowance decreased by $22 million primarily from the use of tax attributes which were previously not realizable. As of December 31, 2021, the total amount of the basis difference in investments indefinitely reinvested outside the United States for which deferred taxes have not been provided is approximately $11.2 billion. The income taxes applicable to repatriating such earnings are not readily determinable. As of December 31, 2021, the Company had no plans which would subject these basis differences to income taxes in the United States or elsewhere.","['The Company evaluates the future realizability of tax credits and loss carryforwards considering the anticipated future earnings of the Company’s subsidiaries as well as tax planning strategies in the associated jurisdictions.', 'Noncurrent deferred tax assets and noncurrent deferred tax liabilities are included in other assets and other longterm liabilities, respectively, in the accompanying Consolidated Balance Sheets.']","<b>Noncurrent deferred tax assets and noncurrent deferred tax liabilities are included in other assets and other longterm liabilities, respectively, in the accompanying Consolidated Balance Sheets.[r.2]</b> Deferred income tax assets and liabilities as of December 31 were as follows ($ in millions) Deferred tax assets Allowance for doubtful accounts Inventories Pension and postretirement benefits Environmental and regulatory compliance Other accruals and prepayments Stockbased compensation expense Operating lease liabilities Tax credit and loss carryforwards Valuation allowances Total deferred tax asset Deferred tax liabilities Property, plant and equipment Insurance, including selfinsurance Basis difference in LYONs Operating lease rightofuse assets Goodwill and other intangibles Total deferred tax liability Net deferred tax liability $ $ 19  $ 93  105  38  348  76  252  544  (242) 1,233 (79) (520) —  (235) (3,962) (4,796) (3,563) $ 24  99  259  27  341  68  215  569  (264) 1,338 (50) (713) (11) (204) (3,814) (4,792) (3,454) <b>The Company evaluates the future realizability of tax credits and loss carryforwards considering the anticipated future earnings of the Company’s subsidiaries as well as tax planning strategies in the associated jurisdictions.[r.1]</b> Deferred taxes associated with U.S. entities consist of net deferred tax liabilities of approximately $2.1 billion and $1.9 billion as of December 31, 2021 and 2020, respectively. Deferred taxes associated with nonU.S. entities consist of net deferred tax liabilities of approximately $1.5 billion and $1.6 billion as of December 31, 2021 and 2020, respectively. During 2021, the Company’s valuation allowance decreased by $22 million primarily from the use of tax attributes which were previously not realizable. As of December 31, 2021, the total amount of the basis difference in investments indefinitely reinvested outside the United States for which deferred taxes have not been provided is approximately $11.2 billion. The income taxes applicable to repatriating such earnings are not readily determinable. As of December 31, 2021, the Company had no plans which would subject these basis differences to income taxes in the United States or elsewhere.","[89.94, 8.77, 1.29]",neutral,"[0.58, 0.05, 99.37]",negative,"[63.52, 5.02, 31.46]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.68,3,"If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the SarbanesOxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b2 of the Exchange Act).",['☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the SarbanesOxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.'],"If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  <b>☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the SarbanesOxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.[r.1]</b> ☒ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b2 of the Exchange Act).","[2.61, 94.57, 2.82]",positive,"[99.99, 0.01, 0.01]",neutral,"[82.67, 3.26, 14.07]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.68,65,"The Environmental & Applied Solutions segment offers products and services that help protect precious resources and keep global food and water supplies safe. Sales in 2021 for this segment by geographic destination (as a percentage of total 2021 sales) were North America, 44% Western Europe, 23% other developed markets, 3% and highgrowth markets, 30%. The Company’s Environmental & Applied Solutions segment consists of the following businesses Water Quality—The Company’s water quality business is a leading provider of instrumentation, consumables, software, services and disinfection systems to help analyze, treat and manage the quality of ultrapure, potable, industrial, waste, ground, source and ocean water in residential, commercial, municipal, industrial and natural resource applications. Danaher entered the water quality sector in the late 1990’s through the acquisitions of Dr. Lange and Hach Company and has enhanced the geographic coverage and capabilities of its products and services through subsequent acquisitions, including the acquisition of Trojan Technologies Inc. in 2004 and ChemTreat, Inc. in 2007. The water quality business designs, manufactures and markets a wide range of analytical instruments, related consumables, software and services that detect and measure chemical, physical and microbiological parameters in ultrapure, potable, industrial, waste, municipal, ground, source and ocean water chemical treatment solutions intended to address corrosion, scaling and biological growth problems in boiler, cooling water and wastewater applications as well as associated analytical services, primarily in applied and industrial end markets and ultraviolet disinfection systems, consumables and services, which disinfect billions of gallons of municipal, industrial and consumer water every day.","['The water quality business designs, manufactures and markets a wide range of analytical instruments, related consumables, software and services that detect and measure chemical, physical and microbiological parameters in ultrapure, potable, industrial, waste, municipal, ground, source and ocean water chemical treatment solutions intended to address corrosion, scaling and biological growth problems in boiler, cooling water and wastewater applications as well as associated analytical services, primarily in applied and industrial end markets and ultraviolet disinfection systems, consumables and services, which disinfect billions of gallons of municipal, industrial and consumer water every day.']","The Environmental & Applied Solutions segment offers products and services that help protect precious resources and keep global food and water supplies safe. Sales in 2021 for this segment by geographic destination (as a percentage of total 2021 sales) were North America, 44% Western Europe, 23% other developed markets, 3% and highgrowth markets, 30%. The Company’s Environmental & Applied Solutions segment consists of the following businesses Water Quality—The Company’s water quality business is a leading provider of instrumentation, consumables, software, services and disinfection systems to help analyze, treat and manage the quality of ultrapure, potable, industrial, waste, ground, source and ocean water in residential, commercial, municipal, industrial and natural resource applications. Danaher entered the water quality sector in the late 1990’s through the acquisitions of Dr. Lange and Hach Company and has enhanced the geographic coverage and capabilities of its products and services through subsequent acquisitions, including the acquisition of Trojan Technologies Inc. in 2004 and ChemTreat, Inc. in 2007. <b>The water quality business designs, manufactures and markets a wide range of analytical instruments, related consumables, software and services that detect and measure chemical, physical and microbiological parameters in ultrapure, potable, industrial, waste, municipal, ground, source and ocean water chemical treatment solutions intended to address corrosion, scaling and biological growth problems in boiler, cooling water and wastewater applications as well as associated analytical services, primarily in applied and industrial end markets and ultraviolet disinfection systems, consumables and services, which disinfect billions of gallons of municipal, industrial and consumer water every day.[r.1]</b>","[0.92, 86.57, 12.51]",positive,"[99.42, 0.57, 0.01]",neutral,"[71.02, 26.16, 2.83]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.63,145,"Our ability to grow revenues, earnings and cash flow at or above our historic rates depends in part upon our ability to identify and successfully acquire and integrate businesses at appropriate prices and realize anticipated synergies, and to make appropriate investments that support our long term strategy. We may not be able to consummate acquisitions at rates similar to the past, which could adversely impact our business. Promising acquisitions and investments are difficult to identify and complete for a number of reasons, including high valuations, competition among prospective buyers or investors, the availability of affordable funding in the capital markets and the need to satisfy applicable closing conditions and obtain applicable antitrust and other regulatory approvals on acceptable terms. In addition, competition for acquisitions and investments has resulted and may result in higher purchase prices. Changes in accounting or regulatory requirements or instability in the credit markets could also adversely impact our ability to consummate acquisitions and investments.",[],"Our ability to grow revenues, earnings and cash flow at or above our historic rates depends in part upon our ability to identify and successfully acquire and integrate businesses at appropriate prices and realize anticipated synergies, and to make appropriate investments that support our long term strategy. We may not be able to consummate acquisitions at rates similar to the past, which could adversely impact our business. Promising acquisitions and investments are difficult to identify and complete for a number of reasons, including high valuations, competition among prospective buyers or investors, the availability of affordable funding in the capital markets and the need to satisfy applicable closing conditions and obtain applicable antitrust and other regulatory approvals on acceptable terms. In addition, competition for acquisitions and investments has resulted and may result in higher purchase prices. Changes in accounting or regulatory requirements or instability in the credit markets could also adversely impact our ability to consummate acquisitions and investments.","[74.85, 21.43, 3.71]",neutral,"[0.1, 0.42, 99.48]",negative,"[37.96, 3.84, 58.2]",negative
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.57,153,"With respect to each of the Communications Disposition, the Fortive Disposition and the Envista Disposition, we entered into a separation agreement and related agreements to govern the separation and related transactions and the relationship between the respective companies going forward. These agreements provide for specific indemnity and liability obligations of each party that can lead to disputes between us and the respective counterparty. If we are required to indemnify any of the other parties under the circumstances set forth in these agreements, we may be subject to substantial liabilities. In addition, with respect to the liabilities for which the other parties have agreed to indemnify us under these agreements, there can be no assurance that the indemnity rights we have against such other parties will be sufficient to protect us against the full amount of the liabilities, or that such other parties will be able to fully satisfy their respective indemnification obligations. It is also possible that a court could disregard the allocation of assets and liabilities agreed to between Danaher and such other parties and require Danaher to assume responsibility for obligations allocated to such other parties. Each of these risks could negatively affect our business and financial statements.",[],"With respect to each of the Communications Disposition, the Fortive Disposition and the Envista Disposition, we entered into a separation agreement and related agreements to govern the separation and related transactions and the relationship between the respective companies going forward. These agreements provide for specific indemnity and liability obligations of each party that can lead to disputes between us and the respective counterparty. If we are required to indemnify any of the other parties under the circumstances set forth in these agreements, we may be subject to substantial liabilities. In addition, with respect to the liabilities for which the other parties have agreed to indemnify us under these agreements, there can be no assurance that the indemnity rights we have against such other parties will be sufficient to protect us against the full amount of the liabilities, or that such other parties will be able to fully satisfy their respective indemnification obligations. It is also possible that a court could disregard the allocation of assets and liabilities agreed to between Danaher and such other parties and require Danaher to assume responsibility for obligations allocated to such other parties. Each of these risks could negatively affect our business and financial statements.","[19.41, 77.93, 2.66]",positive,"[82.4, 0.06, 17.53]",neutral,"[49.66, 2.16, 48.18]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.57,212,"In addition to the environmental, health, safety, health care, medical device, anticorruption, data privacy and other regulations noted elsewhere in this Annual Report, our businesses are subject to extensive regulation by U.S. and nonU.S. governmental and selfregulatory entities at the supranational, federal, state, local and other jurisdictional levels, including the following We are required to comply with various import laws and export control and economic sanctions laws, which may affect our transactions with certain customers, business partners and other persons and dealings between our employees and between our subsidiaries. In certain circumstances, export control and economic sanctions regulations may prohibit the export of certain products, services and technologies. In other circumstances, we may be required to obtain an export license before exporting the controlled item. Compliance with the various import laws that apply to our businesses can restrict our access to, and increase the cost of obtaining, certain products and at times can interrupt our supply of imported inventory. In addition, we sell and provide products and technology to third parties, such as agents, representatives and distributors, who may export such items to endusers, and if any of these third parties do not comply with applicable export or import laws we may incur liability. In addition, from time to time, certain of our subsidiaries have limited business dealings in countries subject to comprehensive sanctions. These business dealings represent an insignificant amount of our consolidated revenues and income but expose us to a heightened risk of violating applicable sanctions regulations. We have established policies and procedures designed to assist with our compliance with such laws and regulations. However, there can be no assurance that our policies and procedures have prevented and will prevent violations of these regulations and any violation can adversely affect our business and financial statements.",[],"In addition to the environmental, health, safety, health care, medical device, anticorruption, data privacy and other regulations noted elsewhere in this Annual Report, our businesses are subject to extensive regulation by U.S. and nonU.S. governmental and selfregulatory entities at the supranational, federal, state, local and other jurisdictional levels, including the following We are required to comply with various import laws and export control and economic sanctions laws, which may affect our transactions with certain customers, business partners and other persons and dealings between our employees and between our subsidiaries. In certain circumstances, export control and economic sanctions regulations may prohibit the export of certain products, services and technologies. In other circumstances, we may be required to obtain an export license before exporting the controlled item. Compliance with the various import laws that apply to our businesses can restrict our access to, and increase the cost of obtaining, certain products and at times can interrupt our supply of imported inventory. In addition, we sell and provide products and technology to third parties, such as agents, representatives and distributors, who may export such items to endusers, and if any of these third parties do not comply with applicable export or import laws we may incur liability. In addition, from time to time, certain of our subsidiaries have limited business dealings in countries subject to comprehensive sanctions. These business dealings represent an insignificant amount of our consolidated revenues and income but expose us to a heightened risk of violating applicable sanctions regulations. We have established policies and procedures designed to assist with our compliance with such laws and regulations. However, there can be no assurance that our policies and procedures have prevented and will prevent violations of these regulations and any violation can adversely affect our business and financial statements.","[21.63, 75.17, 3.2]",positive,"[23.17, 0.09, 76.73]",negative,"[46.44, 2.5, 51.06]",negative
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.56,346,"The Company has filed a wellknown seasoned issuer shelf registration statement on Form S3 with the SEC that registers an indeterminate amount of debt securities, common stock, preferred stock, warrants, depositary shares, purchase contracts and units for future issuance. The Company expects to use net proceeds realized by the Company from future securities sales off this shelf registration statement for general corporate purposes, including without limitation repayment or refinancing of debt or other corporate obligations, acquisitions, capital expenditures, share repurchases, dividends and/or working capital.","['The Company has filed a wellknown seasoned issuer shelf registration statement on Form S3 with the SEC that registers an indeterminate amount of debt securities, common stock, preferred stock, warrants, depositary shares, purchase contracts and units for future issuance.']","<b>The Company has filed a wellknown seasoned issuer shelf registration statement on Form S3 with the SEC that registers an indeterminate amount of debt securities, common stock, preferred stock, warrants, depositary shares, purchase contracts and units for future issuance.[r.1]</b> The Company expects to use net proceeds realized by the Company from future securities sales off this shelf registration statement for general corporate purposes, including without limitation repayment or refinancing of debt or other corporate obligations, acquisitions, capital expenditures, share repurchases, dividends and/or working capital.","[1.39, 94.1, 4.5]",positive,"[99.99, 0.0, 0.01]",neutral,"[86.17, 12.72, 1.11]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.53,260,"The global spread of a novel strain of coronavirus (COVID19) has led to unprecedented restrictions on, and disruptions in, business and personal activities, including as a result of preventive and precautionary measures that we, other businesses, our communities and governments have taken and are taking to mitigate the spread of the virus and to manage its impact. The Company continues to actively monitor the pandemic, including the current spread of certain variants of the virus, and has taken and intends to continue taking steps to identify and seek to mitigate the adverse impacts on, and risks to, the Company’s business (including but not limited to its employees, customers, business partners, manufacturing capabilities and capacity, and supply and distribution channels) posed by the spread of COVID19 and the governmental and community responses thereto. The Company’s businesses have activated their business continuity plans as a result of this pandemic, including taking steps in an effort to help keep our workforce healthy and safe, and are assessing and updating those plans on an ongoing basis. As a result of COVID19 the Company’s businesses have modified certain of their respective business practices, and the Company expects to take such further actions as may be required by government authorities or as determined to be in the best interests of our employees, customers and other business partners. The Company has developed and is implementing returntoworkplace protocols designed to help ensure the health and safety of its employees, customers and business partners, for its businesses to apply as appropriate. Given that the prevalence of COVID19 and the nature of the response thereto (including the degree to which restrictions are being relaxed or reimposed) varies significantly by geography, the impact of the pandemic on the Company’s different business locations around the world at any given time also varies significantly.","['As a result of COVID19 the Company’s businesses have modified certain of their respective business practices, and the Company expects to take such further actions as may be required by government authorities or as determined to be in the best interests of our employees, customers and other business partners.', 'The Company’s businesses have activated their business continuity plans as a result of this pandemic, including taking steps in an effort to help keep our workforce healthy and safe, and are assessing and updating those plans on an ongoing basis.']","The global spread of a novel strain of coronavirus (COVID19) has led to unprecedented restrictions on, and disruptions in, business and personal activities, including as a result of preventive and precautionary measures that we, other businesses, our communities and governments have taken and are taking to mitigate the spread of the virus and to manage its impact. The Company continues to actively monitor the pandemic, including the current spread of certain variants of the virus, and has taken and intends to continue taking steps to identify and seek to mitigate the adverse impacts on, and risks to, the Company’s business (including but not limited to its employees, customers, business partners, manufacturing capabilities and capacity, and supply and distribution channels) posed by the spread of COVID19 and the governmental and community responses thereto. <b>The Company’s businesses have activated their business continuity plans as a result of this pandemic, including taking steps in an effort to help keep our workforce healthy and safe, and are assessing and updating those plans on an ongoing basis.[r.2]</b> <b>As a result of COVID19 the Company’s businesses have modified certain of their respective business practices, and the Company expects to take such further actions as may be required by government authorities or as determined to be in the best interests of our employees, customers and other business partners.[r.1]</b> The Company has developed and is implementing returntoworkplace protocols designed to help ensure the health and safety of its employees, customers and business partners, for its businesses to apply as appropriate. Given that the prevalence of COVID19 and the nature of the response thereto (including the degree to which restrictions are being relaxed or reimposed) varies significantly by geography, the impact of the pandemic on the Company’s different business locations around the world at any given time also varies significantly.","[4.24, 86.43, 9.33]",positive,"[15.36, 0.56, 84.08]",negative,"[80.44, 10.32, 9.24]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.5,321,"The Company’s investment portfolio from time to time includes publiclytraded equity securities that are sensitive to fluctuations in market price. As of December 31, 2021, the Company held $88 million of publiclytraded equity securities. Additionally, the Company holds nonmarketable equity investments in privately held companies that may be impacted by equity price risks. These nonmarketable equity investments are accounted for under the Fair Value Alternative method with changes in fair value recorded in earnings. Volatility in the equity markets or other fair value considerations could affect the value of these investments and require charges or gains to be recognized in earnings.",[],"The Company’s investment portfolio from time to time includes publiclytraded equity securities that are sensitive to fluctuations in market price. As of December 31, 2021, the Company held $88 million of publiclytraded equity securities. Additionally, the Company holds nonmarketable equity investments in privately held companies that may be impacted by equity price risks. These nonmarketable equity investments are accounted for under the Fair Value Alternative method with changes in fair value recorded in earnings. Volatility in the equity markets or other fair value considerations could affect the value of these investments and require charges or gains to be recognized in earnings.","[20.02, 77.42, 2.57]",positive,"[99.96, 0.01, 0.04]",neutral,"[67.72, 3.83, 28.45]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.5,358,"In performing its goodwill impairment testing, the Company estimates the fair value of its reporting units primarily using a marketbased approach which relies on current trading multiples of forecasted EBITDA for companies operating in businesses similar to each of the Company’s reporting units to calculate an estimated fair value of each reporting unit. In evaluating the estimates derived by the marketbased approach, management makes judgments about the relevance and reliability of the multiples by considering factors unique to its reporting units, including operating results, business plans, economic projections, anticipated future cash flows, and transactions and marketplace data as well as judgments about the comparability of the market proxies selected. There are inherent uncertainties related to these assumptions and management’s judgment in applying them to the analysis of goodwill impairment.","['In evaluating the estimates derived by the marketbased approach, management makes judgments about the relevance and reliability of the multiples by considering factors unique to its reporting units, including operating results, business plans, economic projections, anticipated future cash flows, and transactions and marketplace data as well as judgments about the comparability of the market proxies selected.']","In performing its goodwill impairment testing, the Company estimates the fair value of its reporting units primarily using a marketbased approach which relies on current trading multiples of forecasted EBITDA for companies operating in businesses similar to each of the Company’s reporting units to calculate an estimated fair value of each reporting unit. <b>In evaluating the estimates derived by the marketbased approach, management makes judgments about the relevance and reliability of the multiples by considering factors unique to its reporting units, including operating results, business plans, economic projections, anticipated future cash flows, and transactions and marketplace data as well as judgments about the comparability of the market proxies selected.[r.1]</b> There are inherent uncertainties related to these assumptions and management’s judgment in applying them to the analysis of goodwill impairment.","[9.24, 86.19, 4.57]",positive,"[99.98, 0.01, 0.01]",neutral,"[78.96, 6.02, 15.02]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.5,38,"Underpinned by these five Core Values as well as our Shared Purpose – Helping Realize Life’s Potential, the DBS tools are organized into three pillars that are designed to apply to every aspect of our business Growth, Lean and Leadership.","['Underpinned by these five Core Values as well as our Shared Purpose – Helping Realize Life’s Potential, the DBS tools are organized into three pillars that are designed to apply to every aspect of our business Growth, Lean and Leadership.']","<b>Underpinned by these five Core Values as well as our Shared Purpose – Helping Realize Life’s Potential, the DBS tools are organized into three pillars that are designed to apply to every aspect of our business Growth, Lean and Leadership.[r.1]</b>","[0.93, 83.83, 15.24]",positive,"[99.99, 0.01, 0.01]",neutral,"[41.62, 57.99, 0.39]",positive
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.49,139,"For example, in 2021 we generated approximately 13% of our sales from China. Accordingly, our business and financial statements can be adversely influenced by political, economic, legal, compliance, social and business conditions in China generally. Additionally, China’s government continues to play a significant role in regulating industry development by imposing sectorspecific policies, and it maintains control over China’s economic growth through setting monetary policy and determining treatment of particular industries or companies. Further, considerable uncertainty exists regarding the longterm effects of the expansionary monetary and fiscal policies adopted by the central banks and financial authorities of some of the world’s leading economies, including the U.S. and China. Uncertainty or adverse changes to conditions in China or the policies of China’s government or its laws and regulations can adversely affect the overall economic growth of China, or of the particular industries in which we participate, and can adversely affect our business and financial statements.",[],"For example, in 2021 we generated approximately 13% of our sales from China. Accordingly, our business and financial statements can be adversely influenced by political, economic, legal, compliance, social and business conditions in China generally. Additionally, China’s government continues to play a significant role in regulating industry development by imposing sectorspecific policies, and it maintains control over China’s economic growth through setting monetary policy and determining treatment of particular industries or companies. Further, considerable uncertainty exists regarding the longterm effects of the expansionary monetary and fiscal policies adopted by the central banks and financial authorities of some of the world’s leading economies, including the U.S. and China. Uncertainty or adverse changes to conditions in China or the policies of China’s government or its laws and regulations can adversely affect the overall economic growth of China, or of the particular industries in which we participate, and can adversely affect our business and financial statements.","[35.94, 61.23, 2.83]",positive,"[1.79, 0.07, 98.14]",negative,"[55.7, 3.82, 40.48]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.46,567,"RSUs issued under the 2007 Omnibus Incentive Plan provide for the issuance of a share of the Company’s common stock at no cost to the holder. RSUs granted prior to 2022 to employees under the 2007 Omnibus Incentive Plan generally provide for timebased vesting over a fiveyear period, although executive officers and certain other employees have been awarded RSUs with different vesting criteria. RSUs granted subsequent to December 31, 2021 to employees under the amended and restated 2007 Omnibus Incentive Plan generally vest pro rata over a fouryear period, although executive officers and certain other employees have been awarded RSUs with different vesting criteria. The RSUs that have been granted to directors under the 2007 Omnibus Incentive Plan vest on the earlier of the first anniversary of the grant date or the date of, and immediately prior to, the next annual meeting of the Company’s shareholders following the grant date, but the underlying shares are not issued until the earlier of the director’s death or the first day of the seventh month following the director’s retirement from the Board. Prior to vesting, RSUs granted under the 2007 Omnibus Incentive Plan do not have dividend equivalent rights, do not have voting rights and the shares underlying the RSUs are not considered issued and outstanding.",[],"RSUs issued under the 2007 Omnibus Incentive Plan provide for the issuance of a share of the Company’s common stock at no cost to the holder. RSUs granted prior to 2022 to employees under the 2007 Omnibus Incentive Plan generally provide for timebased vesting over a fiveyear period, although executive officers and certain other employees have been awarded RSUs with different vesting criteria. RSUs granted subsequent to December 31, 2021 to employees under the amended and restated 2007 Omnibus Incentive Plan generally vest pro rata over a fouryear period, although executive officers and certain other employees have been awarded RSUs with different vesting criteria. The RSUs that have been granted to directors under the 2007 Omnibus Incentive Plan vest on the earlier of the first anniversary of the grant date or the date of, and immediately prior to, the next annual meeting of the Company’s shareholders following the grant date, but the underlying shares are not issued until the earlier of the director’s death or the first day of the seventh month following the director’s retirement from the Board. Prior to vesting, RSUs granted under the 2007 Omnibus Incentive Plan do not have dividend equivalent rights, do not have voting rights and the shares underlying the RSUs are not considered issued and outstanding.","[4.76, 93.5, 1.74]",positive,"[99.99, 0.01, 0.01]",neutral,"[71.03, 3.49, 25.48]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.41,191,"Our credit facilities and longterm debt obligations also impose certain restrictions on us, including certain restrictions on our ability to incur liens on our assets, and a requirement under our credit facilities to maintain a consolidated leverage ratio (the ratio of consolidated indebtedness to consolidated indebtedness plus shareholders’ equity) of 0.65 to 1.0 or less. If we breach any of these restrictions and cannot obtain a waiver from the lenders on favorable terms, subject to applicable cure periods, the outstanding indebtedness (and any other indebtedness with crossdefault provisions) could be declared immediately due and payable, which would adversely affect our business and financial statements (including our liquidity). If we add new debt in the future, the risks described above would increase.",[],"Our credit facilities and longterm debt obligations also impose certain restrictions on us, including certain restrictions on our ability to incur liens on our assets, and a requirement under our credit facilities to maintain a consolidated leverage ratio (the ratio of consolidated indebtedness to consolidated indebtedness plus shareholders’ equity) of 0.65 to 1.0 or less. If we breach any of these restrictions and cannot obtain a waiver from the lenders on favorable terms, subject to applicable cure periods, the outstanding indebtedness (and any other indebtedness with crossdefault provisions) could be declared immediately due and payable, which would adversely affect our business and financial statements (including our liquidity). If we add new debt in the future, the risks described above would increase.","[60.78, 37.02, 2.2]",neutral,"[0.77, 0.07, 99.16]",negative,"[47.74, 1.92, 50.33]",negative
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.41,268,"In this report, references to the nonGAAP measures of core sales (also referred to as core revenues or sales/revenues from existing businesses) and core sales including Cytiva refer to sales from continuing operations calculated according to generally accepted accounting principles in the United States (GAAP) but excluding sales from acquired businesses (as defined below, as applicable) and the impact of currency translation.","['In this report, references to the nonGAAP measures of core sales (also referred to as core revenues or sales/revenues from existing businesses) and core sales including Cytiva refer to sales from continuing operations calculated according to generally accepted accounting principles in the United States (GAAP) but excluding sales from acquired businesses (as defined below, as applicable) and the impact of currency translation.']","<b>In this report, references to the nonGAAP measures of core sales (also referred to as core revenues or sales/revenues from existing businesses) and core sales including Cytiva refer to sales from continuing operations calculated according to generally accepted accounting principles in the United States (GAAP) but excluding sales from acquired businesses (as defined below, as applicable) and the impact of currency translation.[r.1]</b>","[2.45, 94.91, 2.64]",positive,"[99.99, 0.0, 0.01]",neutral,"[87.63, 5.87, 6.5]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.39,543,"The methods described above may produce a fair value estimate that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Company believes the valuation methods are appropriate and consistent with the methods used by other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.","['Furthermore, while the Company believes the valuation methods are appropriate and consistent with the methods used by other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.']","The methods described above may produce a fair value estimate that may not be indicative of net realizable value or reflective of future fair values. <b>Furthermore, while the Company believes the valuation methods are appropriate and consistent with the methods used by other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.[r.1]</b>","[7.49, 89.06, 3.45]",positive,"[98.98, 0.02, 1.0]",neutral,"[61.93, 4.81, 33.26]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.37,134,"Governmental and private health care providers and payors around the world are increasingly utilizing managed care for the delivery of healthcare services, centralizing purchasing, limiting the number of vendors that may participate in purchasing programs, forming group purchasing organizations and integrated health delivery networks and pursuing consolidation to improve their purchasing leverage and using competitive bid processes to procure healthcare products and services. Payors are also seeking to improve price predictability in an effort to mitigate exposure to future price increases.",[],"Governmental and private health care providers and payors around the world are increasingly utilizing managed care for the delivery of healthcare services, centralizing purchasing, limiting the number of vendors that may participate in purchasing programs, forming group purchasing organizations and integrated health delivery networks and pursuing consolidation to improve their purchasing leverage and using competitive bid processes to procure healthcare products and services. Payors are also seeking to improve price predictability in an effort to mitigate exposure to future price increases.","[1.71, 67.07, 31.22]",positive,"[0.28, 99.68, 0.04]",positive,"[66.82, 31.12, 2.05]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.36,236,"Consistent with SEC Regulation SK Item 103, we have elected to disclose those environmental proceedings with a governmental entity as a party where the Company reasonably believes such proceeding would result in monetary sanctions, exclusive of interest and costs, of $1 million or more.","['Consistent with SEC Regulation SK Item 103, we have elected to disclose those environmental proceedings with a governmental entity as a party where the Company reasonably believes such proceeding would result in monetary sanctions, exclusive of interest and costs, of $1 million or more.']","<b>Consistent with SEC Regulation SK Item 103, we have elected to disclose those environmental proceedings with a governmental entity as a party where the Company reasonably believes such proceeding would result in monetary sanctions, exclusive of interest and costs, of $1 million or more.[r.1]</b>","[23.46, 71.34, 5.2]",positive,"[99.98, 0.0, 0.02]",neutral,"[77.44, 3.79, 18.78]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.34,434,"The Company makes an initial allocation of the purchase price at the date of acquisition based upon its understanding of the fair value of the acquired assets and assumed liabilities. The Company obtains the information used for the purchase price allocation during due diligence and through other sources. In the months after closing, as the Company obtains additional information about the acquired assets and liabilities, including through tangible and intangible asset appraisals, and learns more about the newly acquired business, it is able to refine the estimates of fair value and more accurately allocate the purchase price. The fair values of acquired intangibles are determined based on estimates and assumptions that are deemed reasonable by the Company. Significant assumptions include the discount rates and certain assumptions that form the basis of the forecasted results of the acquired business including earnings before interest, taxes, depreciation and amortization (EBITDA), revenue, revenue growth rates, royalty rates and technology obsolescence rates. These assumptions are forward looking and could be affected by future economic and market conditions. The Company engages thirdparty valuation specialists who review the Company’s critical assumptions and calculations of the fair value of acquired intangible assets in connection with significant acquisitions. Only facts and circumstances that existed as of the acquisition date are considered for subsequent adjustment. The Company is continuing to evaluate certain preacquisition contingencies associated with certain of its 2021 acquisitions and is also in the process of obtaining valuations of certain acquisitionrelated assets and liabilities in connection with these acquisitions. The Company will make appropriate adjustments to the purchase price allocation prior to completion of the measurement period, as required.","['The Company engages thirdparty valuation specialists who review the Company’s critical assumptions and calculations of the fair value of acquired intangible assets in connection with significant acquisitions.', 'The Company is continuing to evaluate certain preacquisition contingencies associated with certain of its 2021 acquisitions and is also in the process of obtaining valuations of certain acquisitionrelated assets and liabilities in connection with these acquisitions.']","The Company makes an initial allocation of the purchase price at the date of acquisition based upon its understanding of the fair value of the acquired assets and assumed liabilities. The Company obtains the information used for the purchase price allocation during due diligence and through other sources. In the months after closing, as the Company obtains additional information about the acquired assets and liabilities, including through tangible and intangible asset appraisals, and learns more about the newly acquired business, it is able to refine the estimates of fair value and more accurately allocate the purchase price. The fair values of acquired intangibles are determined based on estimates and assumptions that are deemed reasonable by the Company. Significant assumptions include the discount rates and certain assumptions that form the basis of the forecasted results of the acquired business including earnings before interest, taxes, depreciation and amortization (EBITDA), revenue, revenue growth rates, royalty rates and technology obsolescence rates. These assumptions are forward looking and could be affected by future economic and market conditions. <b>The Company engages thirdparty valuation specialists who review the Company’s critical assumptions and calculations of the fair value of acquired intangible assets in connection with significant acquisitions.[r.1]</b> Only facts and circumstances that existed as of the acquisition date are considered for subsequent adjustment. <b>The Company is continuing to evaluate certain preacquisition contingencies associated with certain of its 2021 acquisitions and is also in the process of obtaining valuations of certain acquisitionrelated assets and liabilities in connection with these acquisitions.[r.2]</b> The Company will make appropriate adjustments to the purchase price allocation prior to completion of the measurement period, as required.","[1.81, 94.28, 3.91]",positive,"[99.97, 0.03, 0.01]",neutral,"[83.33, 11.78, 4.89]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.29,255,"Refer to Item 1. Business—General for a discussion of Danaher’s strategic objectives and methodologies for delivering longterm shareholder value. Danaher is a multinational business with global operations. During 2021, approximately 62% of Danaher’s sales were derived from customers outside the United States. As a diversified, global business, Danaher’s operations are affected by worldwide, regional and industryspecific economic and political factors. Danaher’s geographic and industry diversity, as well as the range of its products and services, help limit the impact of any one industry or the economy of any single country on its consolidated operating results. The Company’s individual businesses monitor key competitors and customers, including to the extent possible their sales, to gauge relative performance and the outlook for the future.",['Refer to Item 1. Business—General for a discussion of Danaher’s strategic objectives and methodologies for delivering longterm shareholder value.'],"<b>Refer to Item 1. Business—General for a discussion of Danaher’s strategic objectives and methodologies for delivering longterm shareholder value.[r.1]</b> Danaher is a multinational business with global operations. During 2021, approximately 62% of Danaher’s sales were derived from customers outside the United States. As a diversified, global business, Danaher’s operations are affected by worldwide, regional and industryspecific economic and political factors. Danaher’s geographic and industry diversity, as well as the range of its products and services, help limit the impact of any one industry or the economy of any single country on its consolidated operating results. The Company’s individual businesses monitor key competitors and customers, including to the extent possible their sales, to gauge relative performance and the outlook for the future.","[5.44, 91.21, 3.36]",positive,"[99.99, 0.01, 0.01]",neutral,"[77.56, 19.19, 3.25]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.27,229,"In addition, we from time to time incur costs related to remedial efforts or alleged environmental damage associated with past or current waste disposal practices or other hazardous materials handling practices. We are also from time to time party to personal injury, property damage or other claims brought by private parties alleging injury or damage due to the presence of or exposure to hazardous substances. We can also become subject to additional remedial, compliance or personal injury costs due to future events such as changes in existing laws or regulations, changes in agency direction or enforcement policies, developments in remediation technologies, changes in the conduct of our operations and changes in accounting rules. For additional information regarding these risks, refer to the Consolidated Financial Statements included in this Annual Report. We cannot assure you that our liabilities arising from past or future releases of, or exposures to, hazardous substances will not exceed our estimates or adversely affect our reputation and financial statements or that we will not be subject to additional claims for personal injury or remediation in the future based on our past, present or future business activities. However, based on the information we have as of the date of this Annual Report we do not believe that it is reasonably possible that any amounts we may be required to pay in connection with environmental matters in excess of our reserves as of December 31, 2021, will have a material effect on our business or financial statements.","['For additional information regarding these risks, refer to the Consolidated Financial Statements included in this Annual Report.']","In addition, we from time to time incur costs related to remedial efforts or alleged environmental damage associated with past or current waste disposal practices or other hazardous materials handling practices. We are also from time to time party to personal injury, property damage or other claims brought by private parties alleging injury or damage due to the presence of or exposure to hazardous substances. We can also become subject to additional remedial, compliance or personal injury costs due to future events such as changes in existing laws or regulations, changes in agency direction or enforcement policies, developments in remediation technologies, changes in the conduct of our operations and changes in accounting rules. <b>For additional information regarding these risks, refer to the Consolidated Financial Statements included in this Annual Report.[r.1]</b> We cannot assure you that our liabilities arising from past or future releases of, or exposures to, hazardous substances will not exceed our estimates or adversely affect our reputation and financial statements or that we will not be subject to additional claims for personal injury or remediation in the future based on our past, present or future business activities. However, based on the information we have as of the date of this Annual Report we do not believe that it is reasonably possible that any amounts we may be required to pay in connection with environmental matters in excess of our reserves as of December 31, 2021, will have a material effect on our business or financial statements.","[14.58, 82.82, 2.6]",positive,"[92.85, 0.05, 7.09]",neutral,"[52.49, 3.32, 44.19]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.23,76,"Recruitment talent to meet our current and future business needs. We have invested in comprehensive talent acquisition capabilities across all levels of recruitment (including robust branding, labor market analytics, advanced sourcing tools, leading technology and streamlined processes). Our diversity attraction efforts are an important component of our overall talent acquisition strategy and focus on (1) establishing and fostering partnerships with diverse organizations, and (2) effectively sourcing diverse talent.","['We have invested in comprehensive talent acquisition capabilities across all levels of recruitment (including robust branding, labor market analytics, advanced sourcing tools, leading technology and streamlined processes).']","Recruitment talent to meet our current and future business needs. <b>We have invested in comprehensive talent acquisition capabilities across all levels of recruitment (including robust branding, labor market analytics, advanced sourcing tools, leading technology and streamlined processes).[r.1]</b> Our diversity attraction efforts are an important component of our overall talent acquisition strategy and focus on (1) establishing and fostering partnerships with diverse organizations, and (2) effectively sourcing diverse talent.","[0.85, 52.69, 46.46]",positive,"[1.82, 98.14, 0.03]",positive,"[20.08, 79.68, 0.24]",positive
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.19,450,"The accounting requirements for reporting Envista as a discontinued operation were met when the SplitOff was completed. Accordingly, the Consolidated Financial Statements for all periods presented reflect this business as a discontinued operation. The Company allocated a portion of the consolidated interest expense to discontinued operations based on the ratio of the discontinued business’ net assets to the Company’s consolidated net assets. Envista had revenues of approximately $2.6 billion in 2019 prior to the exchange offer.",[],"The accounting requirements for reporting Envista as a discontinued operation were met when the SplitOff was completed. Accordingly, the Consolidated Financial Statements for all periods presented reflect this business as a discontinued operation. The Company allocated a portion of the consolidated interest expense to discontinued operations based on the ratio of the discontinued business’ net assets to the Company’s consolidated net assets. Envista had revenues of approximately $2.6 billion in 2019 prior to the exchange offer.","[26.31, 71.67, 2.02]",positive,"[99.98, 0.0, 0.01]",neutral,"[81.74, 6.58, 11.69]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.19,353,"For a description of the Company’s debt and lease obligations, commitments, and litigation and contingencies, refer to Notes 10, 14, 17 and 18 to the Consolidated Financial Statements.","['For a description of the Company’s debt and lease obligations, commitments, and litigation and contingencies, refer to Notes 10, 14, 17 and 18 to the Consolidated Financial Statements.']","<b>For a description of the Company’s debt and lease obligations, commitments, and litigation and contingencies, refer to Notes 10, 14, 17 and 18 to the Consolidated Financial Statements.[r.1]</b>","[3.47, 94.5, 2.03]",positive,"[99.99, 0.0, 0.01]",neutral,"[87.94, 2.44, 9.61]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.18,340,"During 2021, certain agencies of the U.S. government, including BARDA, agreed to finance an expansion of production capacity related to chromatography, liquid cell culture media, buffers and cell culture powder media and singleuse consumables at certain of the Company’s Life Sciences businesses and the development of diagnostics testing technologies and the expansion of testing production capacity at certain of the Company’s Diagnostics businesses. The Company’s businesses may enter into similar agreements in the future. In consideration of this financing the U.S. government has certain rights, including rights with respect to the allocation of certain of the incremental production capacity associated with such expansion and/or rights in intellectual property produced with its financial assistance. The amount awarded pursuant to these grants in 2021 totaled $568 million and will be paid over periods ranging from one to four years. In 2021, the Company received aggregate payments related to government grants of $73 million that offset operating expenses and capital expenditures of $41 million and $32 million, respectively.",[],"During 2021, certain agencies of the U.S. government, including BARDA, agreed to finance an expansion of production capacity related to chromatography, liquid cell culture media, buffers and cell culture powder media and singleuse consumables at certain of the Company’s Life Sciences businesses and the development of diagnostics testing technologies and the expansion of testing production capacity at certain of the Company’s Diagnostics businesses. The Company’s businesses may enter into similar agreements in the future. In consideration of this financing the U.S. government has certain rights, including rights with respect to the allocation of certain of the incremental production capacity associated with such expansion and/or rights in intellectual property produced with its financial assistance. The amount awarded pursuant to these grants in 2021 totaled $568 million and will be paid over periods ranging from one to four years. In 2021, the Company received aggregate payments related to government grants of $73 million that offset operating expenses and capital expenditures of $41 million and $32 million, respectively.","[0.91, 80.45, 18.64]",positive,"[2.72, 97.24, 0.04]",positive,"[88.38, 9.03, 2.59]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.17,464,"The timing of revenue recognition, billings and cash collections results in billed trade accounts receivable, unbilled receivables (contract assets) and deferred revenue, customer deposits and billings in excess of revenue recognized (contract liabilities) on the Consolidated Balance Sheets. In addition, the Company defers certain costs incurred to obtain a contract (contract costs). Contract assets, liabilities and costs are reported on the accompanying Consolidated Balance Sheets on a contractbycontract basis.","['Contract assets, liabilities and costs are reported on the accompanying Consolidated Balance Sheets on a contractbycontract basis.']","The timing of revenue recognition, billings and cash collections results in billed trade accounts receivable, unbilled receivables (contract assets) and deferred revenue, customer deposits and billings in excess of revenue recognized (contract liabilities) on the Consolidated Balance Sheets. In addition, the Company defers certain costs incurred to obtain a contract (contract costs). <b>Contract assets, liabilities and costs are reported on the accompanying Consolidated Balance Sheets on a contractbycontract basis.[r.1]</b>","[6.02, 91.87, 2.11]",positive,"[99.8, 0.01, 0.19]",neutral,"[83.34, 7.66, 9.0]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.16,82,"The health and wellbeing of our associates has been a key area of focus in our response to the COVID19 pandemic. We launched a global Employee Assistance Program in March 2020 to ensure a consistent support structure for mental health and wellbeing across the Company and have since expanded the program to provide enhanced support with respect to childcare, eldercare and tutoring, among other areas. In the United States, we have provided benefits beyond the requirements of the Families First Act, for example by extending our leave policy to cover elder care and providing for voluntary leaves even in certain circumstances not required by the law. We have also implemented safety precautions on a facility specific basis. The results of our 2021 Associate Engagement Survey questions relating to the pandemic validate the impact of these efforts 87% of surveyed associates believe that associate wellbeing and safety is Danaher’s priority, and 90% of surveyed associates feel supported by their direct supervisor in adapting to changes due to the pandemic.",[],"The health and wellbeing of our associates has been a key area of focus in our response to the COVID19 pandemic. We launched a global Employee Assistance Program in March 2020 to ensure a consistent support structure for mental health and wellbeing across the Company and have since expanded the program to provide enhanced support with respect to childcare, eldercare and tutoring, among other areas. In the United States, we have provided benefits beyond the requirements of the Families First Act, for example by extending our leave policy to cover elder care and providing for voluntary leaves even in certain circumstances not required by the law. We have also implemented safety precautions on a facility specific basis. The results of our 2021 Associate Engagement Survey questions relating to the pandemic validate the impact of these efforts 87% of surveyed associates believe that associate wellbeing and safety is Danaher’s priority, and 90% of surveyed associates feel supported by their direct supervisor in adapting to changes due to the pandemic.","[1.28, 38.05, 60.67]",negative,"[0.11, 99.88, 0.02]",positive,"[37.69, 61.35, 0.96]",positive
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.15,571,"The Company accounts for stockbased compensation by measuring the cost of employee services received in exchange for all equity awards granted based on the fair value of the award as of the grant date. The Company recognizes the compensation expense over the requisite service period (which is generally the vesting period but may be shorter than the vesting period if the employee becomes retirement eligible before the end of the vesting period). The fair value for RSU awards was calculated using the closing price of the Company’s common stock on the date of grant, adjusted for the fact that RSUs do not accrue dividends. The fair value of the PSU awards was calculated using a Monte Carlo pricing model. The fair value of the options granted was calculated using a BlackScholes Merton option pricing model (BlackScholes).",[],"The Company accounts for stockbased compensation by measuring the cost of employee services received in exchange for all equity awards granted based on the fair value of the award as of the grant date. The Company recognizes the compensation expense over the requisite service period (which is generally the vesting period but may be shorter than the vesting period if the employee becomes retirement eligible before the end of the vesting period). The fair value for RSU awards was calculated using the closing price of the Company’s common stock on the date of grant, adjusted for the fact that RSUs do not accrue dividends. The fair value of the PSU awards was calculated using a Monte Carlo pricing model. The fair value of the options granted was calculated using a BlackScholes Merton option pricing model (BlackScholes).","[5.17, 92.4, 2.42]",positive,"[99.99, 0.0, 0.01]",neutral,"[80.62, 11.36, 8.02]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.08,396,"We tested the Company's controls over its accounting for acquisitions, including controls over management’s review of the significant assumptions described above.","[""We tested the Company's controls over its accounting for acquisitions, including controls over management’s review of the significant assumptions described above.""]","<b>We tested the Company's controls over its accounting for acquisitions, including controls over management’s review of the significant assumptions described above.[r.1]</b>","[1.86, 71.85, 26.29]",positive,"[99.99, 0.0, 0.01]",neutral,"[89.27, 3.8, 6.93]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.07,370,"The Company accounts for its investments in the partnerships using the equity method. Accordingly, the investments are initially recorded at cost and adjusted each period for the Company’s share of the partnership’s income or loss and distributions received. The partnerships’ investments are recorded by the partnerships on an estimated fair value basis and pose the same risks and require the same valuation judgments discussed above. As a result, changes in the value of investments in the partnership will have a direct impact on the Company’s earnings. Impairment losses are recognized to reduce the investment’s carrying value to its fair value if there is a decline in fair value below carrying value that is considered to be otherthan temporary. To determine whether there is an otherthantemporary impairment, the Company uses qualitative and quantitative valuation methods.",[],"The Company accounts for its investments in the partnerships using the equity method. Accordingly, the investments are initially recorded at cost and adjusted each period for the Company’s share of the partnership’s income or loss and distributions received. The partnerships’ investments are recorded by the partnerships on an estimated fair value basis and pose the same risks and require the same valuation judgments discussed above. As a result, changes in the value of investments in the partnership will have a direct impact on the Company’s earnings. Impairment losses are recognized to reduce the investment’s carrying value to its fair value if there is a decline in fair value below carrying value that is considered to be otherthan temporary. To determine whether there is an otherthantemporary impairment, the Company uses qualitative and quantitative valuation methods.","[71.52, 26.14, 2.34]",neutral,"[31.05, 0.08, 68.87]",negative,"[62.47, 4.02, 33.51]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.06,415,"Fair Value of Financial Instruments—The Company’s financial instruments consist primarily of cash and cash equivalents, trade accounts receivable, investments in equity securities, availableforsale debt securities and crosscurrency swaps, obligations under trade accounts payable and short and longterm debt. Due to their shortterm nature, the carrying values for cash and cash equivalents, trade accounts receivable and trade accounts payable approximate fair value. Refer to Note 12 for the fair values of the Company’s investments in equity securities, availableforsale debt securities and crosscurrency swaps and other obligations.","['Refer to Note 12 for the fair values of the Company’s investments in equity securities, availableforsale debt securities and crosscurrency swaps and other obligations.']","Fair Value of Financial Instruments—The Company’s financial instruments consist primarily of cash and cash equivalents, trade accounts receivable, investments in equity securities, availableforsale debt securities and crosscurrency swaps, obligations under trade accounts payable and short and longterm debt. Due to their shortterm nature, the carrying values for cash and cash equivalents, trade accounts receivable and trade accounts payable approximate fair value. <b>Refer to Note 12 for the fair values of the Company’s investments in equity securities, availableforsale debt securities and crosscurrency swaps and other obligations.[r.1]</b>","[2.59, 94.65, 2.76]",positive,"[99.99, 0.0, 0.01]",neutral,"[84.67, 7.06, 8.27]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.05,78,"Compensation and Benefits. We are committed to offering competitive compensation and benefits, tailored in form and amount to geography, industry, experience and performance and designed to attract associates, motivate and reward performance, drive growth and support retention. We have a common job architecture across our businesses to provide a standardized framework for defining jobs, job families, and career levels, and set marketaligned pay structures for each career level (adjusted as appropriate for the particular job family, industry, and geography) based on a range of compensation surveys.","['We are committed to offering competitive compensation and benefits, tailored in form and amount to geography, industry, experience and performance and designed to attract associates, motivate and reward performance, drive growth and support retention.']","Compensation and Benefits. <b>We are committed to offering competitive compensation and benefits, tailored in form and amount to geography, industry, experience and performance and designed to attract associates, motivate and reward performance, drive growth and support retention.[r.1]</b> We have a common job architecture across our businesses to provide a standardized framework for defining jobs, job families, and career levels, and set marketaligned pay structures for each career level (adjusted as appropriate for the particular job family, industry, and geography) based on a range of compensation surveys.","[1.22, 88.71, 10.07]",positive,"[73.98, 25.97, 0.06]",neutral,"[30.67, 68.68, 0.66]",positive
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.01,67,"Product Identification—The Company’s product identification business is a leading provider of printers, instruments, software, services and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding and traceability applications for consumer, pharmaceutical and industrial products. Danaher entered the product identification market through the acquisition of Videojet in 2002, and has expanded the product and geographic coverage through various subsequent acquisitions, including the acquisitions of EskoArtwork in 2011 and XRite in 2012. The product identification business designs, manufactures and markets printers, consumables and solutions used to give products unique identities by printing date, lot and bar codes and other information on primary and secondary packaging, applying highquality alphanumeric codes, logos and graphics to a wide range of surfaces at a variety of production line speeds, angles and locations on a product or package. Its vision inspection and trackandtrace solutions also help pharmaceutical and consumer goods manufacturers safeguard the authenticity of their products through supply chains. software for online collaboration, threedimensional virtualization, workflow automation, quality approvals and prepress processes to manage structural design, artwork creation, color and product information for branded packaging and marketing materials. Its packaging solutions help consumer goods manufacturers improve their business processes, shorten time to market and reduce costs across internal departments and external suppliers. innovative color and appearance solutions through standards, software, measurement devices and related services. The business’ expertise in inspiring, virtualizing, selecting, specifying, formulating and measuring color and appearance helps users improve the quality and relevance of their products and reduce costs. flexographic computertoplate imaging equipment, solutions for print process control, press control and quality assurance systems for the packaging, labels and commercial print industries. Its automation, print process and press control solutions help packaging manufacturers reduce lead time and satisfy their customers’ demands for smaller, more frequent print jobs.","['The business’ expertise in inspiring, virtualizing, selecting, specifying, formulating and measuring color and appearance helps users improve the quality and relevance of their products and reduce costs.']","Product Identification—The Company’s product identification business is a leading provider of printers, instruments, software, services and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding and traceability applications for consumer, pharmaceutical and industrial products. Danaher entered the product identification market through the acquisition of Videojet in 2002, and has expanded the product and geographic coverage through various subsequent acquisitions, including the acquisitions of EskoArtwork in 2011 and XRite in 2012. The product identification business designs, manufactures and markets printers, consumables and solutions used to give products unique identities by printing date, lot and bar codes and other information on primary and secondary packaging, applying highquality alphanumeric codes, logos and graphics to a wide range of surfaces at a variety of production line speeds, angles and locations on a product or package. Its vision inspection and trackandtrace solutions also help pharmaceutical and consumer goods manufacturers safeguard the authenticity of their products through supply chains. software for online collaboration, threedimensional virtualization, workflow automation, quality approvals and prepress processes to manage structural design, artwork creation, color and product information for branded packaging and marketing materials. Its packaging solutions help consumer goods manufacturers improve their business processes, shorten time to market and reduce costs across internal departments and external suppliers. innovative color and appearance solutions through standards, software, measurement devices and related services. <b>The business’ expertise in inspiring, virtualizing, selecting, specifying, formulating and measuring color and appearance helps users improve the quality and relevance of their products and reduce costs.[r.1]</b> flexographic computertoplate imaging equipment, solutions for print process control, press control and quality assurance systems for the packaging, labels and commercial print industries. Its automation, print process and press control solutions help packaging manufacturers reduce lead time and satisfy their customers’ demands for smaller, more frequent print jobs.","[1.03, 84.09, 14.88]",positive,"[0.33, 99.65, 0.02]",positive,"[53.43, 45.18, 1.39]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.01,536,"For the years ended December 31, 2021, 2020 and 2019, the Company used an expected longterm rate of return assumption of 6.75%, 7.00%, and 7.00%, respectively, for its U.S. defined benefit pension plan. The Company intends to use an expected longterm rate of return assumption of 6.75% for 2022 for its U.S. plan. This expected rate of return reflects the asset allocation of the plan, and is based primarily on broad, publiclytraded equity and fixedincome indices and forwardlooking estimates of active portfolio and investment management. Longterm rate of return on asset assumptions for the nonU.S. plans were determined on a planbyplan basis based on the composition of assets and ranged from 0.3% to 5.0% in 2021 and 0.5% to 5.0% in 2020, with a weighted average rate of return assumption of 3.3% in 2021 and 3.4% in 2020.",[],"For the years ended December 31, 2021, 2020 and 2019, the Company used an expected longterm rate of return assumption of 6.75%, 7.00%, and 7.00%, respectively, for its U.S. defined benefit pension plan. The Company intends to use an expected longterm rate of return assumption of 6.75% for 2022 for its U.S. plan. This expected rate of return reflects the asset allocation of the plan, and is based primarily on broad, publiclytraded equity and fixedincome indices and forwardlooking estimates of active portfolio and investment management. Longterm rate of return on asset assumptions for the nonU.S. plans were determined on a planbyplan basis based on the composition of assets and ranged from 0.3% to 5.0% in 2021 and 0.5% to 5.0% in 2020, with a weighted average rate of return assumption of 3.3% in 2021 and 3.4% in 2020.","[3.28, 93.88, 2.84]",positive,"[99.99, 0.01, 0.01]",neutral,"[89.13, 8.47, 2.4]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",73.01,453,"In connection with the Envista IPO and Separation, Danaher and Envista entered into various agreements to effect the disposition and provide a framework for their relationship after the Envista Separation, including a separation agreement, transition services agreement, employee matters agreement, tax matters agreement, intellectual property matters agreement and DANAHER BUSINESS SYSTEM (DBS) license agreement. These agreements provide for the allocation between Danaher and Envista of assets, employees, liabilities and obligations (including investments, property and employee benefits and tax related assets and liabilities) attributable to periods prior to, at and after Envista’s separation from Danaher and govern certain relationships between Danaher and Envista after the Envista Separation. In addition, Danaher is also party to various commercial agreements with Envista entities. The amounts paid and received by Danaher for transition services provided under the above agreements as well as sales and purchases to and from Envista were not material to the Company’s results of operations for the years ended December 31, 2021, 2020 and 2019.",[],"In connection with the Envista IPO and Separation, Danaher and Envista entered into various agreements to effect the disposition and provide a framework for their relationship after the Envista Separation, including a separation agreement, transition services agreement, employee matters agreement, tax matters agreement, intellectual property matters agreement and DANAHER BUSINESS SYSTEM (DBS) license agreement. These agreements provide for the allocation between Danaher and Envista of assets, employees, liabilities and obligations (including investments, property and employee benefits and tax related assets and liabilities) attributable to periods prior to, at and after Envista’s separation from Danaher and govern certain relationships between Danaher and Envista after the Envista Separation. In addition, Danaher is also party to various commercial agreements with Envista entities. The amounts paid and received by Danaher for transition services provided under the above agreements as well as sales and purchases to and from Envista were not material to the Company’s results of operations for the years ended December 31, 2021, 2020 and 2019.","[1.9, 95.14, 2.96]",positive,"[99.99, 0.01, 0.01]",neutral,"[84.51, 4.1, 11.4]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",72.96,557,"The Company’s Restated Certificate of Incorporation requires it to indemnify to the full extent authorized or permitted by law any person made, or threatened to be made a party to any action or proceeding by reason of his or her service as a director or officer of the Company, or by reason of serving at the request of the Company as a director or officer of any other entity, subject to limited exceptions. Danaher’s Amended and Restated By laws provide for similar indemnification rights. In addition, Danaher has executed with each director and executive officer of Danaher Corporation an indemnification agreement which provides for substantially similar indemnification rights and under which Danaher has agreed to pay expenses in advance of the final disposition of any such indemnifiable proceeding. While the Company maintains insurance for this type of liability, a significant deductible applies to this coverage and any such liability could exceed the amount of the insurance coverage.",[],"The Company’s Restated Certificate of Incorporation requires it to indemnify to the full extent authorized or permitted by law any person made, or threatened to be made a party to any action or proceeding by reason of his or her service as a director or officer of the Company, or by reason of serving at the request of the Company as a director or officer of any other entity, subject to limited exceptions. Danaher’s Amended and Restated By laws provide for similar indemnification rights. In addition, Danaher has executed with each director and executive officer of Danaher Corporation an indemnification agreement which provides for substantially similar indemnification rights and under which Danaher has agreed to pay expenses in advance of the final disposition of any such indemnifiable proceeding. While the Company maintains insurance for this type of liability, a significant deductible applies to this coverage and any such liability could exceed the amount of the insurance coverage.","[2.11, 93.59, 4.3]",positive,"[99.99, 0.01, 0.01]",neutral,"[87.09, 5.39, 7.52]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",72.95,348,"The Company declared a regular quarterly dividend of $0.21 per share of Company common stock that was paid on January 28, 2022 to holders of record on December 30, 2021. In addition, the Company declared quarterly cash dividends of $11.875 per MCPS Series A and $12.50 per MCPS Series B that were paid on January 15, 2022 to holders of record as of December 31, 2021. Aggregate 2021 and 2020 cash payments for dividends on Company common stock were $578 million and $500 million, respectively, and aggregate 2021 and 2020 cash payments for the dividends on the Company’s MCPS were $164 million and $115 million, respectively. The yearoveryear increase in dividend payments in 2021 primarily relates to dividends paid on the MCPS Series B, which were issued in May 2020, and an increase in the quarterly dividend rate on common stock effective with respect to the dividend paid in the second quarter of 2021.","['The Company declared a regular quarterly dividend of $0.21 per share of Company common stock that was paid on January 28, 2022 to holders of record on December 30, 2021.']","<b>The Company declared a regular quarterly dividend of $0.21 per share of Company common stock that was paid on January 28, 2022 to holders of record on December 30, 2021.[r.1]</b> In addition, the Company declared quarterly cash dividends of $11.875 per MCPS Series A and $12.50 per MCPS Series B that were paid on January 15, 2022 to holders of record as of December 31, 2021. Aggregate 2021 and 2020 cash payments for dividends on Company common stock were $578 million and $500 million, respectively, and aggregate 2021 and 2020 cash payments for the dividends on the Company’s MCPS were $164 million and $115 million, respectively. The yearoveryear increase in dividend payments in 2021 primarily relates to dividends paid on the MCPS Series B, which were issued in May 2020, and an increase in the quarterly dividend rate on common stock effective with respect to the dividend paid in the second quarter of 2021.","[2.56, 66.07, 31.36]",positive,"[90.64, 9.31, 0.05]",neutral,"[90.43, 6.47, 3.1]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",72.93,270,"As noted above, beginning with results for the second quarter of 2020, the Company also presents core sales on a basis that includes Cytiva sales. Prior to the acquisition of Cytiva, Danaher calculated core sales solely on a basis that excluded sales from acquired businesses recorded prior to the first anniversary of the acquisition. However, given Cytiva’s significant size and historical core sales growth rate, in each case compared to Danaher’s existing businesses, management believes it is appropriate to also present core sales on a basis that includes Cytiva sales. Management believes this presentation provides useful information to investors by demonstrating beginning immediately after the acquisition Cytiva’s impact on the Company’s growth profile, rather than waiting to demonstrate such impact until 12 months after the acquisition when Cytiva would normally have been included in Danaher’s core sales calculation. Danaher calculates periodtoperiod core sales growth including Cytiva by adding Cytiva sales to core sales for both the baseline and current periods. Beginning in the second quarter of 2021, Cytiva sales are included in core sales, and therefore the measure core sales including Cytiva is no longer provided for quarterly periods beginning with the second quarter of 2021.",[],"As noted above, beginning with results for the second quarter of 2020, the Company also presents core sales on a basis that includes Cytiva sales. Prior to the acquisition of Cytiva, Danaher calculated core sales solely on a basis that excluded sales from acquired businesses recorded prior to the first anniversary of the acquisition. However, given Cytiva’s significant size and historical core sales growth rate, in each case compared to Danaher’s existing businesses, management believes it is appropriate to also present core sales on a basis that includes Cytiva sales. Management believes this presentation provides useful information to investors by demonstrating beginning immediately after the acquisition Cytiva’s impact on the Company’s growth profile, rather than waiting to demonstrate such impact until 12 months after the acquisition when Cytiva would normally have been included in Danaher’s core sales calculation. Danaher calculates periodtoperiod core sales growth including Cytiva by adding Cytiva sales to core sales for both the baseline and current periods. Beginning in the second quarter of 2021, Cytiva sales are included in core sales, and therefore the measure core sales including Cytiva is no longer provided for quarterly periods beginning with the second quarter of 2021.","[1.55, 92.29, 6.17]",positive,"[99.86, 0.13, 0.01]",neutral,"[63.54, 34.13, 2.33]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",72.93,523,"The Company also uses crosscurrency swap derivative contracts to hedge U.S. dollardenominated longterm debt issuances in a foreign subsidiary whose functional currency is the euro against adverse movements in exchange rates between the U.S. dollar and the euro. These contracts effectively convert these U.S. dollardenominated bonds to obligations denominated in euro. The changes in the fair value of these instruments are recorded in accumulated other comprehensive income (loss) in stockholders’ equity, with a reclassification from accumulated other comprehensive income (loss) to net earnings to offset the remeasurement of the hedged debt that is also recorded in net earnings. Any ineffective portions of the cash flow hedges are reclassified from accumulated other comprehensive income (loss) into earnings during the period of change. The interest income or expense from these swaps are recorded in interest expense in the accompanying Consolidated Statements of Earnings consistent with the classification of interest expense attributable to the underlying debt. These instruments mature on dates ranging from November 2022 to November 2049.","['The changes in the fair value of these instruments are recorded in accumulated other comprehensive income (loss) in stockholders’ equity, with a reclassification from accumulated other comprehensive income (loss) to net earnings to offset the remeasurement of the hedged debt that is also recorded in net earnings.']","The Company also uses crosscurrency swap derivative contracts to hedge U.S. dollardenominated longterm debt issuances in a foreign subsidiary whose functional currency is the euro against adverse movements in exchange rates between the U.S. dollar and the euro. These contracts effectively convert these U.S. dollardenominated bonds to obligations denominated in euro. <b>The changes in the fair value of these instruments are recorded in accumulated other comprehensive income (loss) in stockholders’ equity, with a reclassification from accumulated other comprehensive income (loss) to net earnings to offset the remeasurement of the hedged debt that is also recorded in net earnings.[r.1]</b> Any ineffective portions of the cash flow hedges are reclassified from accumulated other comprehensive income (loss) into earnings during the period of change. The interest income or expense from these swaps are recorded in interest expense in the accompanying Consolidated Statements of Earnings consistent with the classification of interest expense attributable to the underlying debt. These instruments mature on dates ranging from November 2022 to November 2049.","[4.17, 93.15, 2.68]",positive,"[99.99, 0.01, 0.01]",neutral,"[83.59, 4.36, 12.05]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",72.92,555,"The Company has recorded a provision for environmental investigation and remediation and environmentalrelated claims with respect to sites owned or formerly owned by the Company and its subsidiaries and thirdparty sites where the Company has been determined to be a potentially responsible party. The Company generally makes an assessment of the costs involved for its remediation efforts based on environmental studies, as well as its prior experience with similar sites. The ultimate cost of site cleanup is difficult to predict given the uncertainties of the Company’s involvement in certain sites, uncertainties regarding the extent of the required cleanup, the availability of alternative cleanup methods, variations in the interpretation of applicable laws and regulations, the possibility of insurance recoveries with respect to certain sites and the fact that imposition of joint and several liability with right of contribution is possible under the Comprehensive Environmental Response, Compensation and Liability Act of 1980 and other environmental laws and regulations. If the Company determines that potential liability for a particular site or with respect to a personal injury claim is known or considered probable and reasonably estimable, the Company accrues the total estimated loss, including investigation and remediation costs, associated with the site or claim. As of December 31, 2021, the Company had a reserve of $181 million for environmental matters which are known or considered probable and reasonably estimable (of which $143 million are noncurrent), which reflects the Company’s best estimate of the costs to be incurred with respect to such matters.",['The Company has recorded a provision for environmental investigation and remediation and environmentalrelated claims with respect to sites owned or formerly owned by the Company and its subsidiaries and thirdparty sites where the Company has been determined to be a potentially responsible party.'],"<b>The Company has recorded a provision for environmental investigation and remediation and environmentalrelated claims with respect to sites owned or formerly owned by the Company and its subsidiaries and thirdparty sites where the Company has been determined to be a potentially responsible party.[r.1]</b> The Company generally makes an assessment of the costs involved for its remediation efforts based on environmental studies, as well as its prior experience with similar sites. The ultimate cost of site cleanup is difficult to predict given the uncertainties of the Company’s involvement in certain sites, uncertainties regarding the extent of the required cleanup, the availability of alternative cleanup methods, variations in the interpretation of applicable laws and regulations, the possibility of insurance recoveries with respect to certain sites and the fact that imposition of joint and several liability with right of contribution is possible under the Comprehensive Environmental Response, Compensation and Liability Act of 1980 and other environmental laws and regulations. If the Company determines that potential liability for a particular site or with respect to a personal injury claim is known or considered probable and reasonably estimable, the Company accrues the total estimated loss, including investigation and remediation costs, associated with the site or claim. As of December 31, 2021, the Company had a reserve of $181 million for environmental matters which are known or considered probable and reasonably estimable (of which $143 million are noncurrent), which reflects the Company’s best estimate of the costs to be incurred with respect to such matters.","[17.79, 79.8, 2.41]",positive,"[99.98, 0.0, 0.01]",neutral,"[67.25, 4.73, 28.02]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",72.92,338,"For a discussion of the Company’s 2021 and 2020 acquisitions and divestitures refer to —Overview and Note 2 to the Consolidated Financial Statements. In addition, in 2021 and 2020, the Company invested $934 million and $342 million, respectively, in nonmarketable equity securities and partnerships.",['For a discussion of the Company’s 2021 and 2020 acquisitions and divestitures refer to —Overview and Note 2 to the Consolidated Financial Statements.'],"<b>For a discussion of the Company’s 2021 and 2020 acquisitions and divestitures refer to —Overview and Note 2 to the Consolidated Financial Statements.[r.1]</b> In addition, in 2021 and 2020, the Company invested $934 million and $342 million, respectively, in nonmarketable equity securities and partnerships.","[1.31, 93.27, 5.42]",positive,"[99.99, 0.0, 0.01]",neutral,"[90.29, 7.89, 1.82]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",72.91,180,"These risks are particularly pronounced in countries in which we do business that do not have levels of protection of corporate proprietary information, intellectual property, technology and other assets comparable to the United States. The risks we encounter in such countries include but are not limited to the following Joint ventures that we participate in can include restrictions that could compromise our control over the intellectual property, technology and proprietary information of the joint venture As we expand our operations globally, increasing amounts of our data, intellectual property and technology is used and stored in countries outside the United States, and regulations in certain countries require data to be stored locally. These factors increase the risk that such data, intellectual property and technology could be stolen or otherwise compromised Certain of our products have been counterfeited and we may encounter additional and/or increased levels of counterfeiting in the future Governmental entities may adopt regulations or other requirements that give them rights to certain of our intellectual property, technology and/or proprietary information, such as through compulsory licensing or ownership restrictions or requirements In certain countries, we do not have the same ability to enforce intellectual property rights as we do in the U.S.",[],"These risks are particularly pronounced in countries in which we do business that do not have levels of protection of corporate proprietary information, intellectual property, technology and other assets comparable to the United States. The risks we encounter in such countries include but are not limited to the following Joint ventures that we participate in can include restrictions that could compromise our control over the intellectual property, technology and proprietary information of the joint venture As we expand our operations globally, increasing amounts of our data, intellectual property and technology is used and stored in countries outside the United States, and regulations in certain countries require data to be stored locally. These factors increase the risk that such data, intellectual property and technology could be stolen or otherwise compromised Certain of our products have been counterfeited and we may encounter additional and/or increased levels of counterfeiting in the future Governmental entities may adopt regulations or other requirements that give them rights to certain of our intellectual property, technology and/or proprietary information, such as through compulsory licensing or ownership restrictions or requirements In certain countries, we do not have the same ability to enforce intellectual property rights as we do in the U.S.","[36.05, 61.08, 2.86]",positive,"[7.14, 0.14, 92.72]",negative,"[30.83, 1.53, 67.64]",negative
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",72.91,562,"On March 1, 2019, the Company completed the underwritten public offering of 12.1 million shares of Danaher common stock at a price to the public of $123.00 per share (the 2019 Common Stock Offering), resulting in net proceeds of approximately $1.4 billion, after deducting expenses and the underwriters’ discount of $45 million. Simultaneously, the Company completed the underwritten public offering of 1.65 million shares of its 4.75% MCPS Series A, without par value and with a liquidation preference of $1,000 per share (the 2019 MCPS Offering), resulting in net proceeds of approximately $1.6 billion, after deducting expenses and the underwriters’ discount of $50 million. The Company used the net proceeds from the 2019 Common Stock Offering and the 2019 MCPS Offering to fund a portion of the cash consideration payable for, and certain costs associated with, the Cytiva Acquisition. Prior to the completion of the Cytiva Acquisition, the Company invested the net proceeds in shortterm bank deposits and/or interestbearing, investmentgrade securities.",[],"On March 1, 2019, the Company completed the underwritten public offering of 12.1 million shares of Danaher common stock at a price to the public of $123.00 per share (the 2019 Common Stock Offering), resulting in net proceeds of approximately $1.4 billion, after deducting expenses and the underwriters’ discount of $45 million. Simultaneously, the Company completed the underwritten public offering of 1.65 million shares of its 4.75% MCPS Series A, without par value and with a liquidation preference of $1,000 per share (the 2019 MCPS Offering), resulting in net proceeds of approximately $1.6 billion, after deducting expenses and the underwriters’ discount of $50 million. The Company used the net proceeds from the 2019 Common Stock Offering and the 2019 MCPS Offering to fund a portion of the cash consideration payable for, and certain costs associated with, the Cytiva Acquisition. Prior to the completion of the Cytiva Acquisition, the Company invested the net proceeds in shortterm bank deposits and/or interestbearing, investmentgrade securities.","[2.65, 94.02, 3.33]",positive,"[99.99, 0.01, 0.01]",neutral,"[90.11, 7.16, 2.73]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",72.8,200,"In addition, the amount of income taxes we pay is subject to ongoing audits by U.S. federal, state and local tax authorities and by nonU.S. tax authorities, such as the audits described in MD&A and the Company’s Consolidated Financial Statements. If audits result in payments or assessments different from our reserves, our results can be adversely affected. Any further changes to the tax system in the United States or in other jurisdictions (including changes in the taxation of nonU.S. income as further described below) could also adversely affect our financial statements.",[],"In addition, the amount of income taxes we pay is subject to ongoing audits by U.S. federal, state and local tax authorities and by nonU.S. tax authorities, such as the audits described in MD&A and the Company’s Consolidated Financial Statements. If audits result in payments or assessments different from our reserves, our results can be adversely affected. Any further changes to the tax system in the United States or in other jurisdictions (including changes in the taxation of nonU.S. income as further described below) could also adversely affect our financial statements.","[54.86, 42.85, 2.28]",neutral,"[2.53, 0.07, 97.4]",negative,"[35.91, 1.43, 62.65]",negative
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",72.8,361,"If actual results are not consistent with management’s estimates and assumptions, goodwill and other intangible assets may be overstated and a charge would need to be taken against net earnings which would adversely affect the Company’s financial statements. Historically, the Company’s estimates of goodwill and intangible assets have been materially correct.","['If actual results are not consistent with management’s estimates and assumptions, goodwill and other intangible assets may be overstated and a charge would need to be taken against net earnings which would adversely affect the Company’s financial statements.']","<b>If actual results are not consistent with management’s estimates and assumptions, goodwill and other intangible assets may be overstated and a charge would need to be taken against net earnings which would adversely affect the Company’s financial statements.[r.1]</b> Historically, the Company’s estimates of goodwill and intangible assets have been materially correct.","[90.12, 8.02, 1.86]",neutral,"[0.81, 0.05, 99.13]",negative,"[36.66, 2.62, 60.71]",negative
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",72.79,596,The information required by this Item is incorporated by reference from the section entitled Proposal 2–Ratification of Independent Registered Public Accounting Firm in the Proxy Statement for the Company’s 2022 annual meeting of shareholders.,['The information required by this Item is incorporated by reference from the section entitled Proposal 2–Ratification of Independent Registered Public Accounting Firm in the Proxy Statement for the Company’s 2022 annual meeting of shareholders.'],<b>The information required by this Item is incorporated by reference from the section entitled Proposal 2–Ratification of Independent Registered Public Accounting Firm in the Proxy Statement for the Company’s 2022 annual meeting of shareholders.[r.1]</b>,"[1.65, 95.2, 3.15]",positive,"[99.99, 0.0, 0.01]",neutral,"[93.59, 3.56, 2.85]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",72.78,129,"Our businesses operate in industries that are intensely competitive and have been subject to increasing consolidation. Because of the range of the products and services we sell and the variety of markets we serve, we encounter a wide variety of competitors refer to Item 1. Business— Competition for additional details. In order to compete effectively, we must retain longstanding relationships with major customers and continue to grow our business by establishing relationships with new customers, continually developing new products and services to maintain and expand our brand recognition and leadership position in various product and service categories and penetrating new markets, including highgrowth markets. Our ability to compete can also be impacted by changing customer preferences and requirements (for example increased demand for products incorporating digital capabilities or more environmentallyfriendly products and supplier practices) as well as changes in the way healthcare services are delivered (including the movement of some care from acute to nonacute settings and increased focus on chronic disease management). Cost containment efforts by governments and the private sector, particularly in the healthcare industry, are also resulting in increased emphasis on products that reduce costs and improve efficiency and effectiveness. In addition, significant shifts in industry market share have occurred and may in the future occur in connection with product problems, safety alerts and publications about products, reflecting the competitive significance of product quality, product efficacy and quality systems in our industry. Our failure to compete effectively and/or pricing pressures resulting from competition may adversely impact our business and financial statements, and our expansion into new markets may result in greaterthanexpected risks, liabilities and expenses. In addition, the Company’s competitors and customers have from time to time introduced, and may in the future introduce, private label, generic or lowcost products that compete with the Company’s products at lower price points. Competitors’ products can capture significant market share or lead to a decrease in market prices overall, resulting in an adverse effect on the Company’s business and financial statements.","['Cost containment efforts by governments and the private sector, particularly in the healthcare industry, are also resulting in increased emphasis on products that reduce costs and improve efficiency and effectiveness.']","Our businesses operate in industries that are intensely competitive and have been subject to increasing consolidation. Because of the range of the products and services we sell and the variety of markets we serve, we encounter a wide variety of competitors refer to Item 1. Business— Competition for additional details. In order to compete effectively, we must retain longstanding relationships with major customers and continue to grow our business by establishing relationships with new customers, continually developing new products and services to maintain and expand our brand recognition and leadership position in various product and service categories and penetrating new markets, including highgrowth markets. Our ability to compete can also be impacted by changing customer preferences and requirements (for example increased demand for products incorporating digital capabilities or more environmentallyfriendly products and supplier practices) as well as changes in the way healthcare services are delivered (including the movement of some care from acute to nonacute settings and increased focus on chronic disease management). <b>Cost containment efforts by governments and the private sector, particularly in the healthcare industry, are also resulting in increased emphasis on products that reduce costs and improve efficiency and effectiveness.[r.1]</b> In addition, significant shifts in industry market share have occurred and may in the future occur in connection with product problems, safety alerts and publications about products, reflecting the competitive significance of product quality, product efficacy and quality systems in our industry. Our failure to compete effectively and/or pricing pressures resulting from competition may adversely impact our business and financial statements, and our expansion into new markets may result in greaterthanexpected risks, liabilities and expenses. In addition, the Company’s competitors and customers have from time to time introduced, and may in the future introduce, private label, generic or lowcost products that compete with the Company’s products at lower price points. Competitors’ products can capture significant market share or lead to a decrease in market prices overall, resulting in an adverse effect on the Company’s business and financial statements.","[76.9, 16.46, 6.64]",neutral,"[2.14, 92.37, 5.49]",positive,"[63.83, 13.12, 23.05]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",72.77,564,"Holders of MCPS Shares will be entitled to receive, when and if declared by the Company’s Board of Directors, cumulative dividends at the applicable Annual Cumulative Dividend Rate of the Liquidation Preference per share, payable in cash or, subject to certain limitations, by delivery of shares of the Company’s common stock or any combination of cash and shares of the Company’s common stock, at the Company’s election. If declared, dividends on the MCPS Shares are payable quarterly on January 15, April 15, July 15 and October 15 of each year (to, and including, the Mandatory Conversion Date), to the holders of record of the MCPS Shares as they appear on the Company’s stock register at the close of business on the immediately preceding December 31, March 31, June 30 and September 30, respectively.","['Holders of MCPS Shares will be entitled to receive, when and if declared by the Company’s Board of Directors, cumulative dividends at the applicable Annual Cumulative Dividend Rate of the Liquidation Preference per share, payable in cash or, subject to certain limitations, by delivery of shares of the Company’s common stock or any combination of cash and shares of the Company’s common stock, at the Company’s election.']","<b>Holders of MCPS Shares will be entitled to receive, when and if declared by the Company’s Board of Directors, cumulative dividends at the applicable Annual Cumulative Dividend Rate of the Liquidation Preference per share, payable in cash or, subject to certain limitations, by delivery of shares of the Company’s common stock or any combination of cash and shares of the Company’s common stock, at the Company’s election.[r.1]</b> If declared, dividends on the MCPS Shares are payable quarterly on January 15, April 15, July 15 and October 15 of each year (to, and including, the Mandatory Conversion Date), to the holders of record of the MCPS Shares as they appear on the Company’s stock register at the close of business on the immediately preceding December 31, March 31, June 30 and September 30, respectively.","[3.26, 94.69, 2.05]",positive,"[99.99, 0.0, 0.01]",neutral,"[93.65, 3.96, 2.39]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",72.73,559,"On July 16, 2013, the Company’s Board of Directors approved a repurchase program (the Repurchase Program) authorizing the repurchase of up to 20 million shares of the Company’s common stock from time to time on the open market or in privately negotiated transactions. There is no expiration date for the Repurchase Program, and the timing and amount of any shares repurchased under the program will be determined by the Company’s management based on its evaluation of market conditions and other factors. The Repurchase Program may be suspended or discontinued at any time. Any repurchased shares will be available for use in connection with the Company’s equity compensation plans (or any successor plan) and for other corporate purposes. As of December 31, 2021, 20 million shares remained available for repurchase pursuant to the Repurchase Program. The Company expects to fund any future stock repurchases using the Company’s available cash balances or proceeds from the issuance of debt.","['Any repurchased shares will be available for use in connection with the Company’s equity compensation plans (or any successor plan) and for other corporate purposes.', 'On July 16, 2013, the Company’s Board of Directors approved a repurchase program (the Repurchase Program) authorizing the repurchase of up to 20 million shares of the Company’s common stock from time to time on the open market or in privately negotiated transactions.']","<b>On July 16, 2013, the Company’s Board of Directors approved a repurchase program (the Repurchase Program) authorizing the repurchase of up to 20 million shares of the Company’s common stock from time to time on the open market or in privately negotiated transactions.[r.2]</b> There is no expiration date for the Repurchase Program, and the timing and amount of any shares repurchased under the program will be determined by the Company’s management based on its evaluation of market conditions and other factors. The Repurchase Program may be suspended or discontinued at any time. <b>Any repurchased shares will be available for use in connection with the Company’s equity compensation plans (or any successor plan) and for other corporate purposes.[r.1]</b> As of December 31, 2021, 20 million shares remained available for repurchase pursuant to the Repurchase Program. The Company expects to fund any future stock repurchases using the Company’s available cash balances or proceeds from the issuance of debt.","[10.01, 88.17, 1.83]",positive,"[99.98, 0.01, 0.01]",neutral,"[88.98, 8.9, 2.12]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",72.69,483,"The Company disaggregates the service cost component of net periodic benefit costs of noncontributory defined benefit pension plans and other postretirement employee benefit plans and presents the other components of net periodic benefit cost in other income (expense), net. These other components of net period benefit costs include the assumed rate of return on plan assets, partially offset by amortization of actuarial losses and interest. The Company’s net periodic pension cost for the year ended December 31, 2019 includes a settlement loss of $7 million ($6 million after tax) as a result of the transfer of a portion of its nonU.S. pension liabilities related to one defined benefit plan to a thirdparty.","['The Company disaggregates the service cost component of net periodic benefit costs of noncontributory defined benefit pension plans and other postretirement employee benefit plans and presents the other components of net periodic benefit cost in other income (expense), net.']","<b>The Company disaggregates the service cost component of net periodic benefit costs of noncontributory defined benefit pension plans and other postretirement employee benefit plans and presents the other components of net periodic benefit cost in other income (expense), net.[r.1]</b> These other components of net period benefit costs include the assumed rate of return on plan assets, partially offset by amortization of actuarial losses and interest. The Company’s net periodic pension cost for the year ended December 31, 2019 includes a settlement loss of $7 million ($6 million after tax) as a result of the transfer of a portion of its nonU.S. pension liabilities related to one defined benefit plan to a thirdparty.","[43.79, 53.66, 2.55]",positive,"[99.98, 0.01, 0.01]",neutral,"[50.94, 3.03, 46.03]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",72.67,280,"The acquisitions of Cytiva on March 31, 2020 (the Cytiva Acquisition) and Aldevron on August 30, 2021 have provided, and are expected to continue to provide, additional sales and earnings growth opportunities for the Company’s Life Sciences segment by expanding the business’ geographic and product line diversity, including new product and service offerings that complement the Company’s bioprocessing workflow and genomic medicine solutions. In 2021, Cytiva experienced significant increased yearoveryear demand across all major geographies, driven by continued strong demand for instruments and consumables used in the research and development and production of COVID19 related treatments and vaccines and increased demand for nonCOVID 19 related products as well as by the completion of a major project in China. Since acquisition, Aldevron has seen sales growth in all major product lines compared to the prior year period.",[],"The acquisitions of Cytiva on March 31, 2020 (the Cytiva Acquisition) and Aldevron on August 30, 2021 have provided, and are expected to continue to provide, additional sales and earnings growth opportunities for the Company’s Life Sciences segment by expanding the business’ geographic and product line diversity, including new product and service offerings that complement the Company’s bioprocessing workflow and genomic medicine solutions. In 2021, Cytiva experienced significant increased yearoveryear demand across all major geographies, driven by continued strong demand for instruments and consumables used in the research and development and production of COVID19 related treatments and vaccines and increased demand for nonCOVID 19 related products as well as by the completion of a major project in China. Since acquisition, Aldevron has seen sales growth in all major product lines compared to the prior year period.","[1.35, 3.41, 95.24]",negative,"[0.01, 99.97, 0.02]",positive,"[19.88, 79.91, 0.21]",positive
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",72.6,44,"Filtration—The filtration, separation and purification technologies business is a leading provider of products used to remove solid, liquid and gaseous contaminants from a variety of liquids and gases, primarily through the sale of filtration consumables and to a lesser extent systems that incorporate filtration consumables and associated hardware. The business’ core materials and technologies can be applied in many ways to solve complex fluid separation challenges, and are sold across a wide array of applications in two primary business groups Life Sciences. The business’ life sciences technologies facilitate the process of drug discovery, development, regulatory validation and production and are sold to biopharmaceutical and medical customers. In the biopharmaceutical area, the business sells a broad line of filtration and purification technologies, single use bioreactors and associated accessories, hardware and engineered systems primarily to pharmaceutical and biopharmaceutical companies for use in the development and commercialization of chemically synthesized and biologically derived drugs, plasma and vaccines. Biotechnology drugs, plasma and biologically derived vaccines in particular are filtration and purification intensive and represent a significant opportunity for growth for the business in the biopharmaceutical area. In the medical area, hospitals use the Company’s breathing circuit and intravenous filters and water filters to help control the spread of infections.",[],"Filtration—The filtration, separation and purification technologies business is a leading provider of products used to remove solid, liquid and gaseous contaminants from a variety of liquids and gases, primarily through the sale of filtration consumables and to a lesser extent systems that incorporate filtration consumables and associated hardware. The business’ core materials and technologies can be applied in many ways to solve complex fluid separation challenges, and are sold across a wide array of applications in two primary business groups Life Sciences. The business’ life sciences technologies facilitate the process of drug discovery, development, regulatory validation and production and are sold to biopharmaceutical and medical customers. In the biopharmaceutical area, the business sells a broad line of filtration and purification technologies, single use bioreactors and associated accessories, hardware and engineered systems primarily to pharmaceutical and biopharmaceutical companies for use in the development and commercialization of chemically synthesized and biologically derived drugs, plasma and vaccines. Biotechnology drugs, plasma and biologically derived vaccines in particular are filtration and purification intensive and represent a significant opportunity for growth for the business in the biopharmaceutical area. In the medical area, hospitals use the Company’s breathing circuit and intravenous filters and water filters to help control the spread of infections.","[1.21, 92.69, 6.09]",positive,"[99.87, 0.12, 0.01]",neutral,"[39.69, 59.65, 0.65]",positive
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",72.6,344,"Refer to Note 14 to the Consolidated Financial Statements for additional information regarding the Company’s financing activities and indebtedness, including the Company’s outstanding debt as of December 31, 2021, and the Company’s commercial paper program and FiveYear Facility.","['Refer to Note 14 to the Consolidated Financial Statements for additional information regarding the Company’s financing activities and indebtedness, including the Company’s outstanding debt as of December 31, 2021, and the Company’s commercial paper program and FiveYear Facility.']","<b>Refer to Note 14 to the Consolidated Financial Statements for additional information regarding the Company’s financing activities and indebtedness, including the Company’s outstanding debt as of December 31, 2021, and the Company’s commercial paper program and FiveYear Facility.[r.1]</b>","[1.98, 94.55, 3.47]",positive,"[99.99, 0.0, 0.01]",neutral,"[92.06, 2.3, 5.64]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",72.58,580,"In connection with the exercise of certain stock options and the vesting of RSUs previously issued by the Company, a number of shares sufficient to fund statutory minimum tax withholding requirements has been withheld from the total shares issued or released to the award holder (though under the terms of the applicable plan, the shares are considered to have been issued and are not added back to the pool of shares available for grant). During the year ended December 31, 2021, 346 thousand shares with an aggregate value of $81 million were withheld to satisfy the requirement. During the year ended December 31, 2020, 352 thousand shares with an aggregate value of $58 million were withheld to satisfy the requirement. The withholding is treated as a reduction in additional paidin capital in the accompanying Consolidated Statements of Stockholders’ Equity and a reduction in proceeds from the issuance of common stock in connection with stockbased compensation in the Consolidated Statements of Cash Flows.",['The withholding is treated as a reduction in additional paidin capital in the accompanying Consolidated Statements of Stockholders’ Equity and a reduction in proceeds from the issuance of common stock in connection with stockbased compensation in the Consolidated Statements of Cash Flows.'],"In connection with the exercise of certain stock options and the vesting of RSUs previously issued by the Company, a number of shares sufficient to fund statutory minimum tax withholding requirements has been withheld from the total shares issued or released to the award holder (though under the terms of the applicable plan, the shares are considered to have been issued and are not added back to the pool of shares available for grant). During the year ended December 31, 2021, 346 thousand shares with an aggregate value of $81 million were withheld to satisfy the requirement. During the year ended December 31, 2020, 352 thousand shares with an aggregate value of $58 million were withheld to satisfy the requirement. <b>The withholding is treated as a reduction in additional paidin capital in the accompanying Consolidated Statements of Stockholders’ Equity and a reduction in proceeds from the issuance of common stock in connection with stockbased compensation in the Consolidated Statements of Cash Flows.[r.1]</b>","[10.85, 86.76, 2.39]",positive,"[99.72, 0.01, 0.27]",neutral,"[75.21, 2.94, 21.85]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",72.57,256,"As a result of the Company’s geographic and industry diversity, the Company faces a variety of opportunities and challenges, including rapid technological development (particularly with respect to computing, automation, artificial intelligence, mobile connectivity, communications and digitization) in most of the Company’s served markets, the expansion and evolution of opportunities in highgrowth markets, trends and costs associated with a global labor force, consolidation of the Company’s competitors and increasing regulation. The Company operates in a highly competitive business environment in most markets, and the Company’s longterm growth and profitability will depend in particular on its ability to expand its business in highgrowth geographies and highgrowth market segments, identify, consummate and integrate appropriate acquisitions and identify and consummate appropriate investments and strategic partnerships, develop innovative and differentiated new products and services with higher gross profit margins, expand and improve the effectiveness of the Company’s sales force, continue to reduce costs and improve operating efficiency and quality, and effectively address the demands of an increasingly regulated global environment. The Company is making significant investments, organically and through acquisitions and investments, to address the rapid pace of technological change in its served markets and to globalize its manufacturing, research and development and customerfacing resources (particularly in highgrowth markets) in order to be responsive to the Company’s customers throughout the world and improve the efficiency of the Company’s operations.","['The Company operates in a highly competitive business environment in most markets, and the Company’s longterm growth and profitability will depend in particular on its ability to expand its business in highgrowth geographies and highgrowth market segments, identify, consummate and integrate appropriate acquisitions and identify and consummate appropriate investments and strategic partnerships, develop innovative and differentiated new products and services with higher gross profit margins, expand and improve the effectiveness of the Company’s sales force, continue to reduce costs and improve operating efficiency and quality, and effectively address the demands of an increasingly regulated global environment.', 'The Company is making significant investments, organically and through acquisitions and investments, to address the rapid pace of technological change in its served markets and to globalize its manufacturing, research and development and customerfacing resources (particularly in highgrowth markets) in order to be responsive to the Company’s customers throughout the world and improve the efficiency of the Company’s operations.']","As a result of the Company’s geographic and industry diversity, the Company faces a variety of opportunities and challenges, including rapid technological development (particularly with respect to computing, automation, artificial intelligence, mobile connectivity, communications and digitization) in most of the Company’s served markets, the expansion and evolution of opportunities in highgrowth markets, trends and costs associated with a global labor force, consolidation of the Company’s competitors and increasing regulation. <b>The Company operates in a highly competitive business environment in most markets, and the Company’s longterm growth and profitability will depend in particular on its ability to expand its business in highgrowth geographies and highgrowth market segments, identify, consummate and integrate appropriate acquisitions and identify and consummate appropriate investments and strategic partnerships, develop innovative and differentiated new products and services with higher gross profit margins, expand and improve the effectiveness of the Company’s sales force, continue to reduce costs and improve operating efficiency and quality, and effectively address the demands of an increasingly regulated global environment.[r.1]</b> <b>The Company is making significant investments, organically and through acquisitions and investments, to address the rapid pace of technological change in its served markets and to globalize its manufacturing, research and development and customerfacing resources (particularly in highgrowth markets) in order to be responsive to the Company’s customers throughout the world and improve the efficiency of the Company’s operations.[r.2]</b>","[0.93, 18.27, 80.8]",negative,"[0.03, 99.95, 0.02]",positive,"[41.88, 56.9, 1.22]",positive
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",72.55,368,"Investments in earlystage companies have significant risks, including uncertainty regarding the investee company’s ability to successfully develop new technologies and services, bring these new technologies and services to market and gain market acceptance, maintain adequate capitalization and access to cash or other forms of liquidity, and retain critical management personnel. Refer to Item 1A. Risk Factors for a further discussion of the risks related to investing in earlystage companies.",[],"Investments in earlystage companies have significant risks, including uncertainty regarding the investee company’s ability to successfully develop new technologies and services, bring these new technologies and services to market and gain market acceptance, maintain adequate capitalization and access to cash or other forms of liquidity, and retain critical management personnel. Refer to Item 1A. Risk Factors for a further discussion of the risks related to investing in earlystage companies.","[1.79, 88.32, 9.89]",positive,"[3.38, 0.09, 96.52]",negative,"[53.62, 5.17, 41.21]",neutral
"Governance. CSR strategy. Management. Shareholders. ESG reporting and transparency. Structure (independence, diversity, committees). Compensation. Shareholder rights. Takeover defenses",72.55,329,"Net cash used in investing activities consisted primarily of cash paid for acquisitions, capital expenditures and investments, net of proceeds from the sale of investments, and decreased primarily as a result of lower cash paid for acquisitions in 2021 compared to 2020. Refer to Notes 2 and 12 to the Consolidated Financial Statements included in this Annual Report for a discussion of the Company’s acquisitions and investments.",['Refer to Notes 2 and 12 to the Consolidated Financial Statements included in this Annual Report for a discussion of the Company’s acquisitions and investments.'],"Net cash used in investing activities consisted primarily of cash paid for acquisitions, capital expenditures and investments, net of proceeds from the sale of investments, and decreased primarily as a result of lower cash paid for acquisitions in 2021 compared to 2020. <b>Refer to Notes 2 and 12 to the Consolidated Financial Statements included in this Annual Report for a discussion of the Company’s acquisitions and investments.[r.1]</b>","[42.58, 53.31, 4.12]",positive,"[0.17, 0.05, 99.78]",negative,"[70.18, 5.11, 24.7]",neutral
,-1.0,18,,,,,,,,,
,-1.0,73,,,,,,,,,
,-1.0,90,,,,,,,,,
,-1.0,104,,,,,,,,,
,-1.0,112,,,,,,,,,
,-1.0,140,,,,,,,,,
,-1.0,148,,,,,,,,,
,-1.0,175,,,,,,,,,
